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The prevalence of chiral amines in pharmaceutical compounds means that efficient 
synthetic methods are highly desirable. Asymmetric catalysis offers the opportunity for 
enantioselective synthesis of chiral amines under milder reaction conditions. Chemical and 
biological catalysts both offer specific advantages and disadvantages that are different to 
the other catalyst type. Therefore, the combination of catalysts would allow for the 
advantages of each to be exploited, whilst overcoming the associated disadvantages.  
This research investigates the combination of chemical and biological catalysts for the 
production of chiral amines and essential medicines using continuous reactors. Continuous 
reactors are increasingly seen as a method to improve synthesis routes due to their 
improved productivity and safety compared to batch reactors. In addition to continuous 
reactors, immobilised catalysts and design of experiments (DoE) strategies were employed 
for the development of optimised procedures. 
Firstly, the enzymatic kinetic resolution of a chiral primary amine was studied in a 
continuous packed bed reactor (PBR) using an immobilised lipase enzyme. Optimum 
reaction conditions were determined using a one variable at a time (OVAT) approach to 
give the maximum 50% conversion with high product ee in only a 6 min residence time 
(tRes). The PBR system was then applied to an expanded substrate set, including chiral 
amines and alcohols, to act as a comparison to the standard amine. 
Secondly, metal catalysed racemisation was investigated as a method to utilise the waste 
enantiomer from the enzymatic resolution in a dynamic kinetic resolution process (DKR). 
Homogeneous and heterogeneous Ir, Ru and Pd catalysts were tested for the amine 
racemisation step. However, the amount of racemisation observed was not sufficient and 
uncontrolled dimerisation primarily occurred.  
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Next, the enzymatic PBR was applied to the production of essential medicines via 
enzymatic ammoniolysis. The development of cheaper more efficient methods to produce 
essential medicines is vital to make them more affordable and accessible to the developing 
world. In this instance, the reaction conditions were optimised using DoE with the 
objective being to maximise conversion. Nicotinamide and pyrazinamide were produced in 
94% and 100% yields with a tRes of 60 min and 20 min, respectively. The ammoniolysis 
of a chiral substrate was also tested; however, this was not successful using the 
experimental conditions described. 
Finally, metal catalysed N-alkylation using Ir was investigated for the N-alkylation of the 
chiral primary amine as an alternative method to utilise the waste enantiomer from the 
continuous resolution. DoE and microwave heating techniques were employed to optimise 
the reaction conditions and reduce the amount of waste associated with development. In 
this example, the formation of un-desired dimeric products was problematic and so the 
optimisation objectives were both maximum conversion and maximum selectivity for the 
desired product. 
Overall, the transferal of processes into continuous PBR and optimisation techniques 
allowed for the intensification of reaction conditions, which led to more productive, 
efficient routes. However, the difficulties in combining chemical and biological catalysts 
were also highlighted when the combination of reactions was attempted. 
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Chiral amines are prevalent moieties in pharmaceutical molecules, with over 40% of active 






Figure 1. APIs containing chiral amine moieties. 
 
The two enantiomers of a chiral molecule can have different modes of action within the 
body due to the interaction with proteins and enzyme active sites. Enzyme active sites also 
have chiral structures and so each enantiomer of a chiral molecule will bind to the active 
site in a different orientation which can lead to different responses within the body. This 
difference in biological activity means that strict requirements from regulatory bodies are 
in place to fully characterise the mode of action of both enantiomers and to produce single 
enantiomer drugs of very high enantiopurity.
2
 Despite this high demand for single 
enantiomer chiral amines, industrially viable methods for the production of chiral amines 
are still limited.  
The development of a novel pharmaceutical molecule is usually unrestricted by the cost of 
each synthetic step due to the high return provided by a patent protected monopoly of the 
product. However drugs that are no longer protected by a patent do not generate as high a 
25 
 
revenue because of the loss of exclusivity to generic suppliers. Therefore, processes to 
make generic drugs must be stream-lined and cost-effective. Novel processes, 
intensification of reaction conditions, reactor design and optimisation methods present an 
opportunity to develop efficient cost-effective pharmaceutical manufacturing processes in 
both novel and generic pharmaceutical development. 
Catalysis is one of the 12 principles of green chemistry, used as a method to reduce the 
amount of waste associated with chemical manufacturing processes.
3, 4
 Catalysts improve 
the efficiency of reactions, allow less harsh reaction conditions to be used, and reduce the 
amount of waste by removing the need for stoichiometric reagents. Catalysts can be used 
to produce chiral amines via asymmetric synthesis or resolution methodologies.
2
 In 
asymmetric synthesis, chirality is introduced into a prochiral centre using chiral catalysts 
and auxiliaries. Resolution methods involve the separation of the individual enantiomers 
from a racemic mixture and can be carried out by diastereomeric crystallisation or 
enzymatically. Chemical and biological methods for the production of chiral amines will 
now be discussed. 
 
1.1 Asymmetric Synthesis of Chiral Amines 
Primary, secondary and tertiary amines can be produced using chemical catalysis by 
asymmetric reduction, hydrogenation or transfer hydrogenation of imines or reductive 
amination of ketones. Asymmetric reduction methods using borane, silanes or other 
stoichiometric hydrides are not used in industry due to their cost, reactivity and associated 






1.1.1 Asymmetric Hydrogenation of Imines and Enamines 
Asymmetric hydrogenation involves the addition of H2 to an unsaturated system to 
generate a saturated chiral product. A chiral catalyst is employed to induce 
stereoselectivity in the reaction. The first examples of catalytic asymmetric hydrogenation 
were developed independently by Noyori and Knowles. Noyori developed Ru catalysts 
with BINAP and diamine ligands for the asymmetric hydrogenation of ketones to produce 
chiral alcohols (Scheme 1).
6
 Initially the reaction using BINAP ligands required 
functionalised ketone substrates to act as directing groups. This was later improved upon 




Scheme 1. Noyori’s Ru catalysed asymmetric hydrogenation of ketones. (A): Ru-BINAP 
catalyst for the hydrogenation of functionalised ketones; (B): Ru-BINAP-diamine catalyst 




Knowles developed the asymmetric hydrogenation of an enamide for the production of L-
DOPA 12, a treatment for Parkinson’s disease (Scheme 2).
9, 10
 In this reaction enamide 10 
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was hydrogenated using a Rh catalyst to give the chiral amide product 11 in 95% ee, 
cleavage of the amide then yielded the L-DOPA target 12. In 2001, Noyori and Knowles 















 to produce chiral amines have been developed, primarily using Ir, Ru or Rh 
catalysts (Scheme 3). 
 
Scheme 3. General reaction scheme for the asymmetric hydrogenation of imines, enamines 




Using H2 gas in this approach can be considered as a green route to chiral amines because 
there are no by-products. However, there are significant hazards and costs associated with 
the use of H2 gas due to its explosive nature and the need for pressure reactors. 
 
1.1.2 Asymmetric Transfer Hydrogenation 
Asymmetric transfer hydrogenation (ATH)
15
 was later developed in which a hydrogen 
donor molecule (H-donor) is used as the hydrogen source, removing the need for 
potentially explosive H2 gas and expensive pressure reactors. In this case, the hydrogen is 
transferred from the H-donor to the substrate via the chiral catalyst. A major development 
in the area was the use of N-tosyl-1,2-diphenylethylenediamine (TsDPEN) ligands by 
Noyori and Ikariya, which were used for the ATH of ketones.
16, 17
 The Noyori catalyst 
structures are based on a Ru centre with an arene ligand and bidentate diamine ligands 










Isopropanol (iPrOH, 18) is often used as the as the H-donor, however, the reaction is 
reversible due to the acetone by-product. In the reverse reaction acetone can accept 
hydrogen from the amine, re-forming the imine (Scheme 5). The equilibrium can be shifted 
29 
 
in favour of product formation by using iPrOH as the reaction solvent or by removing the 
acetone as it is formed. In the latter case, removing acetone efficiently requires high mass 
transfer rates that can be achieved by applying vacuum distillation to a batch reactor,
20
 or 




Scheme 5. Reversibility of imine reduction in the presence of iPrOH 18. 
 
To overcome the problems associated with using iPrOH, a triethylamine/formic acid 
(TEAF) mixture has also been used as H-donor.
23, 24
 A 5:2 (formic acid:triethylamine) 
molar, single phase, azeotropic mixture is frequently used along with a suitable organic 
solvent. In this case the reaction is irreversible due to the loss of CO2 (Scheme 6). 
 
 
Scheme 6. Irreversibility of imine reduction in the presence of formic acid. 
 
The majority of examples are for the ATH of ketones, although some examples of imine 
ATH to produce chiral amines have been reported. The ATH of imines has mainly been 
applied to cyclic substrates, as this infers greater stability on the imine. Noyori et al. 
reported on the ATH of imines with the [TsDPEN-RuCl(ƞ
6
-arene)] catalysts using TEAF.
24
 
Reduction of the imine 24 to salsolidine 25 was found to be most efficient using a 5:2 
TEAF mixture in MeCN with (S,S)-[TsDPEN-RuCl(p-cymene)] 26  at 28 °C, providing > 





Scheme 7. Asymmetric reduction of 6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline 24 
with (S,S)-[TsDPEN-RuCl(p-cymene)] 26, 5:2 TEAF in MeCN at 28 °C.
24 
 
In this study, the hydrogenation of acyclic imines was also carried out (Scheme 8). 
However, the reactions were lower yielding and showed lower selectivity than the 





Scheme 8. ATH of an acyclic imine using (S,S)-[TsDPEN-RuCl(ƞ
6
-benzene)] 29, TEAF 
3:2 in DCM at 28 °C.
24 
 
ATH of imines has been employed for the synthesis of the tetrahydroisoquinoline core unit 
of almorexant 32 (Scheme 9), an orexin receptor antagonist.
25
 Screening of reactions 
conditions led to a reaction system using the Noyori (R,R)-[TsDPEN-RuCl(p-cymene)] 
31 
 
catalyst 26, TEAF 1:1 in DCM. On a 9 g scale, these conditions gave 99% conversion and 
89% ee after 20 h, Scheme 9. 
 





The reaction was scaled up to 18 and 12 kg batches and compared to an initial 
hydrogenation route using an Ir/TaniaPhos catalyst.
25
 The fixed costs for the two routes 
were the same because the ATH can be run at a higher concentration, despite having a 
longer reaction time. Less waste was produced for the hydrogenation route compared to 
ATH. However, the ATH route had an overall lower cost due to the catalyst prices and had 
greater flexibility because the reaction could be carried out in any standard reactor whereas 
the hydrogenation required a pressure reactor.
  
ATH reactions have also been carried out under aqueous conditions, using HCOONa /H2O 
as the H-donor system.
19, 26, 27
 The ability of these catalysts to work in the presence of 
water was a significant step forward in the drive towards greener and cheaper chemistry. 
 
1.1.3 Hydrogen Borrowing 
The N-alkylation of amines via metal catalysed hydrogen borrowing has recently been 
developed as a method for the production of secondary and tertiary amines. Hydrogen 
borrowing involves the transfer of H2 from the substrate to the metal catalyst and then the 
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H2 is given back to the reagent to form the product. Unlike ATH, where H2 is transferred 
from a H-donor to the substrate via the metal catalyst, hydrogen borrowing does not 
require an additional H-donor. Hydrogen borrowing can be employed for the coupling of 
an amine and an alcohol or the coupling of two amines (Scheme 10). Each process results 
in an N-alkylated amine product of a higher order than the substrate. This method has the 
advantage that the only by-product is H2O when using alcohols or NH3 when coupling 
amines. 
 
Scheme 10. Hydrogen borrowing mechanism for the N-alkylation of amines: (A) coupling 
of amines and alcohols,
28




Fujita et al. reported the N-alkylation of primary amines with alcohols using the 
[Cp*IrCl2]2 catalyst (Scheme 11).
30
 The reaction of aniline with benzyl alcohol gave a 
yield of 88% of only the mono-alkylated product. A range of Ir catalysts were tested, all of 
which had lower activity than [Cp*IrCl2]2. The system was applied to a range of amines 
33 
 
and primary and secondary alcohols, with good yields for all and high selectivity for the 
mono-alkylated product. 
 




Saidi et al. employed the [Cp*IrI2]2 catalyst for the N-alkylation of amines using alcohols 
in H2O by the hydrogen borrowing approach.
28
 The reaction of 1-phenylethylamine 36 
with propan-1-ol using 1 mol% catalyst in water gave the secondary amine, with 96% 
conversion in 6 h (Scheme 12). When the reaction was carried out in H2O, additives were 
not required to activate the catalyst and the addition of K2CO3, which is typically used to 
activate the catalyst, actually caused a reduction in the conversion. Also, no product 
formation was observed when using the analogous [Ru(p-cymene)Cl2]2 catalyst. 
 




The transition metal catalysed coupling of two amines has often been shown to lead to a 
mixture of products due to the ability of both of the amines to undergo oxidation and so 
coupling can occur between two molecules of the same type of amine. Bähn et al. 
presented the first selective N-alkylation of amines using the Ru Shvö catalyst 42 for the 





 The reaction was selective for one product because only the 
aliphatic amine was able to undergo oxidation, which limits the breadth of its application. 
 
 
Scheme 13. N-alkylation of tert-octylamine 40 with 2-phenethylamine 39 using the Shvö 




Saidi et al. reported on the first examples of selective cross-coupling of amines via the 
hydrogen borrowing mechanism using the [Cp*IrI2]2 catalyst when both of the amines 
were able to undergo oxidation.
29
 The N-alkylation of 4-methoxyaniline 43 was used to 
screen the amines that could act as alkyl donors, with 1 mol% [Cp*IrI2]2 in xylene at 155 
°C for 10 h (Scheme 14). 
 
 
Scheme 14. N-alkylation of 4-methoxyaniline 43 with a range of amine donors using the 






Whilst the dehydrogenation step to produce the imine intermediate would result in a loss of 
chirality, Zhang et al. reported a method to introduce enantiopurity into the product by 
using an asymmetric hydrogenation catalyst with the addition of chiral phosphoric acids 
(Scheme 15).
32
 Using this approach, they were able to couple racemic alcohols with non-
chiral primary amines to generate chiral secondary amines with moderate to high 
enantioselectivities (70-97% ee). 
 




These hydrogen borrowing procedures have thus far been carried out at high temperatures 
over long reaction times with high catalyst loadings, making them energy intensive and 
costly. Whilst high temperatures are required for activity, optimisation of the reaction 
conditions may allow the reaction times to be shortened, making a more efficient process. 
  
1.1.4 Bio-Catalysis 
The biocatalytic synthesis of chiral amines can be achieved using imine reductase, 
monoamine oxidase, amine dehydrogenase and transaminase enzymes.
1
 The uniquely high 
36 
 
selectivity of enzymes under mild reaction conditions makes them a very attractive option 
for industrial asymmetric synthesis. Enzymes are also seen as a greener alternative to 
traditional chemical synthesis because there is no demand for precious metals. Conversely, 
enzymes can be sensitive to reaction conditions and have a narrow substrate scope. This 
can be improved through directed mutation and as such there are examples of commercial 
enzymes that can tolerate organic solvents and higher temperatures. In addition, some 
enzymes are cofactor dependent and so require either stoichiometric addition of expensive 
cofactors or additional reagents to be able to recycle the cofactor in situ, such as glucose or 
formate, which generates a significant amount of waste. 
 
1.1.4.1 Enzymatic Asymmetric Reduction of Imines using Imine Reductase 
Imine reductase (IRED) enzymes provide a biologically catalysed route for the synthesis of 
enantiopure amines via the asymmetric reduction of imines (Scheme 16).  
 
Scheme 16. General reaction scheme for imine reductase catalysed chiral amine 
production. 
 
Leipold et al. reported the asymmetric reduction of imines using (S)-IRED from 
Streptomyces sp. GF3546.
33
 The isolated (S)-IRED enzyme was used to convert 2-methyl-
1-pyrroline 51 into 2-methylpyrrolidine 52 (55% conversion and > 95% ee after 18 h), 
using NADPH as the cofactor (Scheme 17). This system was applied to cyclic imine and 
iminium substrates with 5-, 6- and 7-membered rings. The catalytic activity was found to 









A whole cell system was then developed, in which resting E. coli cells overexpressing (S)-
IRED were used to catalyse the reaction (Scheme 18).
33
 The whole cell system allowed for 
the addition of glucose to recycle the cofactor, without the need for the addition of a 
second enzyme to recycle the glucose. The whole cell system was applied to substituted 
dihydroisoquinolines and substituted dihydro-β-carbolines. The system was able to reduce 
5-, 6- and 7-membered cyclic imines as well as iminium ions with 50 – 98% conversion 
and >98% ee for all substrates.  
 
 




The IRED system requires a stable imine substrate. The production of the imines is 
problematic as only cyclic imines are stable enough to resist hydrolysis for reasonable 




1.1.4.2 Enzymatic Asymmetric Oxidation of Amines using Monoamine Oxidase 
Monoamine oxidase (MAO) enzymes catalyse the oxidation of amines to imines under 
mild conditions (Scheme 19A) and they have also been employed for the deracemisation of 





Scheme 19. General reaction scheme for monoamine oxidase catalysed reactions: (A) 
Amine oxidation for imine production; (B) Deracemisation for single enantiomer amine 
production. 
 
Turner et al. subjected monoamine oxidase from Aspergillus niger (MAO-N) to directed 
evolution to create libraries of mutant strains to increase the substrate scope as the wild 
type enzyme had high activity but was only active for a narrow range of achiral 
substrates.
34, 35
 This led to the D5 mutant strain that exhibited activity towards a broad 
range of chiral substrates, with (S)-selectivity. The same group then reported a method for 
the oxidation of substituted pyrrolidines using this MAO-N D5 variant (Scheme 20A).
36
 
The oxidation of the prochiral pyrrolidine 55 (20 mM) was carried out using E. coli cells 
expressing MAO-N in aqueous phosphate buffer (100 mM). The product imine 56 was 
obtained in 77% yield and 94% ee. The imine 56 was then reacted with TMS-CN to make 
a secondary amino nitrile, with a diastereomeric ratio of 97:3 (Scheme 20B). Hydrolysis of 






Scheme 20. (A) Oxidation of pyrrolidine using MAO-N D5 variant, cofactor recycling 
using O2; (B) Asymmetric synthesis of amino acid via oxidation with MAO-N D5 and 




MAO-N derivatives have been used in manufacturing processes. Merck utilised MAO-N 
for the production of the bicyclic [3.1.0]proline intermediate of the hepatitis C drug 










A process was sought by which the imine 61 could be prepared directly from 
dimethylcyclopropylproline 60 via desymmetrisation. A MAO-N catalysed 
desymmetrisation was developed (Scheme 21). Enzyme optimisation was carried out on 
MAO-N through mutation to provide increased activity and thermal stability in comparison 
to the wild type enzyme. Downstream imine trapping reactions gave the desired salt of the 














As mentioned above, MAO can also be used to obtain single enantiomer chiral amines 
through deracemisation. Ghislieri et al. reported the deracemisation of tetrahydro-β-
carbolines, important bioactive alkaloids, using MAO-N variants (Scheme 22 A).
38
 The 
MAO-N enzyme catalysed the enantioselective oxidation of chiral amines to convert one 
enantiomer into an imine, whilst leaving the opposite enantiomer untouched (Scheme 
22B). The nonselective reducing agent ammonia-borane was used to regenerate the 
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racemic amine by reduction of the imine. The opposite amine enantiomer accumulates 
through multiple cycles, leading to deracemisation of the amine sample and so an increase 





Scheme 22. (A) MAO-N D9 and D11 mediated deracemisation of β-carbolines; (B) 
Catalytic cycle for the deracemisation of chiral amines via the combination of 




This method employed borane as the chemical reductant, which is air and moisture 
sensitive, highly toxic, potentially explosive, and atom inefficient. Therefore, this method 
would not be desirable for use on-scale in industry. 
 
1.1.4.3 Enzymatic Reductive Amination of Ketones using Amine Dehydrogenase 
Amine dehydrogenase (AmDH) enzymes present a route to chiral amines through the 




Scheme 23. General reaction scheme for amine dehydrogenase (AmDH) catalysed chiral 
amine production. 
 
Abrahamson et al. produced an AmDH from an amino acid dehydrogenase via protein 
engineering for use in the synthesis of chiral amines.
39
 The substrate for the wild-type 
leucine dehydrogenase (LeuDH) was the α-keto acid, which reacted to give leucine. The 
AmDH that was developed accepted the related methyl isobutyl ketone, to give the 
corresponding chiral amine (Scheme 24). 
  
 





AmDH are NADH dependent enzymes and so it was coupled to a glucose dehydrogenase 
enzyme for cofactor recycling (Scheme 25). The deamination of (R)- and (S)-1-
phenylethylamine was used to determine the enantioselectivity of the AmDH, which was 
found to maintain the (S)-selectivity of the wild-type enzyme. The engineered AmDH was 




Scheme 25. Asymmetric synthesis of amines via amine dehydrogenase, coupled to glucose 




1.1.4.4 Enzymatic Chiral Amine Synthesis using Transaminases 
Transaminase enzymes can be used for the asymmetric synthesis of chiral amines from 
ketones, via the transfer of an amino group from a donor molecule (Scheme 26).  
 
 
Scheme 26. General reaction scheme for transaminase catalysed chiral amine production. 
 
Most notably, Merck employed a transaminase in the penultimate step towards the 
synthesis of the anti-diabetic drug sitagliptin 3 (Januvia, Scheme 27).
40
 In the original 
chemical synthesis route, ketone 73 was first converted to an enamine, followed by Rh 
catalysed asymmetric hydrogenation to give 3.  In the biocatalytic route, the chiral amine 
could be produced directly from ketone 73 using the transaminase. The implementation of 
a biocatalytic approach reduced the number of steps in the synthesis but also improved the 
44 
 
stereoselectivity and reduced the amount of purification that was required because there 
was no longer any Rh in the process waste. 
 
 
Scheme 27. Merck synthesis of sitagliptin 3, employing a transaminase to install the 




Transaminase enzymes can also be used for the kinetic resolution of racemic amines, 
which requires an amine acceptor, typically pyruvate. Pyruvate is required in a 
stoichiometric amount, which is expensive and can also lead to inhibition of the reaction.
41
 
To overcome this, Truppo et al. reported the kinetic resolution of racemic amines via a 
transaminase coupled to an amino acid oxidase (AAO) (Scheme 28A).
41
 The combination 
with an AAO allowed for a catalytic amount of pyruvate to be used as the AAO catalysed 
the regeneration of pyruvate from alanine. The kinetic resolution of 1-phenylethylamine 
was carried out using both the (R)- and (S)-selective transaminases to yield > 99% ee at 
50% conversion in both cases. The system was applied to a range of amine substrates, all 
with the same efficiency. The (S)-selective transaminase was also shown to be able to 
prepare both the (R)- and (S)-enantiomers in > 99% ee, by kinetic resolution and 
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asymmetric synthesis, respectively. The (S)-enantiomers were prepared by the combination 
of the transaminase with lactate dehydrogenase, using L-alanine as the amine donor 
(Scheme 28B). The driving force for the reaction was the reduction of the pyruvate by-
product to lactate by the lactate dehydrogenase. The NADH cofactor required for this 
reaction was recycled by glucose dehydrogenase.  
 
Scheme 28. (A) Kinetic resolution of racemic amines using a transaminase coupled to an 






The production of chiral amines using resolution methodologies involves the separation of 
enantiomers from a racemic mixture that has been created by traditional non-asymmetric 
synthesis. Resolution can be carried out by diastereomeric crystallisation or enzymatically. 
46 
 
Chiral chromatography can be used to separate enantiomers, but is generally a laboratory 
analytical technique so will not be discussed further. 
 
1.2.1 Diastereomeric Crystallisation 
In diastereomeric crystallisation enantiomers are separated by the formation of a 
diastereomeric salt between the chiral amine and a chiral carboxylic acid (Scheme 29).
2, 42
 
One of the diastereomeric salts will then crystallise out of solution, whilst the other 
remains in solution. This difference in solubility allows the two amine enantiomers to be 
separated from each other. 
 
Scheme 29. General reaction scheme for diastereomeric crystallisation of chiral amines. 
 
Diastereomeric crystallisation of a pharmaceutically relevant amine molecule was reported 
by Blacker et al. for the production of single-isomer Sertraline 81, an API for the treatment 
of depression (Scheme 30).
43, 44
 The (1S,4S)-isomer was selected for from a mixture of four 
isomers using (R)-mandelic acid 82 (99% ee). The crystallisation was coupled to a 





Scheme 30. Separation of the isomers of Sertraline 81 via diastereomeric crystallisation, 




Resolution by diastereomeric crystallisation allows for the separation of enantiomers by 
the simple formation of salts, which also means that after the separation the single 
enantiomer amine can be readily obtained from the salt by extraction methods. However, it 
can be difficult to predict which chiral acid and solvent system will be required for a 
particular amine and so a degree of trial and error has to be employed, which can be time 
and resource consuming. Also, the crystallisation process alone is highly wasteful because 
of the leftover undesired enantiomer. This can be improved by coupling to recycling 
procedures as in the sertraline example.
43
 Further procedures for recycling the remaining 
enantiomers from resolution procedures will be discussed later. 
 
1.2.2 Enzymatic Kinetic Resolution 
Enzymatic kinetic resolution uses an enzyme to selectively modify one of the enantiomers 
in a racemic mixture, allowing them to be separated. The most common type of enzymes 
used for this strategy are lipases.
45, 46
 The lipase uses an acyl donor to acylate amine and as 
only one enantiomer is accepted into the enzyme active site, only one product enantiomer 
is formed (Scheme 31). In order for the method to succeed a highly selective enzyme must 
be used to ensure that the rate of acylation of one enantiomer (k1) is much greater than the 




Scheme 31. General reaction scheme for enzymatic kinetic resolution. 
  
The lipase catalysed resolution of chiral amines was first studied by Kitaguchi et al., 
employing the enzyme Subtilisin.
47
 More recently, lipase B from Candida antarctica 
(CalB) has been widely employed for kinetic resolution due to its broad substrate 
specificity and tolerance of temperature and organic solvents. The most common primary 
amine studied for enzymatic resolution is 1-phenylethylamine 36, due to its value in 
asymmetric synthesis.
48, 49
 The development of a commercially available immobilised 
version of the CalB lipase (Novozyme 435, N435)
50
 has led to an increased popularity due 
improved stability and ease of re-use. The first example of the resolution of primary 
amines using N435 with EtOAc as the acyl donor was developed by Reetz (Scheme 32).
51
 
However, conversions were variable and reaction times were long (7 – 60 h). 
 
Scheme 32. Enzymatic resolution of 1-phenylethylamine 36 catalysed by immobilised 






For the kinetic resolution of alcohols, acyl donors such as vinyl acetate are often used. 
However, these donors could not be used for amines due to their higher reactivity that 
leads to un-catalysed background reaction, EtOAc is often used instead.
52
 The reactions 
using EtOAc are highly enantioselective, however the products of these reactions are 
amides, which require harsh conditions to cleave the bond and regenerate the single 
enantiomer amine.
53
 Hoben et al. improved on this by using dibenzyl carbonate 87 as the 




Scheme 33. Lipase catalysed resolution of 1-phenylethylamine 36 using dibenzyl 




There are far fewer examples of lipase catalysed resolution of secondary amines due to the 
lower number of enzymes that will accept these substrates. This is because the extra steric 
bulk on the amine makes it more difficult to fit into the active site.
53
 Breen developed a 
process for the resolution of secondary amines using a carbonate donor and lipase from 
Candida rugosa (Scheme 34).
55
 After 8 h, 47% yield of carbamate 91 was produced, with 









Enzymatic resolution is a well-documented method to obtain chiral amines with high 
enantiopurity and the development of robust enzymes, with increased stability and good 
tolerance of organic solvents, has led to the use of enzymatic resolution in the 
pharmaceutical industry.
2
 However, the resolution approach is inherently wasteful as only 
one enantiomer is generally desired for the API. This means that the maximum possible 
yield is 50% for a resolution process, with the remaining undesired enantiomer being 
waste, unless the resolution can be coupled to another reaction to use the waste enantiomer, 
which will be discussed in the following sections. 
 
1.3 Racemisation 
The racemisation of amines provides an opportunity to recycle the waste enantiomer 
leftover from the resolution process. A classical method employed is base catalysed 
racemisation, in which the substrate is deprotonated at the chiral centre by the base. 
Transfer of the proton back to the substrate gives the racemic molecule. This method 
suffers from a limited substrate scope due to the requirement for a labile proton and as such 
most amines are not suitable for this approach.
56, 57
  
An increasingly popular method is metal catalysed racemisation. In this approach the 
enantiopure amine is first dehydrogenated by the metal catalyst to generate an imine 
intermediate (Scheme 35); this imine can then be re-hydrogenated to regenerate the amine. 
51 
 
The catalysts used are not chiral, so do not favour a particular prochiral face of the imine 
for the re-hydrogenation step, and therefore produce a racemic amine. 
 
 
Scheme 35. Generic reaction scheme for metal catalysed racemisation of amines. 
 
Murahashi et al. first showed that Pd black could be used to racemise amines.
58
 Reetz et al. 
then built upon this by using Pd/C to racemise 1-phenylethylamine.
59
 Using heterogeneous 
Pd catalysts for the racemisation of amines led to the formation of impurities, namely 
ethylbenzene and dimeric impurities. The proposed mechanism for their production is 
shown in Scheme 36.
60
 First, H2 is removed from the single enantiomer substrate to 
generate the imine 92. This imine can then either be re-hydrogenated to give the racemic 
amine or condense with a second amine molecule, producing an imine dimer 93. 
Hydrogenation of the imine dimer then leads to the amine dimer 94. The ethylbenzene 
impurity 95 was formed by hydrogenation and cleavage of the amine dimer, to regenerate 










Parvulescu et al. found that Pd on alkaline-earth supports such as BaSO4 and CaCO3 
suppressed by-product formation, owing to the basic nature of the support.
60
 This group 
also employed microwave heating to enhance the racemisation of chiral amines and 
increase the selectivity for the desired product using these heterogeneous Pd catalysts.
61
 
However, a drawback of this Pd catalysed racemisation is that it is only suitable for 
benzylic substrates. Parvulescu et al. then developed a process to racemise both benzylic 
and aliphatic amines using heterogeneous Raney Ni (RaNi) as a cheaper alternative to 
precious metal catalysts.
62
 These Pd and RaNi catalysts all required H2 gas to be able to 
perform the racemisation and so would require pressure vessels, which can be problematic 
on a laboratory scale. 
The Bäckvall group established a process for the racemisation of chiral alcohols using the 
Ru Shvö catalyst 42,
63, 64
 and then developed modified versions of this catalyst for the 





 Whilst high selectivity for the racemisation of the amine monomer was achieved 
vs. the dimer formation, long reaction times were typically required (24 h). 
 
 
Scheme 37. Ru catalysed primary amine racemisation using modified Shvö catalyst 96, 




Blacker et al. utilised the [Cp*IrI2]2 catalyst for the racemisation of 6,7-dimethoxy-1-
methyl-1,2,3,4-tetrahydroisoquinoline 25 (Scheme 38).
57
 This catalyst provided much 
shorter reaction times and milder reaction conditions, with 25 being racemised after only 2 
h at 40 °C. 
 
 
Scheme 38. Ir catalysed racemisation of 6,7-dimethoxy-1-methyl-1,2,3,4-




In the same study, a range of other chiral amines were shown to racemise with the 
[Cp*IrI2]2 catalyst. It was found that this catalyst was particularly useful for the 
racemisation of secondary amines, whilst primary amines were again shown to form 
54 
 
dimeric products due to the reactivity of the intermediate imine species 92 (Scheme 39). 
Higher temperatures and catalyst loadings were also required for the majority of substrates. 
 




1.4 Dynamic Kinetic Resolution 
Chemical and biological catalysts both have advantages and disadvantages. Metal catalysts 
tend to have a wide substrate scope and high activity but are not always as highly enantio- 
and regioselective as enzymes due to coordination of species within the reaction system. 
As discussed above, biological catalysts have high enantio- and regioselectivities and 
function under milder aqueous conditions however, the substrate scope is often very 
narrow and the stability in organic solvents and at high temperatures can be poor. The 
combination of catalysts would allow for the advantages of each catalyst to be exploited. 
Tandem processes in which multiple catalytic steps occur in one-pot are an attractive route 
for synthesis as the number of purification steps would be reduced, the selectivity and 
substrate scope would be improved and the reactivity enhanced, all of which would lead to 





One of the most common techniques for the combination of enzymes and metal catalysts is 
dynamic kinetic resolution (DKR),
46
 in which enzymatic resolution is coupled to an in situ 
racemisation (Scheme 40). This is an improvement on the classical method of resolution 
described above, which has a theoretical maximum yield of 50% and so is highly wasteful. 
DKR increases the maximum theoretical yield to 100% as the undesired enantiomer is 
converted back to the racemic compound to undergo further enzymatic resolution. As 
previously discussed, to obtain the (S)-Ac product the rate of reaction of the (S)-amine with 
the enzyme must be faster than for the (R)-amine (k1 > k2). For DKR to be successful, the 
rate of racemisation must also be faster, to rapidly convert the (R)-amine to the (S)-amine; 
krac > k2. 
 
Scheme 40. DKR process for obtaining enantiomerically pure amines. 
 
A recent review by Verho et al. highlights the DKR process for both alcohol and amines 
and describes the greater difficulties associated with amine substrates compared to 
alcohols.
53
 Specifically, fewer examples of efficient racemisation methodologies exist for 
amines due to the ability of the amines themselves to act as ligands for the catalysts, 
leading to catalyst deactivation or the need for higher temperatures to break this 
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coordination and re-activate the catalyst. However, amine racemisation in DKR has been 
successfully carried out using Pd, Ru and Ir catalysts and selected examples are described 
below. 
The first example of amine DKR was reported by Reetz, which employed CalB for the 
resolution combined with Pd/C for the racemisation of 1-phenylethylamine 36.
59
 However, 
the reaction was very slow, with only 60% conversion obtained after 8 days. 
 
 




Parvulescu et al. further developed the use of Pd for the DKR of primary amines, utilising 
Pd/BaSO4 as the racemisation catalyst.
60
 Using this method 91% conversion of 1-
phenylethylamine 36 was achieved after 24 h, with > 99% ee for the product. 
Pd nanoparticles were utilised for amine racemisation by Engström et al. in the 
development of an artificial metalloenzyme for the DKR of rac-1-phenylethylamine 36 
(Scheme 42).
69
 Pd nanoparticles and CalB were immobilised within the same pore of a 
siliceous mesocellular foam (MCF). The metalloenzyme was produced from a previously 
developed Pd(0)-aminopropyl MCF,
70
 where the Pd nanoparticles were immobilised in an 
aminopropyl functionalised MCF, the remaining free aminopropyl groups were then 
reacted with glutaraldehyde to form a Schiff base and then CalB was immobilised by a 




Scheme 42. DKR of 1-phenylethylamine 36 using the Pd-CalB hybrid catalyst.
69  
 
The DKR of 36 using the Pd-CalB metalloenzyme gave a 95% yield and a 99% ee after 
reacting for 16 h at 70 °C. This resultant yield was much higher than for the reaction at 80 
°C and the separate component system, indicating that the close proximity of the two 
catalysts within the same cavity of the MCF resulted in enhanced efficiency. The tandem 
catalysis mechanism (Scheme 43) proceeded by the entrance of the racemic amine into the 
cavity, which is selectively acylated on the (R)-enantiomer by the enzyme. The (R)-
enantiomer exits the cavity and the (S)-enantiomer is then racemised by the Pd 
nanoparticles. The racemic amine can then undergo an enzymatic resolution and so a cyclic 
process is set-up. Denaturation of the CalB enzyme was observed due to the polar surface 
of the MCF, which limited the lifetime and turnover of the system. Whilst this method is 








Scheme 43. DKR of 1-phenylethylamine catalysed by the Pd-CalB hybrid catalyst. A: 





The Bäckvall group also reported the combination of CalB with their modified version of 
the Ru Shvö catalyst for the DKR of rac-1-phenylethylamine 36 (Scheme 44).
71
 A range of 
alkyl methoxyacetates were screened as acyl donors alongside the H-donor, iPrOH. The 
acyl donors chosen for the scale up were alkylmethoxy acetates 101a and 101b. The DKR 
was scaled up from 1 mmol to 45 mmol scale using the acyl donor 101a with R = OMe. 
The acyl donor and CalB were added in three portions to give the amide product in 98% ee 








Blacker et al. reported the DKR of secondary amine rac-6,7-dimethoxy-1-methyl-1,2,3,4-
tetrahydroisoquinoline 25, combining their [Cp*IrI2]2 catalysed racemisation with Candida 
rugosa lipase
57, 72
 and the allyl carbonate acyl donor 102 system developed by Breen
55
 
(Scheme 45). An isolated yield of 82% and 96% ee of 103 was obtained after 48 h on a 3 g 
scale. This enzyme was not particularly active and so 50 wt% loading was required 
initially, followed by an additional 20 wt% after 24 h. 
 
 







Another potential way to utilise the waste enantiomer from the resolution step could be to 
perform a second reaction to modify that enantiomer to give a higher value product. The 
metal catalysed hydrogen borrowing approach discussed above could be used to N-alkylate 
the waste enantiomer to provide a chiral secondary amine (Scheme 46). If the reaction 
conditions can be adjusted to maintain the enantiopurity, then this would present a viable 
method to obtain single enantiomer secondary amines. This is difficult to achieve via 
enzymatic resolution as few lipases exist that will accept these substrates. Coupling these 
two procedures would create two different single enantiomer chiral amine products and so 
would be more productive and less wasteful than a resolution alone. 
 
Scheme 46. Potential enzymatic resolution – N-alkylation coupled process. 
 
The combination of metal catalysts with enzymes faces problems in the incompatibility of 
the optimal working conditions of the two individual catalysts such as: solvent preferences, 
differing solubilities, reaction rates and optimum temperatures. As a result, the 
combination of the catalysts may lead to mutual inactivation. Combined processes are 
often carried out with both the metal catalyst and the enzyme in one pot, meaning that a 
compromise on reaction conditions is often required to avoid deactivation. This can result 
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in long reaction times and poor efficiency. The ability to physically isolate the two 
catalysts and operate the two steps under different reaction conditions would potentially 
avoid this compromise and allow the catalysts to operate at their optimum. Continuous 
flow chemistry presents an attractive strategy for isolation of catalytic steps whilst passing 
the reaction solution between them. 
 
1.5 Continuous Flow Chemistry 
In a continuous flow system the reactants are continuously pumped into and the products 
are continuously pumped out of the reactor.
73
 Unlike batch reactors, in which the 
composition of the reaction mixture varies with time, the composition in flow reactors 
varies with distance along the reactor tube. When operating at steady state, the 
concentration of reactants and products at a fixed position within the tube does not vary, 
and so the conversion achieved at the reactor outlet is constant during the entire steady 
state operation. Due to the small reactor volumes and narrow reactor diameters, only small 
amounts of reagents are present in continuous reactors at any one time and heat is 
dissipated readily. This means that continuous reactors are a safer method for using 
hazardous materials or highly exothermic reactions. Flow reactors are able to operate at 
increased temperatures and pressures compared to batch reactors and this intensification of 
reaction conditions can be utilised to reduce reaction times and increase productivity.
74
 





 and online analysis methods.
78, 79
 Using a 
flow system for the isolation of catalysts, with the reagents flowing directly between the 
two vessels, means that no extraction or separation has to be performed between the steps. 
This would not be the case for the analogous procedure carried out in batch with the 
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catalysts isolated in two different vessels, as some form of filtration or extraction would 
have to be carried out. 
 
1.5.1 Immobilised Catalysts in Continuous Reactors 
Immobilisation of enzymes provides many advantages for industrial synthesis, including 
increased stability and the potential to re-use, and are ideally suited for use in flow 
reactors. The main continuous reactor types for using immobilised catalysts are packed bed 
reactors (PBR) and fluidised bed reactors (FBR) (Figure 3).
80
 In PBR, the immobilised 
catalyst is packed within a reactor chamber and the reagents are pumped through. In FBR, 
the immobilised catalyst is suspended within a fluid in the reactor chamber.  
 
 
Figure 3. Schematic of packed bed reactor (A) and fluidised bed reactor (B). (Grey circle 
= catalyst particle) 
 
There are both advantages and disadvantages associated with using either PBRs or FBRs, 
which are described by Levenspiel.
81
 PBRs approximate plug flow behaviour, meaning 
that the reaction solution moves through the reactor bed as a uniform plug of material, 
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giving a narrower residence time distribution (RTD) and so better control and consistency. 
In contrast, FBRs have a more complicated flow pattern that is not well understood and can 
lead to inconsistencies in conversion. In addition, the fluid nature of FBRs means that 
reagent molecules have a lower chance of contact with a catalyst particle than in PBRs and 
so a higher catalyst loading would be required to achieve the same conversion. When using 
large PBRs, the temperature can be difficult to control due to the requirement of 
conducting the heat to the centre of the bed. This can lead to non-uniformity across the bed 
and the generation of hot spots. The FBR has mixing of the solid particles within the fluid 
bed and so the heat is more easily distributed. In terms of particle size, very small particles 
cannot be used in PBRs due to high pressure drop. This is a drop in pressure across the 
reactor bed, which is induced by the friction involved with the fluid passing over the 
catalyst particles. This is not a concern when using FBRs. 
A direct comparison of the two reactor types was presented in recent work by Matte et al. 
which found that PBRs produced the highest conversions compared to a batch reactor and 
a FBR for the production of butyl butyrate using immobilised Thermomyces lanuginosus 
lipase (TLL).
80
 The most common choice of reactor for immobilised catalysts is the PBR. 
Overall, PBRs are much easier to set-up and operate and so this research will focus on the 
use of PBRs when immobilised catalysts are studied under continuous conditions. In 
comparison to batch reactors, PBRs allow for much higher effective catalyst loadings to be 
achieved, which leads to significant reductions in reaction times and concurrent increases 
in productivity. The physical isolation of the catalyst within the reactor bed makes for easy 
separation and re-use of the catalyst, making the process more cost effective and 
industrially viable. In addition, in PBRs the catalyst is not exposed to the high shearing 
conditions of stirred batch reactors and so catalyst breakdown is reduced and lifetime is 
increased. Selected examples of the use of PBRs for amine production include: the 
chemically catalysed N-alkylation of morpholine with benzyl alcohol via hydrogen 
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borrowing using an immobilised Ru catalyst,
82
 the N-alkylation of a range of amines with 
alcohols using a heterogeneous Au/TiO2 catalyst,
83
 and the use of immobilised whole cell 
transaminase enzymes for the biologically catalysed synthesis of chiral amines.
84
 
The availability of immobilised lipase enzymes has led to an increasing number of 
examples of lipase catalysed reactions being carried out in PBR, including esterifications, 
kinetic resolutions, hydrolysis and transesterifications.
85
 For kinetic resolution, the main 




 In one example, the 
Poppe group reported the continuous resolution of 1-phenylethanol 8 and other secondary 
alcohols in a PBR,
87
 using the commercial X-cube reactor from ThalesNano.
91
 The product 
was obtained in 48% yield, 99% ee with a residence time (tRes) of 8.2 min at 25 °C and 
0.082 M (Scheme 47). 
 
 





Sánchez et al. employed a continuous PBR for the kinetic resolution of ibuprofen 107 
using immobilised Rhizomucor miehei lipase (Scheme 48).
89
 Optimisation of the reaction 
variables (temperature, concentration and molar ratio) was first carried out in batch using 
an experimental design approach to provide 50% conversion and 94% ee and then the 
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process was transferred to the continuous reactor. Conversion and enantioselectivity were 
maintained at 46% and 94% in the PBR for 100 h (~100 x tRes).  
 




The group of De Souza carried out the continuous resolution 1-phenylethylamine 36 using 
EtOAc as the acyl donor using a PBR (Scheme 49).
92
 The reactor was packed with the 
commercially available immobilised N435 and the substrate and acyl donor pumped 
through at varying temperatures and concentrations. Optimum conditions were determined 
as 40 min, 70 °C and 0.08 M with 4 equivalents of acyl donor, which provided 48% 
conversion. 
 





1.5.2 Dynamic Kinetic Resolution in Continuous Reactors 
PBRs present an opportunity to couple immobilised enzymes and chemical catalysts in 
separate reactors that are operated at different temperatures. For a DKR process, 
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continuous flow allows for facile multiple re-circulations of the reaction mixture through 
the two separate catalysts, each time increasing the yield of desired product. Using a flow 
reactor for the DKR of primary amines may also reduce dimer formation due to the low 
local concentration of amine. 
Roengpithya et al. combined the Ru Shvo catalyst 42 with CalB for the continuous DKR of 
1-phenylethylamine 36 wherein the enzyme was retained within a membrane reactor and 
the reaction solution containing the racemisation catalyst was flowed through it.
93
 A 
second reaction vessel was included in the system that was heated to 100 °C for the 
racemisation to occur within. After 72 h 99% ee was achieved but isolated yields were 
poor and the mass balance was only 55%. 
De Miranda et al. combined Pd/BaSO4 and CalB for a semi-continuous DKR of 1-
phenylethylamine 36, using ammonium formate as the hydrogen source for the Pd 
catalysed racemisation (Scheme 50).
94
 The lipase was contained within a PBR and 
Pd/BaSO4 was contained within a separate heated reservoir. The reaction solution was 
pumped out of this reservoir into the PBR flow system and then collected back into the 
reservoir. A filter was fitted to ensure that the Pd/BaSO4 ammonium formate mixture 
remained in the reservoir. The solution was re-circulated for 10 h, after which 77% 
conversion and 95% product ee was observed.  
 
Scheme 50. Semi-continuous reactor set-up for the DKR of 1-phenylethylamine 36 






A recent notable example of DKR in a PBR was also reported by De Miranda et al. for the 
resolution of 1-phenylethanol 8, employing immobilised CalB and VOSO4 as the 
heterogeneous racemisation catalyst (Scheme 51).
95
 The two catalysts were constrained 
within the same reactor bed in individual segments separated by cotton segments, so that 
the catalysts were isolated from one another to avoid deactivation. By using vinyl acetate 
105 as the acyl donor, 92% conversion with 99% product ee was achieved with a tRes of 
5.2 min at 70 °C, although selectivity for the desired product was only 68% under these 
conditions. This exemplified how the use of a flow system can overcome the 




Scheme 51. Continuous DKR system developed by De Miranda et al., combining a lipase 




1.5.3 Flow Reactors for Efficient Manufacture 
The intensification of reaction conditions achievable in flow reactors leads to increased 
yields and productivity and a reduction in the cost of the process. When applied to the 
manufacture of essential medicines,
97
 this reduction in cost increases the affordability and 
availability of these drugs to the developing world, where the demand for these essential 
medicines is often at its highest.
98-100
  
In one such example Watts and co-workers employed continuous reactors towards the 
synthesis of lamivudine 110 (Figure 4), an anti-retroviral drug for the treatment of HIV and 
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hepatitis B that is on the World Health Organisation’s (WHO) essential medicines list.
97, 98
 
The continuous process presented reduced reaction times and temperatures to achieve 
increased yields compared to batch synthesis methods. The research was carried out in 
South Africa, with a view to developing cheaper large scale manufacture local to the areas 
where the drug is in high demand.   
 
Figure 4. Structure of lamivudine 110, an essential medicine for the treatment of HIV and 
hepatitis B. 
 
1.6 Research Objectives 
The importance of chiral amines in pharmaceutical molecules has led to an increasing 
demand for efficient, cost-effective methods to obtain enantiopure amines. Both chemical 
and biological catalysts have found applications in this field, however there are 
disadvantages to using each type of catalyst. The combination of catalysts allows for the 
favourable characteristics of each catalyst to be exploited whilst compensating for the un-
favourable characteristics. 
The overall aims of the research were to combine chemical and biological catalysts for the 
production of chiral amines, combining the strengths of the individual catalysts in 
asymmetric synthesis to develop efficient, industrially relevant processes. The use of 
continuous reactors was considered as a way to isolate the two catalysts to avoid 
deactivation and to be able to use more forcing reaction conditions to increase productivity. 
The combination of an enzyme and metal catalyst in continuous reactors for the DKR of 
chiral amines was studied initially. The two steps were investigated independently, with a 
69 
 
view to optimising each reaction before combining as a DKR process. The development 
and optimisation of a continuous enzymatic resolution is presented in Chapter 2 and the 
metal catalysed racemisation of this substrate is discussed in Chapter 3. In Chapter 4, the 
continuous enzyme catalysed coupling of NH3 with esters for the production of 
pharmaceutically relevant amides is presented. This Chapter introduces a design of 
experiments approach to optimisation of the process. Finally in Chapter 5, the metal 
catalysed cross coupling of amines for N-alkylation via the hydrogen borrowing approach 





2 Enzymatic Resolution of a Chiral Primary Amine 
2.1 Introduction 
Enzymatic resolution of chiral amines has been studied extensively in batch,
46
 and 
increasingly in continuous flow.
85, 92
 Immobilised catalysts present an advantage over 
homogeneous or slurry-type catalytic systems due to ease of separation and the potential 
for re-use. The use of a continuous packed bed reactor (PBR) allows for the reagents to be 
exposed to high amounts of catalyst, and easy separation of the catalyst from the solution, 
as the catalyst remains within the reactor whilst the reagents are introduced and the 
products removed from the system.
101
 
In this chapter, the lipase catalysed resolution of the chiral primary amine 1-
phenylethylamine 2.1 was investigated (Scheme 52). Reactions were initially screened 
under batch conditions and then transferred to a continuous system for further reaction 




Scheme 52. Enzymatic resolution of racemic 1-phenylethylamine 2.1. 
 
2.2 Batch Resolution Screening 
Initial screening to determine the effect of the type of the acyl donor and the number of 
equivalents was carried out, using esters 2.3 – 2.8, under batch conditions (Table 1). All 
reactions were carried out using commercially available lipase B from Candida antarctica 
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immobilised on a polyacrylic resin (Novozym 435, N435). Control reactions were also 
carried out for all conditions tested, in which N435 was omitted from the reaction mixture.  
 
Table 1. Screening of acyl donors for resolution of rac-2.1 under batch conditions.
a
 



















24 99 42 30 150 
2 
 
3.5 43 10 19 3 
3 
 
30 86 53 38 23 
4 
 
24 X 0 0 X 
5 
 
24 99 99 50 > 200 
6 
 
24 99 97 49 > 200 
a
Reaction conditions: 0.07 mmol rac-2.1, 1 Eq acyl donor, 10 mg N435, 10 mL toluene, 60 °C; 
b
Determined by chiral GC analysis; 
c
Determined by chiral GC analysis after derivatisation using 
trifluoroacetic anhydride; 
d
Determined using Conversion = [eeamine / (eeamine + eeamide)]*100; 
e
Determined 
using E = {ln[1 – C)*(1 – eeamine)]}/{ln[(1 – C)*(1 + eeamine)]}, where C = conversion; 
 
Enantiomeric excess (ee) for the substrate and product was calculated from gas 






where Area 1 corresponds to the enantiomer with the major peak area and Area 2 
corresponds to the enantiomer with the minor peak area. Conversion of the amine substrate 






This method for calculation of conversion was only used when no other products were 
observed and when the enzyme was completely selective for one enantiomer, generating 
only one product enantiomer. Conversion can be calculated using this method because it is 
in a direct relationship with substrate and product ee, but is only possible when there is 
baseline separation between enantiomer peaks in a chromatogram. In following chapters, 
conversion was calculated from calibration curves that were recorded relative to an internal 
standard. The calibration data was used retrospectively to confirm the conversions 
calculated in this chapter and when a significant discrepancy was determined the 
experiment was repeated. For any reactions that were not selective or had side reactions, 
conversion was determined by comparison of peak integrals in 
1
H NMR. 
Assuming a completely selective reaction, the amine ee will increase as the conversion of 
amine to amide increases (Figure 5). At the start of the reaction there is a racemic mixture 
of amine and so the amine ee starts at zero. As the reaction progresses, one enantiomer of 
the amine is converted preferentially to the amide and so the amine ee increases. At 50% 
conversion, one enantiomer has been completely converted to the amide and so the amine 
is enantiopure and the ee is 100%. As only one enantiomer is being converted to the amide 
then the ee of the amide produced is 100%.  
If the reaction is not completely selective, and some of the other amine enantiomer is also 
converted to the amide, the amide ee will be less than 100%. If both enantiomers are 
completely converted to the amide then the amide ee will become zero, as a racemic 
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mixture of amide has been produced (above 50% conversion on Figure 5). The amine ee 
will not increase if both enantiomers are being converted at the same rate, as a racemic 
mixture is maintained. So for a resolution, the maximum desired conversion is 50% as all 
of one enantiomer will have been converted (Scheme 53). 
 
 








Selectivity values (E) are also shown in Table 1, which give a ratio of the relative rates for 
the two enenatiomers reacting with the catalyst. Larger numbers denote an enzyme that is 
highly selective for one enantiomer and so will give a highly enantiopure product.
102, 103
 
Esters 2.4 and 2.5 showed significant uncatalysed background reaction which resulted in 
low ee for the product amide. In the case of ester 2.4, the reaction was stopped after 3.5 h 
due to the production of by-products that prevented accurate analysis of conversion to the 
desired amide product. The reaction using ester 2.5 showed the formation of a by-product 
during monitoring of the reaction. Gas chromatography – mass spectrometry (GCMS) 
analysis of these samples indicated that this was imine 2.10, formed by reaction of the 
amine with the acetone by-product (Scheme 54). This was not isolated as the imine was 
hydrolysed during the work-up.  
 
Scheme 54. Proposed mechanism for formation of imine by-product 2.10 in the resolution 
of 2.1 using acyl donor 2.5. 
 
Esters 2.3, 2.7 and 2.8 all showed high selectivity for the amide product, with only one 
amide enantiomer being observed in all cases. The reactions using esters 2.7 and 2.8 were 
considerably faster than using ester 2.3, as 50% conversion was observed after 24 h, 
compared to 30%. The initial rate was also faster for esters 2.7 and 2.8, as well as the final 
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conversion being higher. Molecular modelling carried out by Cammenberg et al. indicated 
that the reaction rate was enhanced when using alkyl methoxyacetates as the acyl donor 
due to the presence of a hydrogen bonding interaction between the amine proton and the β–
oxygen of the ester in the active site (Figure 6).
104
 For these types of acyl donors, Bäckvall 
et al. reported that the amide ee increased and yield decreased with decreasing leaving 
group size for methyl-, ethyl- and isopropyl-methoxy acetate.
71
 The leaving group for the 
larger esters would be more stabilised and so more labile, leading to a higher yield. This 
higher reactivity may cause uncatalysed background reaction, which would lead to the 
reduction in the amide ee. 
 





The resolution of 2.1 was tested using 1, 2 and 4 equivalents (Eq) of ester 2.7, relative to 
the total racemic amine present. Increasing the number of Eq of 2.7 increased the initial 
rate of the reaction, with higher conversions observed after 2 h using 2 and 4 Eq (Table 2, 
Entries 3 and 5). However, background reaction was then observed using higher Eq, 
leading to a reduction in amide ee after 24 h. (Table 2, Entries 4 and 6). Due to this, 1 Eq 
of ester 2.7 was used for all further reactions, to maintain amide ee and reduce the waste 





Table 2. Screening of ester 2.7 Eq under batch conditions.
a
 












1 1 2 99 27 21 
2 1 24 99 99 50 
3 2 2 99 46 32 
4 2 24 96 99 54 
5 4 2 99 47 32 
6 4 24 91 99 58 
a
Reaction conditions: 0.07 mmol rac-2.1, 10 mg N435, 10 mL toluene, 60 °C; bDetermined by chiral GC 
analysis; 
c
Determined by chiral GC analysis after derivatisation using trifluoroacetic anhydride; 
d
Determined 
using Conversion = [eeamine / (eeamine + eeamide)]*100; Eq = equivalents of 2.7. 
 
2.3 Continuous Resolution Screening 
The reaction was then transferred to a continuous PBR system for further screening and 
optimisation. It was envisaged that the process could be improved in a PBR as the reactor 
could be filled with a much higher amount of catalyst than would be feasible in batch, 
resulting in a greatly reduced reaction time. Employing a continuous reactor creates a more 
productive system, as the reagents are constantly being pumped into the reactor and the 
products are constantly being pumped out of the reactor, for as long as the catalyst remains 
active. The lifetime of the immobilised catalyst is often longer than in batch because it is 
not exposed to mechanical mixing, which breaks down the support. 
 
2.3.1 Reactor Design 
The continuous reactor set up consisted of a 316 stainless steel tubular reactor (1/4” OD, 
1/8” ID, 3.0 mL), fitted with Supelco stainless steel frits (1/4” diameter). The reactor was 
contained within an aluminium block, heated by aluminium cartridges powered by a 
custom manufactured Eurotherm temperature controller (Figure 7). Temperature 
monitoring was achieved using Green K-type thermocouples. Reagent feeds were 
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introduced into the system using Jasco PU-980 or PU-2085 dual piston pumps. PTFE 
tubing (1/16” OD, 1/32” ID) was used to connect the piston pump to the reactor and at the 
outlet of the reactor. All tee-pieces and unions used were Swagelock 316 stainless steel. 
 
Figure 7. Continuous resolution PBR design. (A) Piston pump; (B) Tubular reactor packed 
with N435; (C) Aluminium heating block; (D) Eurotherm temperature controller; (E) 
Product outlet and collection.  
 
General procedure followed for all further flow reactions: 1 g of N435 was measured out 
and transferred into the stainless steel tube. The tube was then installed within the heating 
block and toluene pumped through the reactor, to purge any air from the system, and then 
the reactor was set to the desired temperature. The reagent stock solutions were made-up 
individually in volumetric flasks, for both amine 2.1 and ester 2.7, using toluene to make-
up the solution to the graduated mark. Equal volumes of the individual amine and ester 
stock solutions were then combined for the reaction mixture. This provided a reaction 
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mixture at half the concentration of the individual stock solutions. Once the reactor reached 
the desired temperature, the reaction mixture was pumped through the reactor at the 
specified flow rate. The flow rate required was determined using the 3 mL volume of the 




The reactor volume (RV) was assigned as the volume of the stainless steel tube packed 
with N435, as control reactions showed that the reaction was only occurring in the 
presence of N435 and so no reaction was occurring in the PTFE tubing that connected the 
reactor to the pump and connected the outlet of the reactor to the collection vessel. The 
reaction mixture was collected at the outlet of the reactor in individual RV samples and 
analysed by chiral GC.  
 
2.3.2 Residence Time Screen 
The tRes within the reactor was varied between 30 – 1.5 min, by adjusting the flow rates 
accordingly (Table 3). Increasing conversion and amine ee was observed with increasing 
tRes, up to the maximum of 50% conversion. Selectivity for (R)-2.11 was maintained at all 
tRes, with only one enantiomer being observed. Steady state was observed after 4 RV and 
maintained throughout operation. Steady state is achieved when the product composition at 
the outlet of the reactor is constant. The optimum tRes was determined to be 6 min, 
producing 99% amide ee, 96% amine ee and 49% conversion to amide (Figure 8). This 
tRes was used for all further reactions as it produced the highest conversion in the least 




Table 3. Screening of tRes in the continuous resolution of rac-2.1.
a 
Entry tRes / min
 
















1 30 0.1 99 99 50 
2 6 0.5 99 96 49 
3 3 1 99 71 42 
4 1.5 2 99 47 32 
a
Reaction conditions: 0.07 M rac-2.1, 1 Eq 2.7, 60 °C, 3 mL reactor volume; bDetermined by chiral GC 
analysis; 
c
Determined by chiral GC analysis after derivatisation with trifluoroacetic anhydride; 
d
Determined 
using Conversion = [eeamine / (eeamine + eeamide)]*100; 
 
Figure 8. Continuous resolution of rac-2.1 with tRes = 6 min at 60 °C. 
 
2.3.3 Temperature Screen 
The temperature of the reactor was then varied between 30 – 100 °C for the continuous 
resolution with a tRes of 6 min (Figure 9). At temperatures of 60 °C and above, maximum 
conversion of 50% was consistently observed. At temperatures up to 50 °C, an initiation 





Figure 9. Temperature profile for the continuous resolution of rac-2.1. 
 
Further investigation was carried out to determine the cause of this initiation period and 
whether it could be prevented. Firstly, the reaction at 30 °C was repeated with a tRes of 30 
min to see if the maximum conversion could be achieved at the lowest temperature. The 
conversion to amide (R)-2.11 did increase from 40% to 49% after the 30 min tRes. The 
ability to achieve maximum conversion showed that the enzyme was not deactivated at 
lower temperatures but unsurprisingly required a longer reaction time. However, this did 
not overcome the initiation period as steady state was still not reached until after 8 RV. 
It was next postulated that the initiation period may have resulted from a reduced amount 
of coordination of the acyl donor to the active site at lower temperatures. The initial step of 
the catalytic mechanism involves the coordination of the acyl donor to the serine (Ser) 
residue in the active site to form an acyl-enzyme intermediate (Scheme 55).
105
 This 
intermediate undergoes nucleophilic attack by the amine to give the amide product and re-




Scheme 55. Lipase active site mechanism (Asp = Aspartic acid, His = Histidine, Ser = 
Serine).
105
 Step 1: Coordination of the acyl donor to the Ser residue of the three key 
residues (catalytic triad) within the active site; Step 2: Proton transfer; Step 3: Formation of 
acyl-enzyme intermediate on Ser and loss of alcohol by-product; Step 4: Nucleophilic 
attack of amine at the ester carbonyl; Step 5: De-coordination of amide from Ser and 
proton transfer to recycle the active site residues. 
 
To investigate whether the coordination of the acyl donor to the Ser in the active site is 
inhibited at lower temperatures, the reaction at 30 °C was repeated with an initial feed of 
only ester 2.7 up to 4 RV followed by the introduction of the amine/ester reaction mixture 
(Figure 10). If the initiation was caused by a reduction in the coordination of the acyl 
donor, then exposing the enzyme to only the acyl donor for a period before the reaction 
would have allowed for some of the acyl donor to coordinate to the enzyme prior to the 
introduction of the amine substrate. For this reaction, the tRes was again reduced to 6 min 
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for speed of analysis and because the absolute value for conversion was not important for 
this experiment. Again steady state was not reached until 7-8 RV, indicating that the 




Figure 10. Continuous resolution of rac-2.1 at 30 °C, with only ester 2.7 in the reagent 
feed for 4 RV prior to starting the reaction (tRes = 6 min). 
 
Finally, it was investigated if the initiation period was due to physical properties of the 
resin at different temperatures and whether pre-heating the reactor would reduce the 
initiation period. To do this, the reactor was heated to 60 °C and flushed with solvent for 
10 RV prior to pumping the reaction mixture at 30 °C (Figure 11). Under these conditions 
steady state was reached after 5 RV, which was much closer to the 3-4 RV required to 
reach steady state at higher temperatures. This finding suggests that the immobilised 
catalyst undergoes physical changes when exposed to higher temperatures, swelling of the 
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resin may occur, which increases the accessibility of the enzyme. Therefore, pre-heating of 
the reactor and a longer tRes would be recommended if lower temperatures were to be 
used in this system. 
 
 
Figure 11. Continuous resolution of rac-2.1 at 30 °C, with only solvent at 60 °C for 10 RV 
prior to starting the reaction (tRes = 6 min). 
 
From the temperature studies, it was decided that 60 °C would be taken as the optimum 
operating temperature because the maximum conversion was achieved within the 6 min 
tRes, there would be a lower energy demand for the process compared to using the 
temperatures above 60 °C, for which the conversion achieved was the same, and there was 




2.3.4 Concentration Screen 
The concentration of reagents was then varied between 0.07 M and 0.70 M for the 
continuous resolution with a tRes of 6 min at 60 °C (Table 4). A significant reduction in 
the conversion was observed for concentrations of 0.28 M and above. At these higher 
concentrations the amine ee observed was lower (< 90%) because the (R)-amine was not 
completely converted. Whilst the amine ee was lower at higher concentrations, the amide 
ee observed remained at >99% for all concentrations as the selectivity for one amine 
enantiomer to be converted to the amide remained the same. This also showed that the 
increased reagent concentration did not cause any un-catalysed background reaction to 
occur.  
Table 4. Screening of concentration in continuous resolution of rac-2.1.  




 / % Amine ee
c
 / % Conversion
d
 / % 
1 0.07 99 96 49 
2 0.14 99 93 48 
3 0.28 99 86 46 
4 0.42 99 71 41 
5 0.56 99 70 41 
6 0.70 99 73 42 
a
Reaction conditions: 1 Eq 2.7, 60 °C, 3 mL reactor volume, 0.5 mL min-1, 6 min tRes; bDetermined by 
chiral GC analysis; 
c
Determined by chiral GC analysis after derivatisation with trifluoroacetic anhydride; 
d
Determined using Conversion = [eeamine / (eeamine + eeamide)]*100; 
 
The reduction in conversion occurs at higher concentrations as the amount of enzyme 
remains constant throughout the reactions and so the number of active sites available for 
the reaction to take place remains constant. An increased number of reagent molecules 
within the system causes saturation of the enzyme active sites, as the number of active sites 
has not increased with the reagent. According to Michaelis-Menten kinetics,
106, 107
 the rate 






where ν is the rate of reaction, Vmax is the maximum rate, [S] is substrate concentration and 
KM is the Michaelis constant, which denotes the [S] at which the rate is half of Vmax.  The 
rate increases with increasing [S] up to Vmax, where all enzyme is bound in the enzyme-
substrate complex. Once Vmax has been reached, the rate will no longer be affected by a 
further increase in [S] as the enzyme is saturated.  
Therefore, a longer tRes would be required to enhance the conversion at higher reagent 
concentrations, to allow the reaction mixture to be exposed to the enzyme for a sufficient 
amount of time for all the reagent molecules to react. A larger catalyst loading could also 
be used, meaning that the ratio of active sites to substrate molecules would be larger and so 
Vmax would not be reached for the concentrations studied. 
 
2.3.5 Catalyst Recyclability 
The longevity of the continuous process developed was then investigated through catalyst 
studies. Deactivation of the catalyst was monitored over 30 h of operation at 60 °C (Figure 
12). No drop in activity was observed within this time scale, with the conversion to amide 
(R)-2.11 remaining at 49% throughout the study. The stability of the catalyst after 
treatment for storage and re-use was also investigated. A batch of catalyst was used in the 
continuous resolution of rac-2.1 and then exposed to ether, as a highly volatile solvent to 
aid in drying out the catalyst. The ether solution was filtered and the dry catalyst stored in 
the fridge. On re-use of the catalyst, no drop in activity was observed as conversion was 





Figure 12. Catalyst deactivation for continuous resolution of rac-2.1 using tRes = 6 min, 
60 °C and 0.07 M. 
 
2.3.6 Reaction Metrics 
Optimum reaction conditions were determined to be 6 min tRes, 60 °C and 0.07 M, 
because this gave the highest conversion in the shortest amount of time. These conditions 
were used for all further continuous resolution studies. De Souza et al. developed an 
analogous continuous system for the resolution of 2.1.
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 This literature process utilised 4 
Eq of EtOAc as the acyl donor, had a tRes of 40 min and was operated at 70 °C and 0.08 
M, to achieve conversions of 48%. The process developed herein, provided a reduction in 
waste due to the use of 1 Eq of acyl donor 2.7 and a reduction in tRes. Space time yield 






where MW is the molecular weight of the product.
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 The optimum reaction conditions 









 was obtained for the process carried out at 
higher reaction concentration (0.7 M), indicating that this would be the optimised reaction 
conditions in terms of productivity. The process developed exhibited a greater productivity 







could be further optimised by increasing the reactor size to allow for a larger amount of 
catalyst to be used, which would be expected to shorten the reaction time and so increase 
the STY. To compare the waste associated with the process at 0.07 and 0.7 M, E factors
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The E factors were calculated as 1.34 and 1.74 for the reactions at 0.07 M and 0.7 M, 
respectively. Therefore the process at 0.07 M had less associated waste. It should be noted 
that solvent and catalyst were not included in the calculation of E factors as it was assumed 
that these could be recycled. 
 
2.3.7 Substrate Scope 
The optimised conditions for conversion for the continuous resolution of rac-2.1 were then 
applied to an expanded substrate set, including chiral amines and alcohols (Table 5). All 






Table 5. Expanded substrate scope for continuous resolution.
a
  

























- 0 0 X 
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94 25 20  
a
Reaction conditions: 0.07 M substrate, 1 eq 2.7, 60 °C, 3 mL reactor volume, 0.5 mL min-1, tRes = 6 min; 
b
Determined by chiral GC analysis; 
c
Determined by chiral GC analysis after derivatisation with 
trifluoroacetic anhydride; 
d
Determined using Conversion = [eesubstrate / (eesubstrate + eeproduct)]*100; 
e
Determined 






Determined using E = {ln[1 – C)*(1 – 
eesubstrate)]}/{ln[(1 – C)*(1 + eesubstrate)]}; 
 
For amine substrates, the 4-fluoro electron withdrawing substituent (2.12) did not affect the 
reaction rate and full conversion was observed within the 6 min tRes (Entry 1). Extending 
the carbon chain between the amine functionality and the aryl group (2.13) only marginally 
reduced the conversion (Entry 2). The enzyme used was not able to resolve secondary 
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amines (Entry 3). 1-Phenylethanol 2.15 showed reduced activity within the continuous 
resolution system (Entry 4), producing 15% conversion compared to 49% conversion for 
2.1. This reflected a lower rate of reaction for alcohols, compared to amines. It would be 
expected that the lower nucleophilicity of alcohols would cause the attack at the Ser-bound 
carbonyl to be slower, and so a longer tRes would be required for alcohols. In general, the 
enzyme also showed a reduced stereospecifity when using alcohol substrates, indicating 
that the enzyme was not able to distinguish between the two enantiomers as efficiently as it 
did for amines. There are literature examples in which high selectivity has been achieved 
for the resolution of 2.15 also using N435,
63, 64
 this indicates that different reaction 
conditions are required to achieve the optimum for this substrate, including different 
solvent, acyl donor and temperature.  
 
2.4 Conclusions 
A robust process was developed for the continuous resolution of a primary chiral amine 
using an immobilised lipase enzyme within a PBR. The type of acyl donor and the number 
of Eq was investigated under batch conditions and then the process was transferred to a 
continuous PBR. The reaction parameters of tRes, temperature and concentration were 
varied within the continuous system using a one variable at a time (OVAT) approach to 
obtain an optimised set of reaction conditions in terms of the highest conversion obtained 
in the shortest tRes (6 min, 60 °C, 0.07 M). During the temperature studies it was found 
that the system suffered from a slow initiation period when operated at lower temperatures 
due to physical changes of the resin. This provided a lower limit for the system operating 
temperature, above which no special treatment of the reactor was required. By transferring 
the reaction from batch into the packed bed reactor the reaction time was significantly 
reduced and the productivity increased due to the ability to greatly increase the catalyst 
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loading. The productivity could have been increased further by using a higher 
concentration of substrate but this would have required a longer tRes. 
The stability of the catalyst within the continuous system was investigated, with no drop in 
activity being observed over 30 h of reaction, showing that the process could be operated 
over the long timescales required for industrial applications. The ability to use the same 
batch of catalyst over long periods or over multiple different reaction runs reduces the 
catalyst contribution to the total cost of the process and so is desirable for commercial 
processes. The process developed also presented improvements on the existing literature 
procedures, with reduced reaction times and increased productivity.  
The optimised continuous resolution conditions obtained were then applied to a range of 
chiral amines and alcohols. It was found that alcohols displayed a lower rate of reaction, 
and a lower selectivity was achieved, using these conditions. Variation in the amine 
substrates had little effect on the outcome of the reaction, however, the enzyme was not 
active for secondary amines.  
This continuous resolution system presents an opportunity for the efficient production of 
single enantiomer chiral amines on a rapid timescale. The coupling of this procedure to a 
racemisation step for the recycling of the undesired enantiomer to develop a more 
productive system will be discussed in the following chapter. 
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3 Metal Catalysed Racemisation of a Chiral Primary Amine 
3.1 Introduction 
As discussed in Chapter 2 (page 74), the maximum theoretical yield achievable for a 
kinetic resolution is 50% when only one enantiomer is desired. This maximum yield can be 
improved by recycling of the undesired enantiomer through racemisation (Scheme 56 A). 
Racemisation creates a mixture of enantiomers, and so more of the desired enantiomer can 
be re-introduced into the resolution, setting up a re-circulation process termed dynamic 
kinetic resolution (DKR). As the desired enantiomer is constantly being formed in the 
racemisation, the overall yield increases above 50%. 
 
Scheme 56. Dynamic kinetic resolution. (A): Re-circulation process showing recycling of 
undesired enantiomer by racemisation; (B): Relatives rates of the two reaction types. 
 
The DKR process relies on the rate of racemisation being fast, and that the enzyme reacts 
with one enantiomer much more quickly than the other (Scheme 56B). Racemisation keeps 
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the ratio of amine enantiomers constant, so that the enzyme selectivity remains the same. 
In a kinetic resolution the enzyme selectivity can decrease as the ratio of amine 
enantiomers changes over the course of the reaction; the higher proportion of undesired 
enantiomer in the reaction, the more likely it becomes that the enzyme will select for the 
undesired enantiomer. Figure 13 exemplifies this for a perfectly selective enzyme, wherein 
the product ee is 100% up to 50% conversion as only one enantiomer is being converted, 
but the ee drops at higher conversions as the other enantiomer begins to be converted to the 
product. For a less selective enzyme, the product ee would begin to drop before the 50% 
conversion is reached, as the enzyme cannot distinguish between the substrate enantiomers 
as efficiently. The selectivity value (described in Chapter 2, page 75) gives a measure of 
the relative rates for the reaction of the two enantiomers of a particular substrate with the 
enzyme. A lower selectivity value would mean that the product ee begins to fall at lower 
conversion values. This would be exacerbated by the change in the ratio of the enantiomers 
during the resolution. 
 
Figure 13. Conversion and product ee for a perfectly selective enzyme, showing a 




The process also requires that the reaction conditions for the two steps are compatible, for 
one-pot reactions. As already discussed, there are many examples in the literature for the 









 The majority of processes are 
carried out as a one-pot procedure under batch conditions and as the two catalysts typically 
have different optimum operating conditions a compromise often has to be reached 
between the conditions. For example, the optimum temperature for enzymes tends to be 
lower (~40 °C) than the temperature required for the metal catalysts (~100 °C). Exposing 
the enzymes to higher temperatures can lead to denaturation of the enzyme. If lower 
temperatures are used, then the metal catalysed reactions are slower or may not occur at 
all, especially if activation requires high temperatures. This can result in a less efficient 




In a recent review, Bäckvall highlights the challenges associated with the DKR of amines 
compared to the more facile DKR of alcohols.
53







 and amino acid racemases.
113
 The 
homogeneous catalysts often require high temperatures to be activated, the heterogeneous 
catalysts are unselective and the enzymes of narrow scope. Since amines can act as ligands 
or surface modifiers, they can also cause inhibition of the catalysts. The high temperatures 
needed to overcome this inhibition are incompatible with the majority of enzymes. Also, 
the reactivity of primary imine intermediates formed during the catalytic cycle generates 
significant dimeric products, which is exacerbated at higher temperatures. 
The objective of this work was to investigate the coupling of the continuous chiral amine 
resolution developed in Chapter 2 with continuous metal catalysed racemisation. Ideally, a 
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heterogeneous catalyst would be used, so that the two catalysts could be isolated in 
separate packed bed reactors (PBRs) operated at different temperatures, to avoid 
compromising on reaction conditions, and thus and develop a more efficient DKR (Scheme 
57).  
 
Scheme 57. Proposed continuous reactor set-up for DKR using PBRs in series. 
 
In this chapter, the metal catalysed racemisation of (S)-1-phenylethylamine (S)-3.1 was 
investigated using heterogeneous and homogeneous Ir, Ru and Pd catalysts. 
 
3.2 Racemisation using Iridium Catalysts 
3.2.1 Heterogeneous Iridium Catalyst 
The racemisation of (S)-3.1 was first studied using a heterogeneous Cp*Ir catalyst 3.2 
(Scheme 58). The catalyst was produced from the [Cp*IrI2]2 dimer by immobilisation on 
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Scheme 58. Racemisation of (S)-3.1 using heterogeneous Cp*Ir catalyst 3.2. 
 
The experiments using heterogeneous catalyst 3.2 were only carried out under continuous 
reaction conditions, using either of the set-ups shown in Figure 14, with a view to 
developing the coupled reactor system. For the first reactor type, catalyst 3.2 was manually 
packed into a stainless steel tubular reactor (4.0 mm ID, 25 cm, 3.1 mL), which was 
installed within a heating jacket set on top of a hot-plate. The reaction stock solution ((S)-
3.1 in toluene) was pumped through the reactor using a Harvard 11 syringe pump, set to 
the desired flow rate. For the second reactor type, catalyst 3.2 was again manually packed 
into a stainless steel tubular reactor (1/4” OD, 1/8” ID, 3 mL), which was installed within 
an aluminium heating block under Eurotherm temperature control. In this case the reaction 




Figure 14. First (A) and second (B) continuous reactor set-ups for the racemisation of (S)-
3.1, using catalyst 3.2. 
 
The catalyst loading, temperature and residence time (tRes) were varied within the 
continuous reactors and the results are presented in Table 6. For all Entries, the entire 
reaction stock solution was pumped through the reactor, collected and a sample taken for 
GC analysis. The solution was then re-circulated through the reactor, up to 4 cycles, so as 
to increase the exposure of the substrate to the catalyst, with the aim of increasing the 
amount of racemisation with each cycle. The reactions were analysed for the change in 
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amine ee using chiral GC, after derivatisation using trifluoroacetic anhydride, as described 
in Chapter 2. 
 




















1 2.5 80 6 0 > 99 
2 2.5 100 6 6 > 99 
3 5 100 6 12 > 99 
4
b
 2.5 110 6 1 > 99 
5
b
 2.5 110 12 1 > 99 
6
b
 2.5 110 30 3 > 99 
a
Reaction conditions: heterogeneous catalyst 3.2, 0.07 M (S)-3.1, toluene, reactor volume = 3.1 mL; 
b
Second reactor type, reactor volume = 3.0 mL; 
c
Calculated relative to the entire solution flowed through the 
reactor over multiple cycles; 
d
Determined by achiral GC analysis; 
e
Determined by chiral GC analysis after 
derivatisation with trifluoroacetic anhydride; Data values shown were obtained after 4 cycles through the 
reactor. 
 
Initially a short tRes of 6 min was tested so as to match the optimum tRes for the 
continuous resolution of rac-3.1 from Chapter 2. The ee of amine 3.1 did not decrease over 
the course of the cycles and so no racemisation was occurring for reaction temperatures 
between 80 – 110 °C with 2.5 mol% catalyst loading (Entries 1,2 and 4). Increasing the 
catalyst loading to 5 mol% did not encourage any racemisation (Entry 3). The tRes was 
then increased to 12 min (Entry 5) and 30 min (Entry 6), however, no racemisation was 
observed. For all of the conditions tested, amine 3.1 was observed to form dimeric 





Scheme 59. Attempted racemisation of (S)-3.1 using heterogeneous Cp*Ir catalyst 3.2, 
showing dimer products. 
 
The dimer products are formed by the reaction between two of the amine molecules, 
according to the proposed catalytic cycle (Scheme 60).
57, 115
 In the catalytic cycle, the 
amine first coordinates to the catalyst and is de-hydrogenated to form an imine. For 
racemisation to occur, the imine must then be re-hydrogenated to re-form the amine, with 
scrambling of the stereochemistry. For dimer formation to occur, a second amine molecule 
reacts with the imine intermediate to form an imine dimer that can be hydrogenated to give 
the amine dimer. The formation of dimers observed therefore indicated that the de-
hydrogenation step was occurring, but that the nucleophilic attack by the second amine 
molecule then occurred preferentially over the re-hydrogenation. Recent work carried out 
by Stirling et al. studying the kinetics and mechanism of the homogeneous [Cp*IrI2]2 
catalyst 3.5 for the racemisation of amines, indicated that the imine dissociates from the Ir 
complex into solution and then re-associates for hydrogenation to occur.
115
 Therefore, the 
dimer formation would occur in solution rather than bound to the catalyst. However, 
unpublished work carried out within the research group suggests that primary imines 
remain bound to the catalyst and dimerisation occurs on the catalyst, as when the imine and 







Scheme 60. Proposed catalytic cycle for racemisation and dimer formation.  
 
The temperatures used for the reactions with catalyst 3.2 were chosen based on previous 
studies carried out within the research group, which showed that the supported catalyst was 
active for longer and could be recycled more times when operated at 80 °C, mainly due to 
decomposition of the Wang resin.
117
 Therefore, reactions were carried out around this 
temperature and not above 110 °C. The catalyst loading was not increased above 5 mol%, 
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relative to the entire solution over the multiple cycles, so as not to increase the cost 
associated with the process. A short tRes would have been favourable for coupling to the 
existing continuous resolution process but increasing the tRes to 30 min did not encourage 
the racemisation. Racemisation may have been achieved with more forcing reaction 
conditions, such as higher temperature, however due to the reasons described, this could 
not be further investigated for catalyst 3.2. 
Initially, the goal was to use the heterogeneous catalyst 3.2 to racemise the amine so as to 
be able to couple this reaction to the continuous resolution described in Chapter 2, using 
continuous PBRs in series. However, testing of the heterogeneous catalyst within the 
required operating conditions: short reaction time required for flow and temperature 
required to maintain catalyst stability; showed that this was not an appropriate set-up.  
 
3.2.2 Homogeneous Iridium Catalyst 
The racemisation of (S)-3.1 was next investigated using the homogeneous [Cp*IrI2]2 
catalyst 3.5 (Scheme 61). This catalyst was employed by Stirling et al. for the DKR of 
secondary amines
72
 and was then applied to the racemisation of a range of primary and 
secondary amines.
57
 Whilst the catalyst was able to racemise secondary amines effectively, 
attempts using primary amines led to mainly the formation of dimers, as observed for the 
heterogeneous Ir catalyst described above. Nevertheless, catalyst 3.5 was tested to 
determine if racemisation of (S)-3.1 could be achieved preferentially over the dimer 
formation by varying the reaction conditions. Using the homogeneous catalyst provided the 
ability to operate at higher temperatures than could be achieved with the heterogeneous 




Scheme 61. Racemisation of (S)-3.1 using [Cp*IrI2]2 catalyst 3.5. 
 
The reactions were carried out under batch conditions, using 0.23 M amine, 2 mol% 
homogeneous [Cp*IrI2]2 catalyst 3.5 in toluene at 100 ºC. The ee of (S)-3.1 was unchanged 
over the course of the reaction, indicating that it was not being racemised (Figure 15). 
However, dimers were again formed until no more monomer remained in the reaction 
solution after 7 h.  
 
Figure 15. Racemisation of (S)-3.1 using [Cp*IrI2]2 catalyst 3.5. (Dimers corresponds to a 





Previous work carried out within the research group showed that the combination of amine 
and imine without any [Cp*IrI2]2 catalyst did not produce dimers.
116
 This showed that 
coordination to the catalyst is required to form dimers. The formation of dimers indicated 
that coordination to the catalyst and de-hydrogenation was occurring but that the reaction 
with a second amine molecule was favoured over the re-hydrogenation of the imine. As no 
racemisation was observed, the H2 produced on de-hydrogenation was not being used to re-
hydrogenate the monomer imine and so was presumably being used to hydrogenate the 
dimer imine, as no gas evolution was observed. 
Based on these findings and other work using catalyst 3.5 (discussed in Chapter 5), 
reaction testing was then carried out using the homogeneous [Cp*IrI2]2 catalyst 3.5 at 
higher temperatures. Reactions were carried out using 0.5 mol% catalyst 3.5 and 1 M (S)-
3.1 in anisole under microwave heating at the specified temperature for 30 min. The 
shorter reaction times were desirable for coupling to the continuous resolution process. The 




Figure 16. High temperature testing for 3.5 catalysed racemisation of (S)-3.1 using 
microwave heating. 
 
At higher temperatures, the amine was found to racemise from 96% ee at 150 °C to 5% ee 
at 200 °C. However, the production of dimers also increased, up to 85% conversion of 
amine at 200 °C. Since racemisation was only achieved when the reaction temperature was 
> 150 °C, this was inappropriate for the heterogeneous catalyst, due to the stability of the 
polymer support. If the racemisation using catalyst 3.5 at 200 °C was coupled to the 
enzymatic resolution, there would be virtually no amine monomer remaining after one 
cycle of resolution-racemisation-resolution. This prevented the possibility of coupling both 
the racemisation and resolution catalysts in separate packed bed reactors. As the 
conversion of the amine monomer to form dimers was so high, the maximum theoretical 
yield of 100% for a DKR could not be achieved. Indeed, for these conditions only around 
54% yield would be possible when combining the resolution-racemisation-resolution steps 




None of the conditions tested allowed for racemisation to be preferred over dimer 
formation and so this substrate/catalyst system was deemed inappropriate for the desired 
DKR process. 
 
Scheme 62. Theoretical combination of enzymatic resolution with [Cp*IrI2]2 racemisation 
at 200 °C, showing maximum possible yield due to percentage decrease in amine monomer 
in solution. 
 
3.3 Racemisation using Ruthenium Catalyst 
The racemisation of (S)-3.1 was then tested using the Ru Shvö catalyst 3.11 (Scheme 63). 
This catalyst was used by Paetzold et al. for the DKR of primary amines, including (S)-
3.1.
112
 Catalyst 3.11 has been used more widely for the DKR of alcohols,
53, 63, 64
 and has 
only been used for a limited scope of amines due to the high temperature required for 
activation of the catalyst, which led to poor selectivity and was not compatible with the 
enzyme.
65
 Bäckvall et al. developed modified versions of the catalyst by substitution of the 
phenyl groups on the Cp ring with para-substituted aryl groups, and was able to achieve 






Scheme 63. Racemisation of (S)-3.1 using the Shvö catalyst 3.11. 
 
A batch reaction was carried out at 100 °C, using 0.23 M (S)-3.1 and 2 mol% loading of 
catalyst 3.11. For this catalyst, a reduction in amine ee was observed over the course of the 
reaction to 2% after 53 h (Figure 17). However, significant formation of dimers was also 
observed, with all of the amine being consumed as dimers after 72 h. 
Whilst the racemisation of (S)-3.1 occurred to a greater extent when using the Ru catalyst 
compared to the Ir catalyst, the formation of dimers was so significant that the amine had 
been almost completely converted by the time the ee had dropped to a sufficiently low 
level. The reaction with the Ru catalyst was also much slower, taking several days to 
racemise. This meant that the reaction was too slow to be able to couple to the continuous 
enzymatic resolution (tRes = 6 min) and to set-up a re-circulating DKR process. For these 
reasons, catalyst 3.11 was not suitable for the racemisation of this substrate and was not 
investigated further. Im et al. reported an immobilised version of the Shvö catalyst, using a 
modified γ-alumina support, for the DKR of 1-phenylethanol.
118
 And so this may be an 
area of further research, although the modified Shvö-type catalysts developed by Bäckvall 








Figure 17. Racemisation of (S)-3.1 using catalyst 3.11 (top panel = area ratio as 






3.4 Racemisation using Palladium Catalyst 
Pd/C heterogeneous catalyst was then tested for the racemisation of (S)-3.1 (Scheme 64). 
The use of Pd/C in a DKR of (S)-3.1 was first described by Reetz,
59
 for which a yield of 
64% was achieved after 8 days. Parvulescu et al. showed that using Pd on alkaline-earth 
supports (BaSO4) gave higher selectivities in the DKR of primary benzylic amines, again 
with reaction times of several days.
60
 In both cases significant hydrogenolysis of the 
benzylamine took place forming ethylbenzene as a by-product. Pd/C is non-selective, so 
limits the types of substrate that can be used. Nevertheless the simplicity of the system 
makes it attractive to evaluate in continuous flow DKR.   
 
 
Scheme 64. Racemisation of (S)-3.1 using Pd/C 
 
3.4.1 Batch Reactions 
The racemisation was studied initially under batch conditions, with variation of 
temperature, catalyst loading and the percentage of Pd in the catalyst (Table 7). All of the 
reactions using Pd/C showed dimer formation but no racemisation of amine 3.1. Increasing 
the percentage of Pd in the catalyst from 5% to 10% did not appear to affect the degree of 
dimer formation (Entries 1 and 3). However, increasing the temperature from 70 to 100 °C 
did increase the conversion of 3.1 to 50% (Entry 2). Pd/BaSO4 was also tested as the 
racemisation catalyst as the literature suggested that alkaline-earth metal supports favour 
the racemisation reaction over any by-product formation.
60
 No racemisation or dimer 






















 / % 
1 5% Pd/C 5.7 70 24 99 16 
2 5% Pd/C 6.4 100 23 99 50 
3 10% Pd/C 8.5 70 23 99 10 
4
b 




Reaction conditions: 0.33 mmol (S)-3.1, 4.0 mL toluene, 200 µL decane as internal standard; 
b
Reaction 
conditions: 0.35 mmol (S)-3.1, 5.0 mL toluene, 5% Pd/ BaSO4 catalyst, 70 °C; 
c
Determined by chiral GC 
after derivatisation with trifluoroacetic anhydride; 
d
Determined by chiral HPLC after derivatisation with 
acetic anhydride; 
e
Determined by achiral GC. 
 
3.4.2 Continuous Reactions 
It was envisaged that transferring the reaction to the continuous PBR would allow for the 
catalyst loading to be increased relative to amine (S)-3.1, and these more forcing 
conditions may enhance the reaction. The second reactor set-up (Figure 14, B) was used 
with the reactor packed with 5% Pd/C catalyst. The reactor was heated to 70 ºC and the 
reaction solution (0.07 M (S)-3.1 in toluene) was pumped through the reactor using a Jasco 
PU-980 dual piston pump, set to a flow rate of 0.1 mL min
-1
 (tRes = 30 min). The catalyst 
loading within the reactor was 24 mol% relative to the total amount of reaction solution 
passed through (24 mL). Each RV was collected separately at the reactor outlet and 
analysed for ee and conversion. No racemisation or dimer formation was observed using 
the continuous system.  
These results indicated that the catalyst loading was not a significant variable for this 
reaction, as increasing the catalyst loading did not enhance the reaction. Based on the 
studies in the literature,
53, 60
 it would also be expected that the reaction of Pd/C would 
require H2 to proceed with the desired racemisation reaction, as the H2 would be available 
to re-hydrogenate the imine and out-compete the dimer formation. The PBR used in these 
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experiments was not designed to allow simultaneous flow of H2 gas. To do this an 
alternative reactor design would be required, such as the Thales Nano H-Cube®
119
 or 
multi-stage continuous stirred tank reactors (CSTRs) that allow triphasic flow with good 
mixing, as being developed in the iPRD lab.
120
 The lack of racemisation using Pd/C under 
any conditions tested meant that this catalyst was not investigated any further. 
 
3.5 Conclusions 
The metal catalysed racemisation of (S)-3.1 was investigated using Ir, Ru and Pd catalysts 
for the potential use in DKR. Heterogeneous Ir catalyst 3.2 was tested using a continuous 
PBR, with a view to coupling to the enzymatic resolution continuous PBR for a DKR 
process. No racemisation occurred but conversion of amine 3.1 to dimer products was 
observed. The formation of dimers in flow was an example of N-alkylation in flow via 
hydrogen borrowing,
29
 which will be investigated further (Chapter 5). Racemisation was 
achieved using homogeneous Ir catalyst 3.5 when high temperatures were used (200 °C). 
Unfortunately, the amount of dimer formation (85%) was prohibitive at this temperature 
for these conditions to be used for the DKR process. 
Using the homogeneous Ru catalyst 3.11 the amine ee did reduce over time to 2% after 53 
h, however, the amount of amine monomer remaining at that time was only 6%, and then 
dropped to 0%. The reaction using this catalyst was very slow and the dimer formation still 
dominated and so this catalyst was not studied any further. The use of the modified Ru 
catalysts developed by Bäckvall may have been beneficial to this process as they displayed 
higher selectivity for the racemisation over the dimer formation.
112
 However, the reported 
DKR using these catalysts required a reaction time of 3 days and so would not have been 
an improvement on the long reaction time for catalyst 3.11 and would still not have been 
suitable for this reactor set-up. 
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Finally, Pd/C was tested under batch conditions and using the continuous PBR. No 
racemisation was observed for any of the reactions and dimer formation was again 
prevalent. Increasing the temperature did not encourage racemisation and caused an 
increase in dimer formation. Increasing the catalyst loading within the PBR did not 
encourage the racemisation. The Pd/C catalyst may require gaseous H2 to achieve 
racemisation, which was not feasible within the current reactor set-up. 
For all conditions tested, dimer formation occurred preferentially over racemisation. The 
presence of dimers indicated that the amine was being de-hydrogenated but that the 
coupling of a second amine molecule was occurring in favour of re-hydrogenation. For the 
reactions in which a drop in amine ee was observed, the formation of dimers was too 
significant and meant that there was little amine monomer remaining in solution by the 
time the ee had dropped to a suitable level. Therefore these catalysts were not suitable for 
the racemisation of (S)-3.1 to be used in the desired continuous DKR system. 
Reducing the concentration of the amine could also be investigated as a method to reduce 
the dimer formation. A lower concentration of amine would reduce the rate of reaction as 
the amine is present in the rate determining step. This may allow re-hydrogenation of the 
monomer imine to occur before dimer formation. Slow addition of the amine into the 




4 Continuous Ammoniolysis for the Production of Amides 
4.1 Introduction 
In Chapter 2 the lipase catalysed reaction of amines with esters for the production of single 
enantiomer amines and amides was studied. In that reaction the amine reacts with the acyl-
intermediate formed in the active site between the ester and the serine residue (Scheme 
65). Many examples exist that employ different nucleophiles
105
 to interact with this 
intermediate, including hydrazine
121, 122





Scheme 65. Reaction of a nucleophile (Nu) with the acyl-enzyme intermediate within the 
lipase active site. (Full active site mechanism shown in Chapter 2). 
 
The reaction of ammonia with the acyl-enzyme intermediate to produce amides, termed 
ammoniolysis, was first described by Sheldon et al. for the production of octanamide 4.2 











The reaction was further developed for the reaction of carboxylic acids, via lipase 
catalysed esterification followed by ammoniolysis,
127
 and amino acid esters.
128, 129
 
Although high conversions and high enantioselectivities were observed, the reactions 




It was envisaged that the use of a continuous PBR, using an immobilised lipase, would 
reduce the reaction time and improve the productivity. The packed bed allows for the 
reaction mixture to be exposed to a much higher amount of catalyst than is possible in a 
batch reaction.
101
 The lifetime of the catalyst may also be increased using the packed 
reactor compared to a stirred vessel, as mechanical stirring can lead to increased 
breakdown of the immobilised catalyst.
85
 Also, the use of an immobilised catalyst allows 
for easy separation and re-use and the constant removal of the reaction stream under flow 
conditions should prevent any hydrolysis of the starting ester to the carboxylic acid that 
could occur in the presence of H2O.  
Slotema et al. reported a continuous procedure for the lipase catalysed ammoniolysis of 
oleic acid 4.3 with NH3 for the synthesis of oleamide 4.4 (Scheme 67).
130
 A PBR was 
employed filled with lipase B from Candida antartica (CalB) and ammonium carbonate 
was used as the NH3 source, with 2-methyl-2-butanol as the solvent. The highest 
conversion achieved was 97% for a 90 min residence time (tRes). 
 
 






Luque et al. described a continuous procedure for the lipase catalysed ammoniolysis of 
ethyl octanoate 4.1, using a gas-liquid membrane reactor in which the enzyme was 
immobilised onto a membrane.
131
 A liquid substrate feed and a gaseous NH3 feed were 
combined in the enzyme membrane reactor and a re-circulation loop set-up. No 
information regarding flow rates and tRes within the reactor were provided, however an 
octanamide 4.2 yield of 95% after 10 h of operation was reported. As a re-circulation 
process was used it can be inferred that a single pass through the enzyme membrane 
reactor was not sufficient to convert all of the substrate. Re-circulation of the reaction 
solution once the substrate has partially converted can lead to inconsistencies in the 
conversion for subsequent cycles. As the substrate concentration is reduced with each 
cycle, the likelihood of contact between the substrate and enzyme is reduced. In addition, 
the system has a finite amount of substrate within the re-circulating mixture. In a truly 
continuous system the substrate solution would be constantly replenished and so the 
throughput of the system would be much higher. 
This chapter describes the development of a lipase catalysed ammoniolysis process using a 
continuous PBR for the production of two generic pharmaceutical compounds: 
nicotinamide and pyrazinamide. The reaction conditions were optimised for conversion 
using a design of experiments (DoE) approach and then further green metrics were 
calculated for the process to determine productivity and efficiency. This technique was 
applied to the resolution of a chiral substrate.  
 
4.2 Ammoniolysis for the Production of Nicotinamide 
Nicotinamide 4.5 (Figure 18) is on the World Health Organisation (WHO) essential 
medicines list, as a member of the vitamin B family.
97
 As these types of essential 
114 
 
medicines are particularly required in the developing world, it is important that generic 
pharmaceuticals such as nicotinamide can be produced using cheap and efficient methods.  
 
 
Figure 18. Structure of nicotinamide 4.5.  
In 2005, Chuck presented a review of the developments in nicotinate production, including 
nicotinamide and nicotinic acid, from starting material synthesis to reaction development 
and work-up procedures.
132
 The most widely used chemical synthesis of nicotinamide 
starts from 3-picoline 4.6, which is subjected to ammoxidation conditions to produce 3-
cyanopyridine 4.7 (Scheme 68A). The nitrile is then hydrolysed by exposure to strongly 
basic conditions to produce nicotinamide 4.5. This chemical synthesis method generally 
suffers from the production of large amounts of nicotinic acid 4.8 as a by-product, due to 
over-hydrolysis in the presence of base (Scheme 68B). 
 
Scheme 68. Chemical synthesis of nicotinamide: (A) Ammoxidation of 3-picoline 4.6 to 
produce 3-cyanopyridine 4.7; (B) Hydrolysis of 3-cyanopyridine 4.7 to produce 






An enzymatic process using nitrile hydratase from Rhodococcus to form amides via the 
hydrolysis of nitriles was identified by Nagasawa et al.
133
 and patented along with Nitto 
Chemical Industry Co (Scheme 69).
134
 Nitrile hydratase enzymes catalyse the hydrolysis of 
nitriles with H2O to produce amides, unlike nitrilase enzymes which catalyse the 
conversion of nitriles to the corresponding carboxylic acids and NH3.
133
 The enzymatic 
reaction was found to be much more selective than the chemical synthesis methods, as no 
nicotinic acid by-product was formed. 
 
 
Scheme 69. Enzymatic hydrolysis of nitriles to form amides using nitrile hydratase. 
 
This was further developed by Lonza,
135
 who have implemented the process in their China 
plant to produce over 3500 tonnes of nicotinamide per year.
136
 The Lonza process involved 
four continuous catalytic reactions, with the final step being the enzymatic hydrolysis in 
which the substrate solution was pumped continuously into a reactor containing the nitrile 
hydratase immobilised in polyacrylamide (Scheme 70). As this is a patented process, broad 









In the following sections the production of nicotinamide via lipase catalysed ammoniolysis 
of the corresponding carboxylic acid and methyl ester was investigated. The aim was to 
develop the reaction in a continuous system to be able to expose the substrate to more 
forcing reaction conditions and to be able to reduce the reaction time whilst achieving high 
conversion to product.  
 
4.2.1 Batch Ammoniolysis 





Scheme 71. Nicotinamide 4.5 synthesis from nicotinic acid 4.8 (N435 = Novozyme 435). 
 
The solubility of nicotinic acid 4.8 was tested in a 3 of commercially available NH3 
solutions: aqueous (30-33% NH3), 1,4-dioxane (0.5 M) and MeOH (0.46 M and 1.79 M, 
prepared from a 7 N commercial solution). Nicotinic acid 4.8 was found to be poorly 
soluble in organic solvents, but was soluble in an aqueous NH3 solution at 0.07 M substrate 
concentration. This substrate concentration was used based on the concentration screening 
results carried out in Chapter 2. Using this result, the reaction to form nicotinamide was 
carried out in an aqueous NH3 solution (0.5 M) using commercially available immobilised 
lipase B from Candida Antarctica (Novozyme 435, N435) at 60 °C (Scheme 71), however 
no product was observed after 24 h. Due to the poor solubility and un-reactivity of 
nicotinic acid, the substrate was changed to methyl nicotinate 4.11. The reaction of methyl 
nicotinate 4.11 to form nicotinamide 4.5 was carried out under batch conditions using NH3 
solution (0.5 M in 1,4-dioxane) and N435 at 60 °C (Scheme 72).  
 
Scheme 72. Nicotinamide 4.5 production from methyl nicotinate 4.11. 
 
The choice of NH3 solution was determined by three factors: availability, solubility and 
reactivity. The three commercially available NH3 solutions considered were aqueous, 
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MeOH and 1,4-dioxane. Aqueous solution was not used due to concerns over the potential 
for hydrolysis to produce the carboxylic acid. MeOH solution would have been preferred 
over 1,4-dioxane in terms of greener solvents,
137
 however no reaction was observed when 
using MeOH solutions (see solvent comparison section). Therefore, NH3 in 1,4-dioxane 
was used as it was commercially available, both the substrate and product showed good 
solubility and the reaction was shown to proceed.  
Under these conditions, nicotinamide 4.5 was obtained in 15% isolated yield after 27 h, 
using an enzyme loading of 14 mg catalyst per mmol of substrate (121 mg substrate, 12 
wt%). A control reaction, carried out in the absence of N435, showed no formation of 
nicotinamide 4.5 after 27 h and so no background reaction was taking place.  
 
4.2.2 Continuous Ammoniolysis 
4.2.2.1 Reactor Design 
The reaction of methyl nicotinate 4.11 to form nicotinamide 4.5 was then transferred to a 
continuous PBR system (Figure 19), described in detail in Chapter 2. The stainless steel 
tubular reactor (1/4” OD, 1/8” ID, 2.8 mL) was manually packed with N435 and a 75 psi 
back-pressure regulator (BPR) was fitted to the outlet of the reactor. The reactor was 
installed within the aluminium heating block and the desired temperature set using the 
Eurotherm temperature controller. A stock solution of methyl nicotinate 4.11 (0.07 M) 
dissolved in NH3 solution (0.5 M in 1,4-dioxane), with biphenyl added as internal standard, 
was pumped through the reactor as one feed using a Jasco PU-2085 dual piston pump. 
Each reactor volume (RV) was collected as a separate sample at the reactor outlet and 
analysed by HPLC, which was calibrated for methyl nicotinate and nicotinamide against 
the internal standard, to determine a percentage conversion for each reactor volume (for 





Figure 19. Continuous ammoniolysis PBR design. (A) Piston pump; (B) Tubular reactor 
packed with N435; (C) Aluminium heating block; (D) Eurotherm temperature controller; 
(E) BPR; (F) Product outlet and collection. 
 
4.2.2.2 Scoping Reactions 
A DoE approach was applied to determine the optimum operating conditions for the 
continuous ammoniolysis of methyl nicotinate 4.11. The most common method employed 
for optimisation of reaction conditions is the one variable at a time approach (OVAT) in 
which one reaction parameter (e.g temperature) is varied until the highest yield is achieved 
and then the temperature is maintained at that optimum value whilst another reaction 
parameter is varied until the highest yield is found. This method requires a large number of 
experiments when many variables are being considered and does not account for any 





 DoE is a statistical method to be able to determine significant variables and 
interactions and to generate optimum conditions for a given process. The nature of 
experimental design defines the specific experiments that are required before any lab work 
is started, allowing for fewer experiments to be carried out. This method is able to account 
for interactions between variables unlike the OVAT approach and can fit a model within 
the design space to predict the outcome for reactions that have not yet been carried out 
experimentally. The type of experimental design will vary depending on the number of 
variables and the objective of the design (screening or optimisation) and is chosen to obtain 
the maximum amount of information about the process.  
The general procedure for optimisation by DoE follows Figure 20. First scoping reactions 
are carried out to determine the design space to be explored, which is defined by the upper 
and lower limits for each of the variables being investigated. Once the appropriate design 
space has been chosen, screening reactions are carried out. These reactions are typically 
employed to determine the variables that have a significant effect on the process and those 
which do not, allowing for the variables to be narrowed down. The optimisation stage 
involves further experimentation within the design space using the significant variables, 
resulting in a response surface across the whole design space and allowing for prediction of 
the optimum conditions. The final stage is robustness testing, in which reactions are carried 
out to verify the predicted optimum. The design space is reduced around the predicted 
optimum and reactions carried out to determine how far from the predicted optimum the 





Figure 20. Stages followed for process optimisation by design of experiments (DoE). 
 
As with all techniques, there are limitations and assumptions made when using DoE. For 
example it is assumed that there are no other unknown competing pathways that could 
occur during the experiment and so the variables and responses chosen can only be those 
that are foreseen by the experimenter and selected for using prior chemical knowledge or 
experimentation. As in traditional OVAT approaches to optimisation, if an important 
variable is omitted from the list of variables tested in a DoE then it will not be included in 
the model. However, statistical tests that can be carried out with DoE data can indicate 
whether there is lack of fit in the model and if a variable is missing. However, it cannot 
give information as to what that variable is, or what the contribution of that variable is to 
the overall reaction outcome. Therefore it is crucial to have some understanding of the 
process before carrying out an experimental design, and the amount of prior knowledge 
will dictate the starting point for the design: scoping, screening or optimisation. 
 
In this work, scoping reactions were first carried out to determine upper and lower limits 
for the three variables being considered: tRes, temperature and catalyst loading (Table 8). 
Catalyst loading was determined as the total mass of immobilised catalyst packed into the 
reactor, 1.0 g catalyst represented a completely filled reactor and so for the lower catalyst 
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loadings, glass beads were mixed with the catalyst before packing into the reactor. This 
ensured the same total reactor volume for all reactions studied. 
 
Table 8. Conversion of methyl nicotinate 4.11 obtained in scoping reactions.
a 








Low 20 40 0.5
b 
29 
Mid 40 60 0.75
b 
78 
Mid 40 60 0.75
b 
76 
High 60 80 1.0 89 
a
Reaction solution =  1.75 mmol methyl nicotinate 4.11 in 25 mL NH3 solution (0.5 M in 1,4-dioxane), 
biphenyl added as internal standard. Reactor volume = 2.8 mL; 
b
Glass beads added to fill the reactor; 
c
Determined by HPLC analysis, after calibration against internal standard. 
 
The results obtained were plotted in Figure 21 with the lower limit set to -1, the mid-point 
set to zero and the upper limit set to +1. Scoping reactions are used to determine whether it 
is likely that a good model fit will be achievable, and therefore that the limits chosen for 
the variables are appropriate. The results of the scoping reactions showed that the design 
space chosen was appropriate and so these limits were used for optimisation reactions. As 
there were only three variables being considered, it was deemed unnecessary to carry out a 





Figure 21. Results of scoping reactions, plotted as lower limit = -1, mid-point = 0 and 
upper limit = +1. 
 
4.2.2.3 Optimisation Reactions 
A response surface methodology (RSM) was then employed to carry out a three-level 
central composite face-centred (CCF) design for three variables.
139
 Three-level designs are 
used for optimisation reactions because a quadratic model is generated, which allows a 
surface to be fitted across the design space. In a CCF design (Figure 22), experiments are 
carried out for the corner points, the centre point and the points in the centre of each face 
(‘star points’) of a cube that has been composed from the three variables attributed to the 




Figure 22. CCF experimental design. (Black spheres indicate corner point and centre point 
experiments, blue spheres indicate star point experiments). 
 
In total 17 experiments were carried out, including 3 replicates of the mid-point experiment 
(Data shown in Appendix A). Statistical design software (MODDE) was used to fit a 
response surface to the data using multiple linear regression (MLR). The summary of fit 
plots (Figure 23) for both conversion of methyl nicotinate 4.11 (left) and conversion to 





validity and reproducibility. The R
2
 value shows how well the model fits the data, the Q
2
 
value is a measure of how well the model predicts new data and the model validity shows 
if there is ‘lack of fit’ in the model, a value greater than 0.25 shows that there is no lack of 
fit. Reproducibility shows the degree of variation in the data obtained from the replicates 
of the centre point experiments.
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 As only conversion of methyl nicotinate 4.11 to 
nicotinamide 4.5 was observed the data and model produced would be expected to be the 
same, which can be seen in the summary of fit plots. There was only a slight difference in 
the values for model validity and reproducibility, with the reproducibility being marginally 
higher and the model validity being marginally lower for the conversion to amide plot.  
The variation between the data for the two responses (conversion of methyl nicotinate and 





Figure 23. Summary of fit plots for conversion of methyl nicotinate 4.11 (left) and 
nicotinamide yield 5 (right). 
 
The model generated was then used to predict optimum conditions, via the optimizer 
function in MODDE. Figure 24 shows the contour plot for the conversion of methyl 
nicotinate model, with the predicted optimum conditions denoted by the black cross. The 
predicted optimum was 99% conversion at 60 min tRes, 67 °C and 1.0 g catalyst loading. 
The contour plots showed that the highest conversions would be achieved at the highest 
tRes and catalyst loadings, but at intermediate temperatures. This would be expected as the 
longer tRes and higher catalyst loadings would mean that the substrate was exposed to 
more catalyst and for a longer period, leading to a higher conversion. The temperature 
effect would also be expected in terms of the recommended operating conditions for N435, 







Figure 24. Contour plot showing conversion of 4.11 for tRes vs. temperature. Percentage 
conversion shown by the contour lines and colour: blue = low conversion, red = high 
conversion. Catalyst loading is not shown on the plot and is set to 1.0 g. Predicted 
optimum conditions denoted by the black cross. 
 
4.2.2.4 Testing of Optimum Conditions 
A reaction was carried out in the continuous reactor using the predicted optimum 
conditions, which gave 94% conversion of ester 4.11. This was the same conversion as was 
achieved for the most forcing conditions, which was unsurprising as a large area of the 
contour plot showed 95 – 100% conversion (red). This also indicated that even less forcing 
conditions could still be used to achieve the optimum conversion, as the temperature was 
reduced from 80 °C to 67 °C without a drop in conversion. The model predicted a large 
area of the design space where the optimum conversion could be achieved, and so further 
reactions could be carried out to determine how far from the predicted optimum conditions 
reactions can be carried out without observing a decrease in conversion. The conversion 
obtained with the predicted optimum conditions was slightly lower than the predicted 
conversion. Solid formation was observed within the PTFE tubing between the reactor 
127 
 
outlet and the BPR inlet, which had been previously observed for some reactions with high 
conversions, and so the difference in conversion between the predicted and experimental 
could be attributed to the build-up of material within the tubing when high amounts of 
product were being formed. A control reaction was also carried out under these conditions, 
wherein the reactor was packed with glass beads only. No conversion was observed in this 
control reaction. 
 
4.2.2.5 Comparison of 1,4-Dioxane and Methanol NH3 solutions 
To confirm that 1,4-dioxane was the best choice of solvent, the continuous reaction was 
tested using NH3 solutions in MeOH at two different concentrations. The solutions were 
prepared by dilution of a commercially available 7 N NH3 in MeOH solution and the 
concentration verified by titration with a standardised HCl solution. The two solutions 
(0.46 and 1.79 M) were tested in the continuous system. The concentration of methyl 
nicotinate 4.11 was 0.07 M so as to be consistent with the amount of substrate used in the 
1,4-dioxane reaction and allow for a comparison in the results. Both of the reactions 
showed no conversion of methyl nicotinate 4.11 to nicotinamide 4.5. It was proposed that 
this was due to the MeOH stripping water molecules (Figure 25) from the enzyme surface, 
leading to disruption of the catalyst structure and consequent deactivation.
141, 142
 The 
enzyme surface forms interactions with water molecules that are integral to maintaining the 
3D shape of the enzyme. If these water molecules are removed the 3D shape will be able to 
change, affecting the ability to accept substrates into the active site. The lack of conversion 
could also be a result of the MeOH being able to compete with the NH3 to react at the acyl-
enzyme intermediate, which would result in regeneration of the methyl ester substrate. 
To probe this, the continuous reactor was packed with N435, primed with the NH3 in 





the NH3 in MeOH solution flowed through the reactor for 2 RV (tRes = 60 min). After this, 
the reactor was primed with NH3 in 1,4-dioxane solution (0.5 M) and then a reaction stock 
solution of methyl nicotinate 4.11 was flowed through the reactor for 5 RV (tRes = 60 
min). HPLC analysis of the samples obtained whilst flowing the reaction stock solution 




Figure 25. Proposed stripping of water molecules from enzyme structure in the presence of 
MeOH, showing loss of defined 3D structure. 
 
These results confirmed that 1,4-dioxane was the most appropriate solvent of those 
investigated for this system, as the desired reaction occurred with high conversion and the 
solution is commercially available. 
The dioxane solution was the most appropriate for the process of the solutions tested. 
However, the solvents tested in this study were by no means an exhaustive list and so a 
more favourable solvent in terms of green solvents
137
 could be found with access to more 
resources and more time to increase the screen. Dioxane is not a preferred solvent as it is a 
suspected carcinogen, and so susbstitution is recommended according to the green solvent 
guide. Industrial processes have to meet specific targets in terms of green chemistry 
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approaches and so ensuring that green reagents and solvents are selected early in the 
process development would save time and money. 
 
4.2.2.6 Reaction Metrics 
Transfer of the process from batch to the continuous PBR and subsequent optimisation by 
DoE led to an improvement in conversion and a much reduced reaction time: 94% in 1 h 
compared to 15% in 27 h under batch conditions.  The use of an experimental design 
allowed for reaction optimisation to be achieved faster and with fewer experiments than 
would be required in an OVAT. The catalyst loadings for the initial batch reaction and the 
optimised continuous procedure (per RV) were 14 mg and 5 g of catalyst per mmol of 
substrate, respectively. The high exposure of the substrate to catalyst achievable in the 
PBR resulted in high conversions in shorter tRes, which was not feasible in batch. The 
loading of the catalyst was high in the continuous reactor, which may seem unfavourable 
compared to batch, but the longevity study described in Chapter 2 showed that the catalyst 
was capable of operating for at least 30 h without any reduction in activity. If it could be 
assumed that the catalyst would have the same longevity in this case the catalyst loading 
would actually be much lower relative to the entire amount of reaction solution over time. 
Additionally, the tRes in the resolution study was 6 min and so the catalyst would have 
turned over more times in the 30 h than in the 60 min process developed in this Chapter. 
The turnover numbers (TON) for the resolution and ammoniolysis processes were, 1.05 
and 0.196 mmol of substrate h
-1
 g of catalyst
-1
, respectively. This means that 31.5 mmol of 
substrate was converted in 30 h in the continuous resolution but only 5.88 mmol of 
substrate would be converted in 30 h for the continuous ammoniolysis. The reduced 
number of turnovers per unit time may lead to the catalyst being active for an even longer 
period. A theoretical calculation of the catalyst loading relative to the entire solution that 
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would be flowed through the reactor during 30 h of operation would give 0.17 g of catalyst 
per mmol of substrate. 
Additional reaction metrics were next calculated to assess the productivity and efficiency 
of the optimised continuous process. Space time yield (STY)
108
 is a measure of 
productivity of the process in terms of amount of material produced per volume per time 
and is calculated according to Equation 2.5. The optimised continuous process for the 




. This was quite low due to the 
long tRes and low substrate concentration, which both led to a reasonably low amount of 
product being produced per hour. Although the initial batch reaction carried out before 




, which was 
considerably lower than the continuous process and due to the lengthy reaction time and 
low conversion observed when using un-optimised conditions. The nitrile hydratase 
process described by Nagasawa operated at a much higher substrate concentration of 12 M, 
giving a higher productivity.
133
 However, the reaction time was 9 h and whole cell 
catalysts were used, which could not be recovered and re-used. 
Process mass intensity (PMI) is a measure of the efficiency of the process and the 
associated waste.
143
 It describes how much of the total reaction mass (including solvents 




The PMI for the optimised process was 177, this was high because the reaction 
concentration was quite low and so a higher proportion of the reaction mass was made up 
of solvent compared to the substrate and so a higher proportion of the reaction mass was 
not incorporated in the final product. Solvents are routinely recycled on an industrial scale 
and so the PMI for this process could be reduced by recycling the solvent. Also, for a 
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catalytic process to be industrially viable the catalyst needs to be re-used multiple times 
and so the catalyst is often omitted from calculations of waste and efficiency, which would 
lead to a more preferable PMI. 
Both the STY and PMI may be improved by increasing the substrate concentration within 
the reactor. This variable was not investigated in the experimental design as it was desired 
to keep a low complexity in the design, with a low number of variables. If a fourth variable 
was introduced into the CCF design, 30 experiments would have been required (including 
3 centre point repeats). Additionally, concentration screening carried out in Chapter 2 
showed that higher concentrations would have required a longer tRes for this fully packed 
reactor bed. As the optimum tRes developed for nicotinamide production was already quite 
lengthy for flow (60 min), this would not have been preferable.  
 
4.2.3 Discussion 
The lipase catalysed ammoniolysis of methyl nicotinate 4.11 for the production of 
pharmaceutically relevant nicotinamide 4.5 was carried out using an immobilised enzyme 
within a continuous PBR. After initial testing in batch, the process was transferred to the 
continuous reactor and optimised using DoE.  
The aim was to develop an efficient process for the synthesis of a generic pharmaceutical 
and synthetic building block. By transferring the process into a packed bed reactor, the 
substrate could be exposed to a much higher amount of catalyst than was feasible in a 
batch reactor, leading to a higher conversion in a shorter amount of time. When reactions 
were carried out in batch using the same amount of reaction solution and catalyst loading 
as in the continuous reaction it was difficult to mix the catalyst throughout the whole 
solution without increasing the stirrer speed to a point where high attrition of the particles 
was observed. The use of a PBR also allowed for the catalyst to be constrained within the 
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reactor bed and so isolated from the solution, which would allow for easier separation and 
re-use than in batch.  
The immobilised catalyst used was commercially available and widely used in industry. 
The NH3 solution was also commercially available and, whilst the solvent was not 
preferred in terms of green solvents,
137
 a comparison against a MeOH solution confirmed 
that the 1,4-dioxane solution was the most appropriate for this system. In this case, the vast 
difference in reactivity between the two solvents meant that productivity outweighed 
greenness. 
The reaction conditions were optimised via DoE using a CCF design for three variables: 
temperature, tRes and catalyst loading. Using this design, 17 experiments were carried out 
and the data modelled to be able to predict optimum reaction conditions. Using these 
predicted optimum conditions (67 °C, 60 min, 1 g catalyst) 94% conversion was achieved. 
STY and PMI metrics were calculated to determine the productivity and efficiency of the 
process developed. This showed a significant improvement on the initial batch reactions 
due to the large reduction in reaction time. However, the substrate concentration was quite 
low in the reaction and so this led to lower values for STY and PMI than would be desired. 
This may be improved by further experimentation into the effect of concentration on the 
process. 
Compared to existing ammoniolysis reactions in batch the procedure developed herein had 
a vastly reduced reaction time and so a much greater productivity. For example, the batch 











 for this process. The tRes was also shorter than for the 
continuous PBR employed by Slotema et al.
130
 and the high conversion was achieved with 
a single pass through the reactor unlike the re-circulation required for the continuous 
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No nicotinic acid by-product was observed in this system which is an advantage over the 
traditional chemical synthesis
132
 of nicotinamide 4.5 and is analogous with the nitrile 
hydratase procedure.
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 As specific reaction conditions for the nitrile hydratase procedure 
used for manufacture by Lonza were not available, a more detailed comparison could not 
be made. Whilst the nicotinamide product itself is a generic pharmaceutical the nitrile 
hydratase procedure is not and is protected under patent and so the process is not widely 
applicable. The immobilised nitrile hydratase is protected and so is not commercially 
available, meaning that a direct price comparison could not be carried out between the 
nitrile hydratase and lipase. However, because N435 is commercially available and has 
been widely used in academia and industry and there are more examples of commercially 
available lipases than nitrile hydratase, it can be reasonably inferred that the lipase would 
be cheaper than the nitrile hydratase and so the contribution of cost from the enzyme to the 
whole process would be lower for the lipase catalysed process. 
The reaction was not investigated any further as high conversions were obtained within a 
much shorter time frame than in batch. Ideally, a further reduction in the tRes for the 
process would be desired. However, further increasing the temperature would be 
unfavourable due to the effect on the long term stability of the enzyme, and the amount of 
catalyst could not easily be increased as this would require a larger reactor and heating 
block to be able to pack more into it. Therefore it would have been difficult to force this 




4.3 Ammoniolysis for the Production of Pyrazinamide 
Pyrazinamide 4.12 (Figure 26) is a treatment for tuberculosis (TB) that is also on the WHO 
essential medicines list.
97
 In 2005, 1.8 million people died from TB, with 95% of these 
deaths occurring in developing countries.
144
 The higher occurrence of TB cases in 
developing countries reaffirms the need for cheap and efficient routes for pyrazinamide 
synthesis to ensure it is affordable and accessible. 
 
Figure 26. Structure of pyrazinamide 4.12. 
 
Pyrazinamide was synthesised by Hall and Spoerri in 1940 from pyrazine-2,3-dicarboxylic 
acid 4.13 (Scheme 73).
145
 The first step involves decarboxylation at 210 °C to give 
pyrazine-2-carboxylic acid 4.14, followed by esterification with MeOH to give methyl 
pyrazine-carboxylate 4.15. The final step was the chemical ammoniolysis step for the 
reaction of NH3 with methyl ester 4.15 to produce pyrazinamide 4.12, which required 
reaction overnight to give a 92% yield. Pyrazinamide can also be synthesized 











Suresh et al. reported the Pd-catalysed aminocarbonylation of hetero-aryl halides to 
produce primary amides, and applied this to the production of pyrazinamide 4.12 to 
achieve 76% yield on 10 mmol scale after 3 h (Scheme 74).
146
 The use of expensive metal 
catalysts, ligands and a high number of reaction components would lead to a high reaction 
cost if this were to be carried out on larger scale. In addition, in pharmaceutical synthesis it 
is unfavourable to have a metal catalysed reaction as the final step in the synthesis of an 
active pharmaceutical ingredient (API). The United States Food and Drug Administration 
(FDA) guidelines for impurities in APIs requires Pd levels to be < 10 ppm and so stringent 
purification must be carried out to ensure the removal of the metal, leading to increased 
cost and processing time.
147
 The continuous lipase procedure in this work uses far fewer 
reaction components and does not use metal catalysts and so circumvents these process 
issues.   
 




An example of the continuous flow synthesis of pyrazinamide 4.12 was presented by 
Ingham et al. as an intermediate in the automated production of piperazine-2-carboxamide 
4.18 (Scheme 75).
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 Pyrazinamide 4.12 was produced by the hydration of pyrazine-2-
carbonitrile 4.17 using hydrous zirconia in a PBR in quantitative yields after a 20 min tRes 
at 100 °C. It was found that without the addition of H2O to the reagent stream the catalyst 






Scheme 75. Literature automated continuous flow synthesis of pyrazinamide 4.12 and 




In the following sections, the reaction conditions developed in the continuous production 
of nicotinamide 4.5 was applied to the synthesis of pyrazinamide 4.12 to determine 
optimum conversion. Green metrics were again calculated to determine productivity and 
efficiency. 
 
4.3.1 Continuous Ammoniolysis 
The optimum conditions determined for nicotinamide 4.5 were applied to the production of 
pyrazinamide 4.12 from the methyl ester 4.15 in the continuous reactor (Scheme 76).  
 
 
Scheme 76. Lipase catalysed ammoniolysis of methyl ester 4.15 to produce pyrazinamide 
4.12. 
 
The continuous reactor set-up was the same as used for the nicotinamide studies (Figure 
19). The continuous reaction using the predicted optimum conditions (60 min tRes, 67 °C, 
1.0 g catalyst) gave full conversion of the methyl ester 4.15 to pyrazinamide 4.12 (Table 9, 
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Entry 1). Due to the complete conversion observed under these conditions the reaction was 
further investigated using less forcing conditions (Table 9). Complete conversion was 
observed even at the lower limits of the variables (Entry 3) and so the reaction at the lower 
limits was repeated with the catalyst further reduced to 0.25 g (Entry 4), for which 98% 
conversion was observed. A control reaction was carried out using the lower limits of tRes 
and temperature, with the reactor packed with glass beads (Entry 5). A small amount of 
pyrazinamide 4.12 product was observed in the HPLC samples, with a conversion of 1.5%. 
The control reaction was then repeated at the upper limits of tRes and temperature, for 
which a conversion of 10% was observed (Entry 6). A batch reaction was also carried out 
using the least forcing conditions, 98% conversion was observed after the 20 min reaction. 
 
Table 9. Lipase catalysed continuous ammoniolysis for pyrazinamide 4.12 formation.
a
 








1 60 67 1.0 100 
2 40 60 0.75
b 
100 
3 20 40 0.50
b 
100 
4 20 40 0.25
 b
 98 
5 20 40 0 1.5 
6 60 80 0 10 
a
Reaction solution =  1.75 mmol methyl ester 4.15 in 25 mL NH3 solution (0.5 M in 1,4-dioxane), biphenyl 
added as internal standard. Reactor volume = 2.8 mL; 
b
Glass beads added to fill the reactor; 
c
Determined by 
HPLC analysis, after calibration against internal standard. 
 
4.3.1.1 Comparison of 1,4-Dioxane and Methanol NH3 solutions 
From the positive results using NH3 in 1,4-dioxane described above, the reaction using the 
lower limit was repeated using the two different NH3 in MeOH solutions used in the 
nicotinamide study (0.46 and 1.79 M). Ester 4.15 was not completely soluble in the MeOH 
solution and so the reactor set-up had to be modified to include a filter on the end of the 
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tubing that was pumping out of the reaction stock solution to prevent solid from blocking 
the pump head. The poor solubility meant that inconsistencies were seen in the amount of 
ester 4.15 observed in the HPLC samples. The reference sample taken from the reaction 
stock had to be filtered before running the HPLC analysis. Therefore, some of ester 4.15 
was removed and a reference from which to calculate the conversion in the reactor vs. the 
stock solution could not be obtained.  
However, all HPLC samples showed the presence of pyrazinamide 4.12, including the 
reference sample taken from the reaction stock, indicating that the reaction was occurring 
without the N435 catalyst. A comparison of the concentrations determined from the HPLC 
data showed that the concentration of pyrazinamide 4.12 in the reaction stock was equal to 
the concentration in the samples collected at the outlet of the reactor and so no further 
reaction was occurring in the presence of the lipase. This reflected the deactivation of the 
enzyme observed when using the MeOH solutions in the nicotinamide study. The poor 
solubility, inconsistencies in analysis and un-catalysed background reaction showed that an 
NH3 solution in MeOH was not appropriate for this continuous lipase system and 
confirmed that the NH3 solution in 1,4-dioxane was the most suitable.  
 
4.3.1.2 Reaction Metrics 
The reaction metrics were again calculated to determine the productivity and efficiency of 
the process and to give a comparison of the two substrates. The STY was calculated for the 




. This showed a 
higher productivity than the nicotinamide process as the tRes was shorter for the 
pyrazinamide process and so more product was produced per hour. The PMI was 
calculated as 141, which was slightly lower than the nicotinamide PMI, due to the 
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reduction in catalyst loading. Again these metrics could be improved by investigation of 
the effect of substrate concentration, requiring further experimentation.   
 
4.3.2 Discussion 
Due to the high yield of pyrazinamide 4.12 achieved with the least forcing conditions, 
further optimisation for this substrate was deemed unnecessary. The pyrazinamide reaction 
required a shorter tRes to achieve the same high conversions as for the nicotinamide 
reaction, indicating that the catalyst was more reactive toward the pyrazinamide substrate. 
This is due to the presence of the second nitrogen atom in the aromatic ring for the 
pyrazine, which makes the ring more electron deficient and consequently makes the 
carbonyl carbon more electrophilic. The higher electrophilicity of the carbonyl carbon 
allows for more facile nucleophilic attack by the serine residue in the active site and by 
NH3 and so the reaction progress more readily than for nicotinamide. 
The continuous enzymatic process developed in this work achieved the same conversion 
within the same tRes as in the continuous chemical process described by Ingham et al.
148
 
However, the reaction temperature was significantly reduced for the enzymatic reaction 
(40 °C) compared to the chemical reaction (100 °C), showing a much lower energy 
demand for the enzymatic process. 
 
4.4 Ammoniolysis of a Chiral Substrate 
Wegman et al. described the lipase catalysed ammoniolysis of phenylglycine esters and in 
situ racemisation under batch conditions (Scheme 77, A).
129
 Variation of the ester group, 
solvent and temperature produced phenylglycine amide 4.20 in 85% conversion and 88% 
ee for the DKR process. The coupled reaction had to be carried out at -20 °C to favour 
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ester racemisation over amide racemisation, which required a 66 h reaction time. The 
individual ammoniolysis reaction gave 46% conversion to amide 4.20 with 78% ee after 4 




Scheme 77. Ammoniolysis of phenylglycine with in situ racemisation. (A): Dynamic 




The use of the continuous process developed herein could reduce these lengthy reaction 
times. It was desired to test the process developed on a chiral substrate to determine the 
enzyme selectivity under ammoniolysis conditions and to be able to produce single 





4.4.1 Batch Ammoniolysis 
The ammoniolysis of N-acetyl-(D/L)-phenylalanine 4.21 was investigated, to determine the 
selectivity of the reaction. The predicted optimum conditions in terms of temperature (67 
°C) and catalyst loading (scaled down according to reaction volume) from the nicotinamide 
optimisation were used in batch for the reaction with N-acetyl-(D/L)-phenylalanine 4.21 
(Scheme 78).  
 
Scheme 78. Batch test of ammoniolysis of N-acetyl-(D/L)-phenylalanine 4.21. 
 
The N-acetyl protected version was used to prevent any reaction of the unprotected amine 
with the acyl-enzyme intermediate, formed within the active site, which could have led to 
dimer by-products. After 24 h, no reaction was observed and the ee of ester 4.21 remained 
at 9% throughout the course of the reaction. 
A range of immobilised lipase enzymes were then tested in batch to try to obtain some 
reactivity. The enzymes used were Lipase A from Candida antarctica (CalA), Candida 
rugosa lipase and Thermomyces lanuginosus lipase (TLL), all of which were immobilised 
on Immobead 150. Batch reactions were carried out for each of the enzymes, and for N435 
as a comparison, using conditions based on those reported by López-Serrano et al.
149
 The 
reactions were carried out at 50 mM substrate concentration, in NH3 solution (0.5 M in 1,4-
dioxane) at 40 °C . Two reactions were carried out using C. Rugosa lipase as the activity 
for this batch of enzyme was much lower than the other enzymes tested and so a second 
reaction was carried out with 3.5 g lipase to achieve a similar activity to the other enzymes. 
However, the mass of immobilised C. Rugosa lipase required to achieve the higher activity 
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was so large that the reaction mixture was unable to be stirred properly. Regardless, no 
conversion was observed using any of the enzymes, under these conditions.  
The literature procedures used NH3 saturated tert-butanol and so the 0.5 M NH3 solution in 
1,4-dioxane may not be concentrated enough for this substrate. The literature procedure 
also required sub-zero temperatures to achieve a reasonable conversion and selectivity, 
which would not be possible with the continuous reactor set-up described in this work. 
 
4.5 Conclusions 
Lipase catalysed ammoniolysis was investigated using the continuous PBR for the 
production of two essential medicines: nicotinamide 4.5 and pyrazinamide 4.12. The 
continuous procedure was first developed for nicotinamide 4.5 production and optimised 
using a DoE approach to achieve high conversion to product in a short reaction time 
compared to batch studies.  
Whilst this study was being carried out, Andrade et al. published a similar system for the 
production of carboxamide derivatives using immobilised CalB in a PBR.
150
 The study 
demonstrated the coupling of amines and esters to produce carboxamides in generally high 
yields in a short tRes (10 min). They also employed the reactor for the coupling of NH3 









The reaction to produce 4.23 and 4.24 gave high conversions for the 10 min tRes however, 
the tRes had to be increased for product 4.25 to achieve a reasonable conversion. Whilst 
this literature procedure had shorter tRes than the process developed herein, the substrate 
scope indicated that the tRes needed to be increased to achieve high conversion for 
different substrates. Also, the reaction concentration was 3.5-fold more dilute for the 
literature procedure and used saturated NH3 solution, which would indicate a lower process 
efficiency. Interestingly, they also showed continuous operation of the coupling of amines 
and esters over a 14 h period (84 x tRes) without any loss of CalB activity. This reflects the 
results described in Chapter 2 for the stability of the enzyme over long periods (30 h) and 
re-iterates the potential for the long term operation of the continuous ammoniolysis 
developed herein.  
The optimised procedure developed for nicotinamide 4.5 was then applied to the 
continuous production of pyrazinamide 4.12. The higher activity observed for this 
substrate allowed for much less forcing reaction conditions to be used without a loss in 
conversion. 
To determine the selectivity of the lipase under ammoniolysis conditions, a chiral substrate 
4.21 was then studied. However, no reactivity was observed using the conditions tested. 
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The literature precedence for this type of substrate showed low conversions and the 
requirement for sub-zero temperatures, which was not feasible for this piece of work. 
Unfortunately, the chiral example could not be studied any further. 
The process described herein represents a cheap and efficient route to two generic 




5 Iridium Catalysed N-Alkylation of Primary Chiral Amines 
5.1 Introduction 
The formation of dimers during the attempted racemisation of 1-phenylethylamine 5.1 
described in Chapter 3 prompted investigation into the N-alkylation reaction of 1-






Scheme 80. Hydrogen borrowing methodology for the coupling of amines. 
  
The dimer formation observed was a result of the coupling of two molecules of the same 
type of amine in Step 2 of Scheme 80. To achieve N-alkylation using this method, a second 
type of amine needs to be coupled to the first amine type in Step 2. This hetero-coupling 
must be favoured over the homo-coupling to preferentially form the desired N-alkylated 
product. 
The N-alkylation reaction could present an opportunity to utilise the remaining amine 
enantiomer from the enzymatic resolution of 1-phenylethylamine 5.1 described in Chapter 




Scheme 81. Proposed coupling of enzymatic resolution and iridium catalysed N-alkylation. 
 
In this chapter, the iridium catalysed coupling of two amines for the N-alkylation of 5.1 
was investigated with a view to coupling the reaction to the continuous resolution process 
described in Chapter 2. The N-alkylation of rac-5.1 was first studied using a heterogeneous 
and a homogeneous catalyst. DoE was employed to determine significant variables and 
optimum operating conditions. The N-alkylation of single enantiomer 5.1 was then studied 
for coupling to the enzymatic resolution. The selectivity observed gave some insights into 
the catalytic mechanism, which are also presented. 
 
5.2 N-Alkylation of Racemic 1-Phenylethylamine 
5.2.1 Heterogeneous catalyst 
5.2.1.1 Batch Reactions 
The coupling of rac-5.1 with di-isopropylamine 5.5 using an iridium Cp* catalyst was 
studied (Scheme 82). Initially, the reactions were investigated using a heterogeneous 
Cp*iridium catalyst 5.9), which was immobilised on the Wang resin through a 5-carbon 
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chain (supplied by Yorkshire Process Technologies).
114
 The use of an immobilised catalyst 
would enable the coupling of the N-alkylation and enzymatic resolution processes in 
continuous flow as the separate catalysts could be set-up in packed bed reactors in series. 
This would allow for isolation of the two catalysts and therefore operation of the individual 
catalytic reactions under different conditions. Di-isopropylamine was chosen for this study 
as this amine donor performed the best in a literature screen, providing 98% of the desired 





Scheme 82. N-alkylation of rac-5.1 using di-isopropylamine 5.5 and immobilised 
Cp*iridium catalyst 5.9. 
 
The desired product 5.6 may be obtained according to the proposed mechanism, shown 




Scheme 83. Proposed catalytic cycle for [Cp*IrI2]2 catalysed N-alkylation. 
 
In the mechanism shown, the cross-coupled imine 5.17 de-coordinates from the catalyst 
and then re-coordinates for the hydrogenation step to occur and to re-form the active 
catalyst. This could be confirmed by labelling studies, wherein deuterated imine 5.17 could 
be added to the reaction mixture, to see if the deuterium is observed in the final product 
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5.6. As the steps are reversible, the incorporation of deuterium in the product would mean 
that 5.17 is released from the catalyst in Step 7. This would allow both 5.17 and the 
deuterated version to re-coordinate in Step 9, leading to deuterated product. The homo-
coupled products 5.7 and 5.8 would be formed by the coordination of amine 5.1 to the 
catalyst in Step 1 of the cycle. 
 
 
Figure 27. N-alkylation of rac-5.1 with 5.5 using immobilised Cp*iridium catalyst 5.9, 
under batch conditions. (rac-5.1 shown in green, desired product rac-5.6 shown in blue, 
dimers shown in red). 
 
An initial reaction was carried out under batch conditions, at 130 ºC in xylene with a 
catalyst loading of (0.5 mol%) and 3 equivalents (Eq) of 5.5 (Figure 27). The reactions 
were analysed by GCMS to determine the percentage composition of the substrate and 
products within the reaction sample. The percentage composition was determined from the 
area% of each component that was obtained from the auto-integration feature on the 
GCMS data analysis software (ChemStation). After 20 h, full conversion of amine 5.1 was 
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observed to the desired N-alkylated product 5.6 (63%) and dimers (37%), compared to the 
reaction using homogeneous [Cp*IrI2]2 reported by Saidi et al. to give a 98% yield of 5.6 
at 155 ºC in xylene after 10 h.
29
 
The full conversion achieved was encouraging, however the reaction time was long and 
selectivity for desired product was only 63%. It was envisaged that the unfavourably long 
reaction time could be reduced by the more forcing conditions achievable in the continuous 
PBR and that the selectivity could be improved through optimisation strategies. 
Previous unpublished studies within the research group had shown that the polymer 
support and immobilised catalyst were stable for longer periods at temperatures lower than 
130 ºC,
117
 therefore the temperature was reduced to 100 ºC for further reactions to allow 
for recycling of the catalyst. 
 
5.2.1.2 Continuous Reactions 
As the reaction was shown to proceed in batch, the reaction was transferred directly to a 
continuous system using the immobilised catalyst within a PBR without further 
investigation in batch. This continuous system would allow for the reaction mixture to be 
exposed to a much higher amount of catalyst than would be feasible in batch. These more 
forcing conditions within the flow reactor would reduce the reaction time required to 
achieve high conversion. The PBR would also allow for easy re-use of the catalyst as the 
catalyst is retained in the reactor and so separate from the reaction solution. 
The continuous reactor set-up (Figure 28) was described in detail in Chapter 2 and 
consisted of a 2.8 mL stainless steel tubular reactor (1/4” OD, 1/8” ID), which was 
manually packed with immobilised catalyst 5.9 (ICP > 0.3 mmol/g) to a loading of 4.7 
mol%, calculated relative to one reactor volume (RV). The reactor was housed within an 
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aluminium heating block under Eurotherm temperature control. rac-5.1 (0.5 M) and 5.5 (3 
Eq) were dissolved in toluene as a single stock solution. The stock solution was fed into 
the reactor using a Jasco PU-2085 dual piston pump, with a 60 min residence time (tRes), 
under 40 psi back pressure.  
 
Figure 28. Reactor set-up for continuous N-alkylation using immobilised catalyst. (A): 
Piston pump; (B): Tubular reactor packed with immobilised catalyst; (C): Aluminium 
heating block; (D) Eurotherm temperature controller; (E) BPR; (F): Product outlet and 
collection. 
 
For this reaction the conversion observed was very low with the highest value being 24 
area% after 3 RV. This also rapidly decreased to 6 area% after 7 RV, which indicated 
deactivation of the catalyst (Figure 29). It was observed that the eluent from the reactor 
was highly coloured, suggesting leaching of the iridium from the resin. This was 
investigated further to determine the reason for the low conversion and to ascertain 
whether the catalyst had leached off the resin. A microwave batch test using the catalyst 
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recovered from the continuous reactor showed no conversion after heating to 100 °C for 3 
x 60 min periods. A further microwave reaction using a fresh portion of immobilised 
catalyst, again showed no conversion after heating to 100 °C for 3 x 60 min periods. This 
further testing indicated that higher temperatures would be required for the reaction to 
progress in the desired time scale. As previously stated, the heterogeneous catalyst cannot 
be operated at higher temperatures due to long term stability, therefore all further reactions 
were carried out using homogeneous catalyst.  
 
 
Figure 29. Continuous N-alkylation of rac-5.1 using immobilised Cp*iridium catalyst 5.9. 





 RV were too dilute to carry out GCMS analysis). 
 
The reaction time could not be increased in the continuous reactor due to three main 
reasons. Firstly, due to the desired coupled process. If one of the reactions is much slower 
than the other then it would be impractical to combine then as it would be difficult to 
match the flow rates and tRes. Secondly, long residence times were not feasible with the 
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current pump capabilities as the flow rates required would be lower than could be reliably 
achieved. Thirdly, a long tRes and accompanying slow flow rate creates a low fluid 
velocity within the tube, which leads to a broadening of the residence time distribution 
(RTD).
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 A broadening of the RTD can lead to variation in the conversion observed as a 
large number of molecules will have a shorter tRes than desired and so a lower conversion 
may be observed. It can also cause a reduction in the selectivity of a reaction, when the 
selectivity for a particular product is dependent on the tRes. The molecules with a longer 
tRes than desired are exposed to the reaction conditions for a longer period, which may 
favour a different reaction pathway or cause over-reaction of the desired product. This can 
lead to an increase in the amount of by-products and so reduction in the selectivity. 
 
5.2.2 Homogenous catalyst 
5.2.2.1 Microwave Batch Reactions 
Due to the problems with the immobilised catalyst, further studies were carried out using 
the homogeneous [Cp*IrI2]2 catalyst (5.10). This catalyst was used by Saidi et al. for the 
selective cross coupling of two amines to produce N-isopropyl derivatives of anilines and 
benzylamines.
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 Whilst these reactions were generally high yielding, long reaction times of 
10 h were used. The aim of this piece of work was to improve on these reaction conditions 
through optimisation by DoE, thereby reducing reaction times whilst maintaining high 





Scheme 84. N-alkylation of rac-5.1 using 5.5 and homogeneous [Cp*IrI2]2 catalyst 5.10. 
 
Reactions were carried out under microwave batch heating using homogeneous [Cp*IrI2]2 
catalyst 5.10, microwave heating was used as it enabled higher temperatures to be reached 
than conventionally heated batch. As the catalyst was not immobilised on a resin, it could 
be heated to higher temperatures and so all microwave testing was carried out at 
temperatures of 100 ºC and above, to ensure higher conversions.  
Initial experiments using microwave heating (Table 10) confirmed that 100 °C was too low 
for the reaction to proceed in these short reaction times (Entries 1 and 2). Temperatures of 
150 °C and above were sufficient to obtain conversion within the desired time frame, with 
full conversion being observed after only 10 min at 220 °C (Entries 6 and 7). Interestingly, 
the selectivity for desired product was greatly increased when using 3 Eq of 5.5, compared 
to 1 Eq (Entries 6 and 7). These experiments also showed that the catalyst loading could be 































1 100 10 0.1 0.1 1 100 0 0 
2 100 30 0.2 1 3 100 0 0 
3 150 10 1.0 0.5 3 28 69 3 
4 200 10 1.0 0.5 3 5 84 11 
5 200 30 0.5 1 3 0 89 11 
6
b
 220 10 0.2 1 1 0 64 36 
7
b
 220 10 0.1 1 3 0 93 7 
a
Reaction conditions: rac-5.1, di-isopropylamine 5.5, [Cp*IrI2]2 5.9, toluene, biphenyl added as internal 
standard, total reaction volume = 2 mL; 
b
Solvent = anisole; 
c
Percentage composition determined by GCMS 
analysis; Eq = equivalents of 5.5. 
    
The overall aim was to use a continuous reactor for the N-alkylation reaction to allow 
coupling to the continuous resolution, however it was decided to carry out further 
screening and optimisation experiments using microwave batch heating to allow for 
smaller reaction volumes to be used so that less catalyst could be used per experiment. The 
optimum conditions determined from the microwave studies would then be transferred to 
the continuous reactor for development of the coupled process. 
 
5.2.3 Optimisation of Racemic N-Alkylation  
5.2.3.1 Screening Design 
The reaction was optimised using a DoE approach, with the aim to maximise the yield of 
N-alkylated product and limit the yield of dimers. First, screening experiments were carried 
out following a fractional factorial Resolution V design, to determine the important 
variables.
152, 153
 A fractional factorial design was chosen as this would reduce the number 
of experiments to be carried out and so would save time and reagents. For screening 
purposes a fractional factorial is sufficient to determine the few important variables from a 
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large group of variables. A full factorial two-level (-1 and +1) design for 5 variables would 
require 32 experiments. The fractional factorial Resolution V two-level design for 5 
variables required 16 experiments (plus 3 mid-point experiments) and so was preferred. 
The variables considered were: temperature, reaction time, catalyst loading, concentration 
of 5.1 and Eq of 5.5 (Table 11). The limits for the variables were chosen based on the 
results obtained in the initial microwave reactions described above and the desire to have 
short reaction times (≤ 30 min) and reasonably low catalyst loadings (≤ 0.5 mol%). The 
upper limit of temperature was set to 200 °C as 220 °C could not be achieved consistently 
within the microwave.  
 
Table 11. Variables with limits for first racemic N-alkylation screening design. 
Variable Low Mid High 
Temperature / ºC 150 175 200 
Reaction time / min 10 20 30 
Catalyst loading / mol% 0.1 0.3 0.5 
Amine 5.1 concentration / M 0.1 0.55 1.0 
Eq of 5.5 1 2 3 
 
All further reactions were analysed by achiral GC and conversions were determined from 
the analyte peak areas, after calibration against internal standard (for further details and 
calibration plots see Experimental Chapter). 
The responses generated were: conversion of amine 5.1, desired product yield, dimer yield 
and selectivity. The results from the screening design are shown in Appendix B and 
showed a broad range in conversions of amine 5.1 from 0 to 93%. Statistical design 
software (MODDE) was used to generate models for each response (Figure 30), using 




Figure 30. Summary of fit plots for all 4 responses from the first screening design. 
 




 and model 
validity was only achieved for the dimer yield response. After analysis of the experimental 
data points, it was determined that the range in the results was too great to obtain a reliable 
model fitting for the other 3 responses. For example, the data obtained for conversion of 
amine 5.1 ranged from 0 – 93%. The model works by fitting polynomial curves to the data 
until it finds the best fit. When the data covers such a large range of responses, as obtained 
in this screen, the model can struggle to fit the data as exampled by Figure 31. For this 
theoretical data set, a polynomial curve has been fit to the data over the whole range (A) 
and over part of the range (B). This shows that the curve can achieve a more reliable fit 
when a narrower data range is used as the curve cannot take into account any deviations 
from the curve, as shown in (A). For this same reason data cannot be extrapolated from the 
curves obtained within the model, as a good fit outside of the limits tested for the variables 





Figure 31. Comparison of polynomial fitting for a theoretical data set over different 
ranges. 
 
Due to the difficulties with the data fitting, the screening design was repeated with new 
limits for the variables to narrow the data range. This would be advantageous for the model 
fitting and would also act as a second step to further hone the reaction conditions to give 
the best conversions. The selection of new limits for the variables was carried out as 
follows. The reactions at 150 °C showed the lowest conversions and so the lower limit was 
increased to 180 °C. The range for the catalyst loading was narrowed as the conversion 
was lower using 0.1 mol%, however the maximum limit of 0.5 mol% was maintained so as 
to conserve catalyst and reduce the cost associated with the process. The limits for the 
reaction time were not changed as a short reaction time was still desired. It was observed 
that the higher the Eq of 5.5 the greater the selectivity for the desired product and so the 
number of Eq was increased for the new screen to enhance the selectivity. To check 
whether the new limits would be appropriate, scoping reactions were first carried out at the 























Low 180 10 0.3 0.5 2 50 
Mid 190 20 0.4 0.75 3.5 95 
High 200 30 0.5 1.0 5 87 
a
Reaction conditions: rac-5.1, di-isopropylamine 5.5, [Cp*IrI2]2 5.10, anisole, biphenyl added as internal 
standard; 
b
Determined by achiral GC analysis, after calibration against internal standard; Eq = equivalents of 
5.5. 
 
Figure 32. Scoping reactions for the second set of racemic N-alkylation of variable limits. 
 
In Figure 32 the results from the scoping reactions were plotted with the reaction level 
being attributed to -1 for the lower limit, 0 for the mid-point and +1 for the upper limit. 
The results showed that the limits chosen for the variables were appropriate, and so these 




Table 13. Variables with limits for the second racemic N-alkylation screening design. 
Variable Low Mid High 
Temperature / ºC 180 190 200 
Reaction time / min 10 20 30 
Catalyst loading / mol% 0.3 0.4 0.5 
Amine 5.1 concentration / M 0.5 0.75 1.0 
Eq of 5.5 2 3.5 5 
 
Again, 19 experiments were carried out according to the fraction factorial Resolution V 
screening design (Table 44). The results from the screening design were modelled using 
statistical design software to identify important variables and determine the optimum 
reaction conditions. These results showed a much narrower range than the first screen, with 
conversion of amine 5.1 values between 74 and 97%.  
 
5.2.3.2 Models from Screening Designs140 
For the second screening design, models were generated for each of the 4 responses 
(Figure 33) and then analysed for the degree of fitting. The models generated for the 





, however the model validities were low. The models generated for the 




 and validity 
were all low. The reproducibility is also shown in Figure 33 and was high for all 4 






Figure 33. Summary of fit plots for all 4 responses from the second screening design. 
 
The models with overall poor fitting (dimer yield and selectivity) are considered first. The 




 showed a poor fit to the existing data and poor prediction of new 
data points, as described in Chapter 4. The low model validities meant that there was a 
significant lack of fit within the models.  
The difficulty with fitting a reliable model in the case of dimer yield and selectivity 
appeared to be due to the lack of variation in the experimental data within the chosen 
design space. The experimental data values for dimer yield and selectivity only varied 
between 5 - 14% and 85 - 96%, respectively (Figure 34). The lack of variation indicated 
that, within this design space, the change in variables had little effect on the reaction 
outcome and so the model fitting was unable to determine the significant variables. As 





Figure 34. Experimental data points for dimer yield (red) and selectivity (blue) from the 
second screening design. (Replicate experiments are highlighted within the ovals). 
 
During the first screening design, the model fitting for dimer yield (Figure 30) showed a 




, validity and reproducibility were all high. The 
experimental results varied between 0 - 43% for dimer yield and the data showed more 
variation (Figure 35) compared to the data from the second screening design discussed 
above. This further illustrated that a more reliable model was obtained from the data that 
showed larger variation. This could also indicate that the design space chosen in the first 
screening design was more appropriate to generate a model and determine the significant 




Figure 35. Experimental data points for dimer yield from first screening design. 
 
If the design space chosen is appropriate to determine the significant variables for a 
particular response, then the variation in the experimental results will be tolerated within 
the model. However if the design space is not appropriate for a particular response, then 
variation in the experimental results (either too little variation that generates a straight line 
or too much variation to be able to pick out a trend) will be detrimental to the model fitting 
as it cannot determine which variables are having an effect on the outcome of the reaction.  
It was decided that it was not appropriate to consider models for all four responses as, 
whilst the model for each response was developed independently, the design space 
explored was the same and so was not appropriate to generate a reliable model for each of 
the four separate responses. Therefore, the responses for dimer yield and selectivity were 
no longer considered. The aim of the study was to determine the significant variables in 
order to ensure a high yield of desired product, and so considering only the responses for 
conversion of amine 5.1 and desired product yield would be sufficient to achieve this. 
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The models generated for the conversion of amine 5.1 and desired product yield were next 
considered. From the second screening design a much better model fit was achieved 




. The reproducibility values were 
again high due to the centre point replicate experiments. However, the model validity was 
very low. Low model validity can indicate outliers within the data, that the data requires a 
transformation (e.g logarithmic function) or be caused by missing terms within the model. 
In this case there were no outliers observed and the use of a transformation did not improve 
the fit of the models. Further analysis of the model fitting was next carried out to assess the 
lack of fit and determine if it was due to missing terms within the model. 
The data showed more variation than for the dimer yield and selectivity, with values 
between 74 - 97% for amine 5.1 conversion and 66 - 91% for desired product yield and so 
a lack of variation in the data was not considered to be responsible for the low model 
validity. 
The lack of fit plots for both conversion of amine 5.1 and desired product yield showed a 
significant lack of fit (Figure 36). In this plot, the 1
st
 bar is the standard deviation of the 
lack of fit, the 2
nd
 bar is standard deviation of the pure error and the 3
rd
 bar is the standard 
deviation of the pure error multiplied by the critical value for the confidence level (95%). 
If the 3
rd
 bar is smaller than the first bar then there is a lack of fit, which was the case for 




Figure 36. Lack of fit plots for conversion of amine 5.1 (left) and desired product 5.6 yield 
(right) from the second screening design. 
 
If the lack of fit is caused by missing square terms within the model, then this can be 
indicated using main effect plots (Figure 37), which show the data points in relation to 
confidence intervals for each variable. When the data points lie outside the confidence 
intervals (dashed lines), as in this case, then there is curvature in the model. Curvature in 
model means that there are missing square terms. This can also be confirmed by the 
residuals vs. variables plot (Figure 38), which shows the trend in the data points for each 
variable. Ideally the spread of the data points would be random with no apparent trend. In 
this case the data shows an arched or curved pattern for some of the variables, indicating 
that there is curvature associated with the particular variable and so a quadratic term 
relating to this variable is missing from the model. The fractional factorial Resolution V 
screening design used in this study does not account for square terms as only two-levels 






Figure 37. Main effect plots for conversion of amine 5.1 (left) and desired product yield 
(right) from second the screening design. (Green circles are experimental data points, blue 
squares are experimental data points for the centre point replicates, dashed lines denote the 
upper and lower confidence intervals. Variable shown is temperature). 
 
As the models appeared to be missing square terms and showed a significant lack of fit, 
then the important variables could not be determined empirically using this screening 
design. This indicated that a different type of design may have been required to obtain a 
better model for the data and to be able to pick out the significant variables and determine 
optimum operating conditions. As square terms appeared to be important then a response 
surface methodology (RSM) approach should be employed as this develops a quadratic 
model and can describe curvature within the model as it can account for interaction effects 
and quadratic effects (squared terms).
139
 The types of design that could be used include 
central composite designs such as CCF, which would require 33 experiments for a 
fractional factorial or 52 experiments for a full factorial. A Box-Behnken design could also 
be used,
154
 which would require 46 experiments. Both of these types of design require 
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three levels for each of the variables, resulting in a higher number of experiments than the 
two-level screening designs.  
 
 
Figure 38. Residuals vs. variable plots for conversion of amine 5.1 (left) and desired 
product yield (right) from the second screening design. (Variable shown is temperature). 
 
At the start of the screening and optimisation process it was not known that square terms 
would be required and so it would not have been appropriate to start with a design type that 
would require such a large number of experiments. Also, the choice of experimental design 
was dependent on the objective: screening designs allow for the important variables to be 
selected from a large number of un-important variables, whereas RSM designs are 
generally used once the number of variables has been reduced (either by screening or by 
existing chemical knowledge) and are used to find optimum conditions and develop a 
robust process.
138
 Therefore a screening design was selected to be able to narrow down the 
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number of significant variables and to be able to investigate the large number of variables 
in fewer experiments than would be required for an RSM.  
Once it had become apparent that a different type of design would have been more 
appropriate, the experiments that had already been carried out were sufficient to show 
experimentally derived optimum conditions (180 °C, 10 min, 0.5 mol%, 1 M and 5 Eq of 
5.5), which gave very high conversions. Therefore it was deemed unnecessary to carry out 
a new type of design that would require a large number of experiments and would be a 
waste of material. If the experimental results did not produce such high conversions, then it 
would have been advisable to do further testing and to try a different type of screening 
design. 
 
5.2.3.3 Testing of Optimum Conditions 
The experimentally observed optimum conditions were determined to be: 180 °C, 10 min, 
0.5 mol%, 1 M and 5 Eq of 5.5, which gave 96% conversion of amine 5.1 and 91% desired 
product yield. These conditions were then used within a continuous reactor system, to 
determine if the conditions were completely transferable and to be able to increase the 
throughput of the reaction, as the microwave reactions would be limited by the batch 
size.
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 The reactor set-up used was the same as for the heterogeneous catalyst in Section 
5.2.1 with some modifications (Figure 39). The stainless steel tubular reactor was used as 
an empty cartridge and not packed with catalyst in this instance. As higher temperatures 
were required, a 250 psi BPR was fitted to the outlet of the reactor. Also, screening 
reactions had shown that the catalyst was poorly soluble at room temperature and so the 
reagents were combined in a beaker and stirred in a sand bath (40 °C) to encourage 
dissolution. Due to the potential presence of solid in the stirred reaction solution, a filter 
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Figure 39. Continuous reactor set-up for rac-5.1 N-alkylation. (A): Reaction solution with 
in-line filter; (B): Piston pump; (C): Tubular reactor; (D): Aluminium heating block; (E) 
Eurotherm temperature controller; (F) BPR; (G): Product outlet and collection. 
 
For this continuous reaction using 180 °C, 10 min, 0.5 mol% catalyst loading, 1 M of rac-
5.1, 5 Eq of 5.5, the conversion of amine 5.1 and desired product yield were 27 and 25%, 
respectively, compared to 96 and 91% under microwave conditions. When the reagents 
were combined it was observed that a particulate suspension formed when 5.5 was added 
and large clumps of orange solid were observed in the reaction solution beaker at the end 
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of the reaction (Figure 40). This indicated that not all of the material was being pumped 
into the reactor and so the reaction composition and consequently the conversion was 
lower than expected. 
 
Figure 40. Continuous flow reaction stock solution (1 M). Left: stirred solution during 
reaction; Right: remaining stock solution at end of reaction. 
 
The same reaction was repeated at half the concentration to see if this prevented the solid 
formation. The reaction solution was a clear orange solution under these conditions with 
little solid observed (Figure 41), indicating that all of the desired material was able to enter 
the reactor system. To confirm this, a sample was taken from the reaction mixture and also 
from the tubing in between the pump and the reactor and analysed for amine concentration 
by GC. These samples showed the same amine concentration, meaning that the reactor 
concentration matched the desired concentration. For this reaction using 180 °C, 10 min, 
0.5 mol%, 0.5 M, 5 Eq, the conversion of amine 5.1 and desired product yield were 60 and 
59%, respectively. Whilst this was an improvement on the more concentrated continuous 




Figure 41. Continuous flow reaction stock solution, during 0.5 M reaction. 
 
Next, the set-up was modified to use two pumps, feeding the reagents into a tee-piece prior 
to entering the heated reactor (Figure 42), to determine if the presence of 5.5 caused the 
solid formation in the catalyst solution. Pump A contained 5.5 in anisole and Pump B 
contained rac-5.1 and catalyst 5.10 dissolved in anisole, with internal standard added to 
both solutions. The same reaction conditions as the one pump set-up were used (180 ºC, 
tRes = 10 min, 0.5 mol% catalyst loading). When the two feeds met at the tee-piece the 
reagent concentrations were reduced, as the addition of a second feed diluted the first. For 
example, if a feed containing a 1 M reagent meets a second feed the reagent concentration 
will be diluted to 0.5 M, if the two feeds have equal flow rates. Therefore the 
concentrations of the stock solutions needed to be increased to account for this dilution. In 
this case the stock concentration for 5.5 was 6.25 M and the stock concentration for rac-5.1 
was 5.0 M and the ratio of the pump flow rates was 0.8:0.2, to obtain the desired 






Figure 42. Continuous N-alkylation reactor using two pumps. (A): Reaction solution with 
in-line filter; (B): Piston pump A; (C) Piston pump B; (D): Tubular reactor; (E): 
Aluminium heating block; (F) Eurotherm temperature controller; (G) BPR; (H): Product 
outlet and collection. 
 
Samples were collected for each RV up to 7 RV. GC analysis of the samples showed that 
the amine 5.1 conversion varied between 39 and 57% across the RV (Figure 43). Variation 
was also observed for the desired product yield, from 8 to 63%. Again, the difficulty in 
reaching steady state suggested that the amount of catalyst being pumped into the reactor 
was inconsistent over the course of the reaction. The removal of 5.5 from the catalyst stock 
solution seemed to have improved the conversion compared to the one pump set-up 





Figure 43. Continuous N-alkylation of rac-5.1 with 5.5 using the two pump reactor set-up. 
 
The conversion achieved under continuous flow conditions was much lower than in the 
microwave batch reactions. For the continuous reaction, the poor solubility of catalyst at 
lower temperatures meant that not all of the catalyst was able to be pumped into the 
reactor, leading to a lower conversion than would be expected. In the microwave reaction 
all of the catalyst and reagents were in the same reaction vessel and so the catalyst loading 
remained consistent. Also, the whole reaction solution was exposed to the high reaction 
temperature and so the catalyst was completely dissolved in the solution. The poor 
solubility of the catalyst in the continuous reaction could also be responsible for the 
difficulty in reaching steady state, as not all of the catalyst could be pumped into the 
reactor this may have led to variation in the catalyst loading between reactor volumes. To 
overcome this problem, the catalyst stock solution would need to be heated to a much 
higher temperature to ensure dissolution. This would require a heated pump head to ensure 
no precipitation in the pump and the catalyst solution being heated to a higher temperature 
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in the sand bath. Heating the solution to a higher temperature increases the risk of 
evaporation and may cause some reaction to occur in the stirred vessel. To prevent any 
reaction in the stirred vessel the reagents would need to be separated into different feeds, 
which would require multiple pumps. However, the homogeneity of the solution appeared 
to also be affected by the addition of amine to the catalyst solution, giving rise to a change 
from a dark brown suspension of catalyst to a clear orange solution. Therefore, the 
presence of the amine in the catalyst stock solution may also be required for catalyst 
solubility and activation and so separating the reagents into multiple feeds may also hinder 
the reaction.  
 
5.2.3.4 Reaction Metrics for Optimum Microwave Conditions 
Reaction metrics were calculated for the optimum microwave conditions: 180 °C, 10 min, 
0.5 mol%, 1 M, 5 Eq to determine the efficiency of the process. The Process Mass 
Intensity (PMI)
143
 was calculated as 5.4, according to Equation 4.1. The PMI of a process 
describes the quantity of the materials being used in a process that are present in the final 
product and so it is a measure of efficiency. A PMI value of 1 would indicate a process in 
which all or the reagents are combined in the final product and therefore no waste is 
produced. As the calculation includes catalysts and solvents, a process that has no 
associated waste is very unlikely. The PMI for this reaction using existing literature 
conditions developed by Saidi et al. (98% yield, 155 °C, 10 h, 1 mol%, 0.5 M, 3 Eq) was 
calculated as 10.5.
29
 This comparison showed that the optimum conditions developed 
herein exhibited a reduction in reaction time, catalyst loading and PMI and so an increase 
in efficiency. When the process is more dilute, a larger amount of the reaction mixture is 
made up of solvent and so less of the total mass of the process is incorporated into the 
product. Whilst the two processes had similar values for the numerator in the PMI 
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equation, the denominator was 2.5-fold greater for the process developed herein, compared 
to the literature process, as more of the reaction mixture was incorporated into the product. 
(Note: these calculations did not include any work-up or purification procedures as this 
information was not available in the literature). 
 
5.3 N-alkylation of Single Enantiomer 1-Phenylethylamine 
The N-alkylation of single enantiomer 5.1 was then investigated for the potential of 
coupling to the continuous enzymatic resolution (Chapter 2) with the view to alkylating the 




Scheme 85. Coupled resolution – N-alkylation reaction design. 
 
As discussed previously, kinetic resolution has a maximum yield of 50% when only one 
enantiomer is desired. This means that the other 50% is waste, unless it can be recycled or 
used in a subsequent reaction. Coupling the kinetic resolution to an N-alkylation reaction 
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would provide the opportunity to re-use the undesired enantiomer. The reaction would 
produce a single enantiomer secondary amine, a higher value product than the primary 
amine. It is difficult to obtain single enantiomer secondary amines via enzymatic resolution 
as few enzymes have been shown to accept secondary amine substrates,
55, 72
 this coupled 
procedure would provide a solution to not only reuse the leftover primary amine 
enantiomer, but also to access single enantiomer secondary amines. The aim of the 
following sections was to determine if the single enantiomer amine could be alkylated 
without racemisation, to obtain single enantiomer N-alkylated product and then develop a 
coupled process.  
 
5.3.1 Microwave Single Enantiomer N-Alkylation Reactions 
Initially the single enantiomer N-alkylation was studied to determine whether the primary 
amine could be N-alkylated without racemisation. The reactions were carried out using (S)-
5.1 under microwave heating, following the procedure described above in Section 5.2.3 
(Scheme 86). 
 
Scheme 86. [Cp*IrI2]2 (5.10) catalysed N-alkylation of (S)-5.1. 
 
The reactions were first carried out at temperatures of 150, 175 and 200 °C, as higher 
temperatures showed higher conversion when investigating the racemic N-alkylation. All 
of these reactions were carried out at the specified temperature for 30 min, using 0.5 mol% 
catalyst 5.10, 1 M (S)-5.1 and 3 Eq of 5.5. The data showed that, whilst higher conversions 
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were obtained at 175 and 200 °C, the desired product ee dropped significantly as the 
temperature was increased, to only 5% ee at 200 °C (Figure 44). The reaction at 150 °C 
gave reasonable desired product yield and maintained a high ee of 96%, and so this 
temperature was chosen for further development of the reaction. 
 
 
Figure 44. Temperature studies for single enantiomer N-alkylation microwave reactions. 
 
Further reactions were then carried out to increase the conversion and improve the 
selectivity for the reaction at 150 °C (Table 14). The number of Eq of 5.5 was increased 
from 3 to 5 (Entry 2). As all other parameters remained constant, this did not affect the 
overall conversion of amine 5.1 but it did increase the selectivity for desired product by 
10%. The reaction time was then increased from 30 min to 1 h, which increased the desired 
product yield from 53 to 92% (Entry 3). From these studies it was decided that 150 °C for 
1 h and 5 Eq of 5.5 were the most appropriate conditions for the N-alkylation reaction 
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using 0.5 mol% catalyst 5.10 and 1 M (S)-5.1, to achieve high conversion and selectivity 
for desired N-alkylated product and to maintain high product ee.  
 
Table 14. Single enantiomer N-alkylation microwave reactions at 150 °C.
a 
Entry Reaction 
















 / % 
1 30 3 60 49 82 96 
2 30 5 58 53 91 99 
3 60 5 97 92 95 95 
a
Reaction conditions: 1 M (S)-5.1, 0.5 mol % [Cp*IrI2]2 5.10, anisole, biphenyl added as internal standard, 
150 °C; 
b
Determined by achiral GC analysis after calibration against internal standard; 
c
Determined as 
(Desired product yield / Conversion of 1)*100; 
d
Determined by chiral GC as [(Area1 – Area2)/(Area1 + 
Area2)]*100; Eq = equivalents of 5.5. 
 
A reaction was carried out using these conditions for the single enantiomer N-alkylation in 
the continuous reactor, to assess the feasibility for coupling to the continuous resolution. 
The reactor was set-up according to the description in Section 5.2.1, using one pump. The 
reactor temperature was set to 150 °C and the flow rate was set to 0.047 mL min
-1
 (tRes = 
60 min). GC analysis showed 20% conversion of amine 5.1 and 19% yield of desired 
product 5.6 (95% ee), giving a selectivity of 95%. Whilst the high selectivity and ee was 
encouraging, the conversion was significantly lower than that observed in the microwave 
reaction (97%). As in the continuous racemic N-alkylation reactions, some solid was 
observed in the reaction stock solution and so the conversion may have been lower as not 
all of the catalyst was able to be pumped into the reactor as discussed in Section 5.2.3. 
The continuous resolution using the N435 packed reactor was repeated using the 
conditions from Chapter 2 (0.07 M rac-5.1, 1 Eq of methyl methoxyacetate 5.2, 6 min 
tRes) at 150 °C to check the effect of the high temperature required for the N-alkylation 
step. Inconsistencies were observed under these conditions as the conversion of 5.1 varied 
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from 48 to 61% between 4 RV and 10 RV (Figure 45). Previous studies had shown that 
steady state was reached by 4 RV but in this case steady state was not reached even after 
10 RV. The ee observed for amine 5.1 also indicated variation in the reaction as it 
increased from 58% after 4 RV to 78% after 10 RV. The reaction using these conditions at 
60 °C gave 96% ee for amine 5.1, suggesting that the high temperature was inhibiting the 
enzyme. When unpacking the reactor, it was observed that some of the catalyst beads had 
discoloured, indicating that the catalyst was being degraded by the high temperature. These 
observations confirmed that the coupled process would benefit from having isolated 
catalytic reactions as the high temperatures required for the N-alkylation reaction are not 
compatible with the enzyme. 
 
Figure 45. Conversion and ee of amine 5.1 for the continuous resolution at 150 °C. 
(Conversion determined by achiral GC, after calibration against internal standard; ee was 




5.3.2 Development of N-Alkylation – Resolution Coupled Process 
5.3.2.1 Inhibition Testing 
Microwave reactions were carried out to test for any inhibition caused by the coupling of 
the two processes (Table 15). All of the reactions were carried out using the same 
concentrations and equivalents of reagents and catalysts, unless stated otherwise. Firstly, a 
resolution reaction was carried out using conditions developed in Chapter 2: 0.07 M rac-
5.1, 1 Eq of methyl methoxy acetate 5.2, 60 °C, 6 min reaction time (Entry 1). The reaction 
was then repeated with the addition of 5 Eq of 5.5 and 0.5 mol% catalyst 5.10 to see if the 
presence of the N-alkylation reaction components would inhibit the resolution reaction 
(Entry 2). This did not inhibit the reaction as the conversion was the same for both 
reactions. It was important to ensure that no inhibition would occur if the N-alkylation 
reaction components were pumped through the N435 packed bed to set-up a recirculation 
procedure. This also confirmed that no N-alkylation was occurring at 60 °C, so re-
enforcing the requirement for two separately heated reactors. The converse reactions were 
then carried out to test for inhibition of the N-alkylation reaction in the presence of methyl 
methoxy acetate 5.2 (Entries 3 and 4). The enzyme was omitted from these reactions as 
this would remain in the packed bed reactor and so would not circulate through the 
alkylation reactor in the coupled process. The reaction in the presence of the ester gave a 
higher conversion of 5.1 than the reaction without, 73% compared to 33%. Possibly due to 
some favourable coordination of the ester to the catalyst that leads to enhancement of the 
rate. However, catalytic structures were not isolated and so no structural analysis was 
carried out to confirm this. 
Reactions were then carried out to determine if the presence of the resolution product 
amide 5.3 would inhibit the N-alkylation reaction step. The reaction conditions in Table 15, 
Entry 3 were used with the addition of 1 Eq of amide 5.3. 70% yield of desired N-alkylated 
product was achieved, again showing a higher conversion in the presence of the additive 
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compared to reaction without. This could again be due to coordination of the amide to the 
catalyst, leading to enhancement of the rate. 
 
Table 15. Microwave reactions to test for inhibition in coupled process.
a
 











 / % 
1 1 0 N435 60 6 14 
2 1 5 N435, [Cp*IrI2]2 60 6 14 
3 0 5 [Cp*IrI2]2 150 60 33
c 
4 1 5 [Cp*IrI2]2 150 60 73
c 
a
Reaction conditions: 0.07 M rac-5.1, 143 mg N435, 0.5 mol % [Cp*IrI2]2 5.10, toluene, 2 mL reaction 
volume, biphenyl added as internal standard; 
b
Determined by achiral GC analysis after calibration against 
internal standard; 
c
Average of three runs. 
 
5.3.2.2 Stepwise Reaction Testing 
As these studies indicated that the coupling of the two reactions would not cause any 
inhibition, a stepwise approach to coupling the reactions under microwave heating was 
next investigated (Scheme 87).  
First, the resolution was carried out using the same conditions as above (Table 15, Entry 
1), but with a longer reaction time of 30 min to encourage a higher conversion. Next the 
reaction solution was transferred to a second vessel, with filtering to remove the N435, and 
then [Cp*IrI2]2 and 5.5 were added and the reaction returned to the microwave for the N-
alkylation step. After the first step, 42% conversion of amine 5.1 was observed. However, 
only a further 12% conversion of amine 5.1 was observed after the second step, with only a 
4% yield of desired N-alkylated product 5.6. The low yield of N-alkylated product is 
particularly significant because the reagent ratios were calculated based on the 
concentration of amine 5.1 at the start of the resolution reaction, meaning that the catalyst 
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loading for the N-alkylation step was increased from 0.5 mol% to around 1 mol% and the 
number of Eq of 5.5 was increased from 5 to 10.  
 
 
Scheme 87. Microwave coupled reaction, stepwise approach. 
 
The inhibition testing indicated that the conversion for the N-alkylation step should not 
have been hindered by the presence of the components from the resolution step and so this 
result was unexpected. The only other difference between the inhibition testing and the 
stepwise coupled reaction was the presence of N435 and so further inhibition studies were 
carried out to determine if this was the cause of the low yield of the N-alkylated product. 
For the stepwise approach N435 was filtered-off after the first step, and so this was 
repeated to determine if any material was leaching off the resin and causing the inhibition 
(Scheme 88). N435 and toluene were stirred for 30 min at 60 °C under microwave heating, 
then the mixture was filtered and the filtrate used in the N-alkylation step at 150 °C for 1 h, 




Scheme 88. Testing of resin leaching for N-alkylation inhibition. 
 
A standard N-alkylation reaction with N435 added to the mixture gave 1% of 5.6 after 1 h. 
These results suggested that the low conversion observed in the stepwise coupled 
procedure was due to the presence of N435. As the solution was filtered to remove the 
solid catalyst it would appear that either enzyme was leaching off the resin or the solid 
support was being degraded and material was leaching into the solution, which led to 
inhibition of the N-alkylation reaction. This could be tested by using a different support for 
the enzyme to see if the same effect was observed or by doing imaging such as scanning 
electron microscopy, of the polymer support before and after the reaction to look for any 
degradation. 
This may have resulted from the stirring within the microwave breaking down the resin. 
However, a stepwise coupled reaction was attempted wherein the resolution was carried 
out using the continuous packed bed reactor and then the eluent was collected and used in a 
microwave N-alkylation reaction (Scheme 89), for which the same effect was observed. 
The yield of 5.6 was only 4% in this case, which would suggest that the stirring in the 
microwave was not causing any further degradation of N435 compared to the packed bed 
reactor. This indicates that the degradation was not due to stirring as the immobilised 




Scheme 89. Continuous resolution coupled to microwave batch N-alkylation, stepwise 
approach. 
 
It is not currently fully understood what part of the immobilised enzyme was causing the 
inhibition of the N-alkylation step. However, a microwave experiment combining the 
filtrate from stirring N435 in toluene with the resolution reaction components at 60 °C for 
30 min showed no production of amide 5.3 (Scheme 90). This would suggest that enzyme 
was not being washed off the resin in significant enough quantities for the filtrate to have 
catalytic activity in the resolution. This was also re-enforced by the long term operation of 
the enzyme under continuous flow conditions described in Chapter 2. If the enzyme was 
leaching from the resin, the conversion within the resolution reactor would have been 




Scheme 90. Testing of enzyme leaching for resolution activity of filtrate. 
 
5.4 Mechanistic Considerations 
These investigations allowed for some further insights into the catalytic mechanism 
(Scheme 83) in the presence of two amines. Reactions were carried out to probe the effect 
of the Eq of amine 5.5 on the selectivity of the reaction for N-alkylation vs. dimer 
formation (Table 16). The results showed that the number of Eq of the alkylating agent had 
a significant effect on the selectivity of the reaction. High temperature was used to ensure 
full conversion of the starting material. When the Eq were increased from 1 to 3, the yield 
of desired product and the selectivity increased by 29%.  
 
Table 16. Racemic N-alkylation testing of equivalents of 5.5.
a 










 / % 
1 1 100 64 36 
2 3 100 93 7 
a
Reaction conditions: 1 M rac-5.1, 0.1 mol% [Cp*IrI2]2 5.10, anisole, 10 min, 220 °C, microwave heating;
 
b
Determined by achiral GC analysis; 
c
Determined as (Conversion of 5.1 – Desired product 5.6 yield); Eq = 
equivalents of 5.5. 
 
This re-inforced that amine 5.5 first coordinates to the catalyst, followed by reaction of 
amine 5.1 to give the desired N-alkylated product 5.6. At higher Eq, amine 5.5 out-
competes amine 5.1 to coordinate to the catalyst. This is because the increase in the 
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number of molecules of a particular species will mean that the likelihood of that species 
coming into contact with the catalyst is increased and so the rate of reaction for that species 
will be increased. When less amine 5.5 is present, amine 5.1 is able to coordinate to the 
catalyst and then a second molecule of 5.1 can react to form dimers. 
The retention of stereochemistry when N-alkylating single enantiomer amine 5.1 also gave 
some insight into the mechanism of the catalytic reaction. The production of N-alkylated 
amine without racemising the chiral centre suggested that amine 5.5 was coordinating to 
the iridium centre, rather than amine 5.1. If amine 5.1 reacted with the iridium centre 
before N-alkylating, scrambling of the chiral centre would be expected (Scheme 91).  
 
 
Scheme 91. Stereochemical outcome based on competition of amine coordination. (A): 
Amine 5.5 coordination; (B): Amine 5.1 coordination. 
 
A reaction was carried out using 3 Eq iPrOH 5.27 as the alkylating agent instead of amine 
5.5 (Scheme 92). Interestingly, only 1% of N-alkylated product 5.6 and 36% of dimers 




Scheme 92. N-alkylation reaction using iPrOH 5.22 as the alkylating agent. 
 
When iPrOH was used, amine 5.1 was able to coordinate to the catalyst in the first step of 
the catalytic cycle as there was no competition from the alkylating agent. Then a second 




The iridium catalysed N-alkylation of rac-5.1 via hydrogen borrowing methodology was 
investigated and experimental design was employed to screen reaction conditions with a 
view to optimising the reaction. High conversion and selectivity for the desired product 5.6 
was achieved through the screening design under microwave batch heated conditions, in 
much reduced reaction times compared to literature batch studies. For the substrate studied, 
Saidi et al. reported a 98% yield of N-alkylated product after 10 h at 155 °C, using 1 mol% 
[Cp*IrI2]2 and 3 Eq of 5.5.
29
 The analogous process using iPrOH as the alkylating agent 
gave 91% yield of N-alkylated product after 10 h at 115 °C.
28
 The process described herein 
showed a much reduced reaction time (10 min) and a reduction in the catalyst loading (0.5 
mol%), leading to a reduction in the PMI. Therefore this process was a more efficient and 
cheaper alternative to these existing literature procedures.  
The aim was to transfer the reaction from microwave batch heating to the continuous 
reactor to increase the throughput and for the potential to couple to sequential continuous 
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processes. Unfortunately, the poor solubility of the catalyst at ambient temperatures led to 
inconsistencies in the quantity of catalyst that was able to be pumped into the reactor, 
which caused variation in the conversions obtained for each RV and prevented steady state 
from being reached. This also led to the conversions achieved being much lower than when 
using microwave batch heating as not all of the desired catalyst was present in the reactor 
and so the catalyst loading was lower than calculated. Further work would be required to 
improve the catalyst solubility to be able to consistently carry out the reaction within the 
continuous reactor. 
The N-alkylation of single enantiomer 5.1 was then studied under microwave heating to 
determine if the amine could be N-alkylated. After only a few further experiments, a 92% 
yield of the single enantiomer N-alkylated product 5.6 (95% ee) was achieved after 1 h at 
150 °C. To be able to reduce the reaction time the temperature needed to be increased, 
which caused the ee to be significantly reduced and increased the formation of dimers.  
It was envisaged that the single enantiomer N-alkylation could be coupled to the enzymatic 
resolution discussed in Chapter 2 as a method to utilise the underivatised enantiomer and 
produce single enantiomer secondary amines. For the development of the coupled process, 
inhibition reactions were carried out to determine if any of the components from one of the 
reactions would hinder the other reaction. No inhibition of the resolution reaction was 
observed in the presence of the N-alkylation reaction components. Interestingly, the 
addition of ester 5.2 or amide 5.3 appeared to enhance the N-alkylation reaction, giving ~ 
40% higher conversions compared to control reaction. These studies indicated that each 
reaction would not be inhibited by the components from the other reaction and so coupling 
the two procedures should be feasible. However when the coupled process was attempted 
in a stepwise manner, a much lower conversion was observed for the N-alkylation step. 
Further studies indicated that this was likely due to some material leaching from the 
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immobilised enzyme, either from the enzyme itself or from the support. The support was a 
polymer of methacrylate and so perhaps some methacrylate was leaching off and inhibiting 
the catalyst. Further work would be required to determine the specific cause of the 
inhibition and whether it can be prevented. 
The selectivity and retention of stereochemistry observed prompted some interesting 
insights into the catalytic mechanism, in terms of the order in which the two different 
amines coordinate to the catalyst. Amine 5.5 appeared to outcompete amine 5.1 for 
coordination to the iridium centre and so by increasing the Eq of 5.5 the selectivity for 
desired product was significantly increased, with only a few percent of dimers observed.  
In summary, screening and optimisation of reaction conditions allowed for a fast and 
highly selective procedure to be developed for the N-alkylation of a primary amine. 
Application of this to the single enantiomer amine provided a method to single enantiomer 
N-alkylated secondary amine and a way to re-use the undesired enantiomer remaining from 
the enzymatic resolution. Both procedures provided high conversion and selectivity for 
desired product in a much shorter time frame than existing methods. There is potential for 
the process to be transferred into the continuous reactor to increase the throughput and to 
couple the reaction to the enzymatic resolution, however, further development would be 




In this research, methods were sought for the combination of chemical and biological 
catalysts for the production of chiral amines and essential medicines. Continuous reactors 
and optimisation strategies were employed to increase the productivity and efficiency. 
Generally, by using immobilised catalysts in packed bed reactors (PBRs) the catalyst 
loading could be greatly increased, leading to reduced reaction times and greater 
productivity. 
Firstly, the lipase catalysed kinetic resolution of a chiral primary amine was studied; 
initially in batch and then in a continuous PBR. The reaction was optimised using a one 
variable at a time (OVAT) approach, to give a highly selective process with reduced 
reaction times and higher productivity than existing literature.
92
  
Secondly, the racemisation of the chiral primary amine was investigated using Ir, Ru and 
Pd catalysts for the potential to recycle the waste enantiomer from the resolution in a 
continuous DKR process. The racemisation of primary amines is known to be difficult due 
to the lack of appropriate catalysts and unfortunately the substrate chosen was not suitable 
for racemisation by the catalysts tested, due to the high reactivity of the imine intermediate 
which led to the formation of dimers over racemisation.  
Next, the continuous lipase catalysed reaction of esters with NH3 for the production of two 
essential medicines was studied. Optimisation by DoE was carried out in the continuous 
PBR to determine optimum operating conditions in terms of conversion. Nicotinamide, a 
member of the vitamin B family, was produced in 94% yield with a tRes of 60 min at 67 
°C. Pyrazinamide, a treatment for TB, was produced in quantitative yield with a tRes of 
only 20 min at 40 °C. The ammoniolysis of a chiral amino acid ester was then investigated. 
However, no reaction was observed with a range of different immobilised lipases.  
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Finally, the Ir catalysed N-alkylation of a chiral primary amine was investigated; utilising a 
DoE screen to favour hetero-coupling over homo-coupling. Optimisation studies were 
carried out under microwave heated batch conditions so as to save material. A limitation of 
using homogeneous catalysis in flow is that it can be wasteful, without a method to 
efficiently recover and re-use the catalyst. The optimum conditions gave 96% conversion 
and 94% selectivity for the desired hetero-coupled product after only 10 min, which was a 
vastly reduced reaction time compared to existing processes. The optimised process was 
then transferred to the flow reactor. Unfortunately, poor catalyst solubility resulted in 
lower conversions and inconsistencies in the continuous set-up. It was also determined that 
the enantiopurity of substrate could be maintained to achieve single enantiomer N-
alkylated product (92% yield, 95% ee) by minor modification of the optimised reaction 
conditions developed for the racemic amine, providing a method to utilise the waste 
enantiomer from the kinetic resolution step. However, compatibility issues arose when 
trying to telescope the two steps, in that the enzyme support appeared to inhibit the Ir 
catalyst. This is a remaining challenge to be overcome for this procedure. 
The research described herein shows improved methods for chiral amine production, whilst 
also highlighting the challenges associated with asymmetric synthesis of amines. The 
studies showed how the use of continuous reactors, microwave heating and optimisation 
strategies can lead to lower waste, shorter reaction times and reduced energy demand, 
resulting in higher efficiency and productivity. 
 
6.1 Further Work 
The continuous resolution PBR was only applied to a limited number of substrates in this 
work and it would be useful to expand the substrate scope further. The literature shows that 
N435 is active for a wide range of amine and alcohol substrates and so it would be 
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interesting to study some more valuable, pharmaceutically relevant molecules and 
determine optimum methods to produce them in the lipase PBR. The secondary amines 
tested within this research did not show any reactivity with N435 and so a range of 
different immobilised lipases would need to be tested in order to increase the scope and 
generality of the reactor system. This would also be the case for expanding the substrate 
scope for the lipase catalysed ammoniolysis reactions in the PBR. 
In the racemisation studies the catalyst that showed the greatest degree of racemisation vs. 
dimer formation was the Shvö catalyst, although the reaction time was long. Immobilised 
versions of the Ru Shvö-type catalysts could be investigated for combination with the 
lipase catalysed resolution in sequential PBRs. Kim et al. presented polymer bound 
versions of an Ru catalyst 6.1 for the racemisation of alcohols.
156
 Their immobilisation 
strategy could be applied to the modified Shvö catalysts 6.2 developed by Bäckvall and co-
workers that were more active for the racemisation of amines.
66
 The PBR would allow 
higher catalyst loading per reactor volume to be achieved and so the reaction time may be 
reduced to give a more viable DKR system. In the catalyst screening carried out by the 
Bäckvall group for amine racemisation,
66
 catalyst 6.3 gave full racemisation in only 19 h, 
with very high selectivity for the desired reaction (> 98%). It could be envisaged that this 
catalyst could be immobilised by polymerisation on the styrene group to create a 




Figure 46. (A) Immobilised Ru racemisation catalyst 6.1 developed by Kim et al.
156
 and 
modified Shvö catalyst 6.2 for amine racemisation developed by Bäckvall and co-
workers;
66
 (B) Potential heterogeneous racemisation catalyst 6.4, based on Ru catalyst 6.3 
tested by Bäckvall.
66
(Grey spheres denote polymer resin). 
 
Another route to explore further would be the heterogeneous Pd catalysed racemisation. Pd 
catalysts using alkaline earth supports developed by the de Vos group showed high 
selectivity for racemisation vs. dimer formation in the presence of H2.
60
 A current 
limitation in this work was that the current reactor set-up was unable to include gas feeds 
and so the Pd catalyst testing was carried out without the presence of H2. Reactor 
development for the addition of gas feeds would be the next step to be able to utilise these 
catalysts under their optimum operating conditions, this development is currently ongoing 
within the research group.  
However, the overriding issue with the amine racemisation is the lack of suitable catalysts. 
Therefore, the most valuable improvements in this area of amine racemisation would be in 
catalyst development, which was unfortunately beyond the remit of this project. 
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For the N-alkylation step in the continuous reactor to be developed further, the difficulties 
with the solubility in flow reactor need to be addressed. Lowering the concentration of the 
substrate appeared to reduce the amount of solid build-up in the stirred vessel and so 
lowering the concentration further may improve this. Whilst the DoE showed that 
changing the concentration had little effect on the yield and selectivity, this would reduce 
the productivity of the overall process and so would not be favourable. As previously 
discussed, increasing the temperature of the stirred vessel may increase the catalyst 
solubility; however, experiments would need to be carried out to determine whether any 
background reaction would occur between the catalyst and the substrate in the stirred 
vessel and would likely need a heated pump. 
Further investigation into the cause of the N-alkylation inhibition in the presence of the 
immobilised lipase would also be required to determine if this can be overcome. In 
addition different supports for the enzyme could be tested to circumvent this. If these 
problems can be overcome, the coupling of the enzymatic resolution and the N-alkylation 
in the continuous system would present an opportunity to produce a single enantiomer 
amide from the resolution step and a single enantiomer secondary amine from the N-
alkylation step. This would be a valuable process because there are only a few examples of 
lipases that can accept secondary amine substrates.
55, 72
  
Alternatives to di-isopropylamine could also be investigated as the alkyl donor in the N-
alkylation, which may prevent dimer formation at less harsh conditions. If the coordination 
of di-isopropylamine is inhibited by the steric bulk, then using a smaller donor such as di-
ethylamine may ensure that only the alkyl donor coordinates to the catalyst. If the alkyl 
donor can completely outcompete 1-phenylethylamine for coordination to the catalyst, then 
this would result in only the desired hetero-coupled product. 
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Another area for development that would increase the value of the lipase PBR process is 
the integration of downstream processing techniques and in-line analytical techniques, to 
allow for more rapid analysis and determination of optimum conditions. The combination 
of chemo- and bio-catalysed reactions could be extended beyond DKR to combine the 
lipase catalysed resolution with other continuous synthetic steps for telescoped PBR 
processes. For example Ötvös et al. reported the asymmetric aldol reaction in a continuous 
PBR using an immobilised peptide catalyst 6.9.
157
 The optimum ee was only 80% and so 
the lipase PBR could be employed sequentially for the resolution to obtain single 
enantiomer product (Scheme 93). 
 
Scheme 93. Potential coupling of the lipase catalysed resolution PBR with a continuous 





In summary, chemical manufacturing methods must be constantly adapted and developed 
to achieve more efficient, cost-effective routes to target compounds. The intensification of 
reaction conditions achievable in flow reactors, combined with the recyclability of 
immobilised catalysts in PBRs, presents a viable solution to this requirement for more 
efficient, productive manufacturing routes. The combination of chemical and biological 
catalysts is a desirable concept to exploit the advantages of each catalyst type, however, 
196 
 
incompatibility issues means that this is not a trivial task. The work in this thesis has 
contributed to the development of continuous enzymatic PBRs and the use of optimisation 
strategies for increased productivity in the synthesis of chiral amines and essential 
medicines, whilst also highlighting some of the challenges associated with combining 




7.1 General Experimental Methods 
Unless otherwise stated, all reagents and solvents were purchased from Sigma Aldrich, Fisher 
Chemical, Acros Organics, Alfa Aesar, Merck or VWR International and were used without 
further purification. Pd/C and Pd/BaSO4 catalysts were purchased from Johnson Matthey and 
the immobilised iridium catalyst was supplied by Yorkshire Process Technology. The activity 
for the Novozyme 435 batch used herein was not provided by the vendor. However an 
analogous product can be purchased from Sigma Aldrich with a quoted activity of ≥ 5000 
U/g, which could be used in place of the N435 batch used. Thin layer chromatography (TLC) 
was carried out using silica gel 60 F254 plates (Merck). Purifications by column 
chromatography were performed using silica gel, either manually or using a Biotage Isolera 
purification system. NMR spectra were obtained using Bruker Advance 500 at 500 MHz or 
using Bruker DPX 300 at 300 MHz for 
1
H NMR and using Bruker Advance 500 at 126 MHz 
for 
13
C NMR. NMR samples were recorded in CDCl3 or DMSO-d
6
. Chemical shifts (δ) are 
reported in ppm and coupling constants (J) in Hz. Multiplicities are denoted as follows: s = 
singlet, d = doublet, t = triplet, quart = quartet, quint = quintet, m = multiplet and br s = broad 
singlet. Compound multiplicities are denoted as: dd = doublet of doublets, dt = doublet of 
triplets etc. GCMS analysis was carried out on an Agilent HP-6890 instrument equipped with 
a HP-5973 mass selective detector and fitted with a HP-5MS column (30 m x 0.32 mm, 0.25 
µm film thickness), He carrier gas. LCMS analysis was carried out on an Agilent 1290 
UHPLC with Bruker HCT-Ultra detector. High resolution mass spectrometry (HRMS) was 
carried out on a Bruker micrOTOF with electrospray ionisation (ESI). Achiral GC analysis 
was carried out on an Agilent 7890B instrument fitted with a HP-5 column (30 m x 0.32 mm, 
0.25 µm film thickness), H2 carrier gas, FID detector. Chiral GC analysis was carried out on 
an Agilent HP-6890 instrument fitted with a CP-Chirasil-Dex-CB column (25 m x 0.25 mm, 
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0.25 µm film thickness), H2 carrier gas, FID detector. Achiral HPLC analysis was carried out 
on an Agilent HP-1100 instrument fitted with a Sigma Ascentis Express C18 column (5 cm x 
6.6 mm, 2.7 μm particle size) with VICI Valco 4-port sample injection (CI4W.06 manual 
valve, DCI4W.06 rotor, medium torque EUDA actuator, 0.06 μL injection volume). Chiral 
HPLC analysis was carried out on an Agilent HP-1100 instrument fitted with a Chiralpak AD 
column (25 cm x 4.6 mm, 10 µm particle size), 20 °C, 10 µL injection volume. All GC oven 
gradients and HPLC solvent gradients are described in the subsequent sections, with the 
corresponding analytes. Infrared (IR) analysis was carried out using a Bruker Alpha FT-IR. 
All microwave reactions were carried out in a CEM Discover SP Microwave Synthesizer. 
 
7.2 Experimental Details Relating to Chapter 2 
7.2.1 Chiral analysis standard method 
Unless otherwise stated, all reactions were analysed by chiral GC to determine enantiomeric 
excess (ee) according to the following GC oven method: 90 °C (hold for 30 min); 40°/min to 
180 °C (hold for 10 min); Inj = 300 °C; Det = 300 °C; H2 carrier gas; 15 psi. 










7.2.2 Preparation of analytical standards 
7.2.2.1 N-Acetyl-1-phenylethylamine: 
 
Triethylamine (1.02 g, 10.0 mmol) was added to rac-1-phenylethylamine (1.03 g, 8.53 mmol) 
in DCM (20 mL). The mixture was cooled on ice and acetic anhydride (0.94 g, 9.20 mmol) 
was added dropwise. The reaction was stirred at room temperature for 1.5 h. H2O (20 mL) 
was then added and the layers separated. The organic phase was washed with HCl (1 M, 20 
mL), dried (MgSO4) and the solvent removed under vacuum to give N-(1-
phenylethyl)acetamide as a white solid (1.16 g, 7.08 mmol, 83%). 
1
H NMR (500 MHz, 
CDCl3): δ 1.42 (d, J = 7.0 Hz, 3H, CHCH3), 1.92 (s, 3H, C(O)CH3), 5.07 (app quint, J = 7.0 
Hz, 1H, CHCH3), 5.58 (br s, 1H, NH), 7.19 – 7.29 (m, 5H, Ar-H); 
13
C NMR (126 MHz, 
CDCl3): δ 21.7 (CH3), 23.5 (CH), 48.8 (C(O)CH3), 126.2 (ArC-H), 127.4 (ArC-H), 128.7 




164.4; IR (solid): ν 3261, 3071, 3023, 
2972, 2930, 2870, 2824, 1640, 1548, 1490, 1444 cm
-1
; Chiral GC analysis using standard 
method described in Section 7.2.1: tR(N-acetyl-[(1R)-1-phenylethyl]amine) = 32.1 min, tR(N-









7.2.2.2 2-Methoxy-N-(1-phenylethyl)acetamide:  
 
Methylmethoxy acetate (0.86g, 8.28 mmol) was added to rac-1-phenylethylamine (0.25 g, 
2.09 mmol) in toluene (20 mL) and heated to 70 °C. After 48 h, the mixture was cooled to 
room temperature and HCl (1 M, 20 mL) was added. The layers were separated and the 
organic was dried (MgSO4) and the solvent removed under vacuum to give 2-methoxy-N-(1-
phenylethyl)acetamide as a white solid (0.046 g, 0.23 mmol, 11%). 
1
H NMR (500 MHz, 
CDCl3): δ 1.45 (d, J = 7.0 Hz, 3H, CH3), 3.34 (s, 3H, OCH3), 3.80 (d, J = 15 Hz, 1H, CHH), 
3.85 (d, J = 15 Hz, 1H, CHH), 5.11 (app quint, J = 7.0 Hz, 1H, CH), 6.67 (br s, 1H, NH), 7.18 
– 7.22 (m, 1H, Ar-H), 7.24 – 7.29 (m, 4H, Ar-H); 
13
C NMR (126 MHz, CDCl3): δ 21.9 (CH3), 
48.0 (CH), 59.1 (OCH3), 72.0 (OCH2), 126.2 (ArC-H), 127.4 (ArC-H), 128.7 (ArC-H), 143.0 




194.4; IR (solid): ν 3324, 3032, 2976, 2938, 2831, 
2830, 1650, 1524, 1450 cm
-1
; Chiral GC analysis using standard method described in Section 
7.2.1: tR(2-methoxy-N-[(1R)-1-phenylethyl]acetamide) = 32.7 min, tR(2-methoxy-N-[(1S)-1-






1-(4-Fluorophenyl)ethylamine (0.10 g, 0.73 mmol) was dissolved in DCM (5 mL) and the 
solution was cooled on ice. Methoxyacetyl chloride (0.15 g, 1.42 mmol) was then added 
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dropwise. After stirring for 1.5 h at room temperature, H2O (5 mL) was added and the layers 
were separated. The aqueous phase was extracted with DCM (3 x 10 mL). The combined 
organic phases were dried (MgSO4) and the solvent removed under vacuum to give a 
colourless oil. The crude product was purified by flash column chromatography (100% 
EtOAc) to give N-[1-(4-fluorophenyl)ethyl]-2-methoxy-acetamide as a white solid (0.096 g, 
0.46 mmol, 63%). 
1
H NMR (500 MHz, CDCl3): δ 1.50 (d, J = 7.0 Hz, 3H, CHCH3), 3.41 (s, 
3H, OCH3), 3.80 (d, J = 15 Hz, 1H, CHH), 3.85 (d, J = 15 Hz, 1H, CHH), 5.16 (quart, J = 7.0 
Hz, 1H, CHCH3), 6.75 (br s, 1H, NH), 7.01 – 7.04 (m, 2H, Ar-H), 7.28 – 7.31 (m, 2H, Ar-H); 
13
C NMR (126 MHz, CDCl3): δ 21.9 (CH3), 47.5 (CH), 59.1 (OCH3), 71.0 (CH2), 115.4, 
115.6 (d, ArC-H), 127.8, 127.8 (d, ArC-H), 138.7, 138.7 (d, Ar-C), 161.1, 163.0 (d, CF), 




234.4; Rf = 0.62 (100% EtOAc); IR (liquid film): ν 3409, 
3305, 2978, 2934, 2828, 1737, 1655, 1500 cm
-1
; Chiral GC oven method: 80 °C (hold for 30 
min); 40°/min to 180 °C (hold for 10 min): tRN-[1R-(4-fluorophenyl)ethyl]-2-methoxy-
acetamide = 33.1 min, tRN-[1S-(4-fluorophenyl)ethyl]-2-methoxy-acetamide = 33.2 min. Two 
drops of trifluoroacetic anhydride were added to samples to obtain ee for 1-(4-
fluorophenyl)ethylamine: tR1R-(4-fluorophenyl)ethylamine = 22.6 min, tR1S-(4-






2-Amino-4-phenylbutane (0.10 g, 0.69 mmol) was dissolved in DCM (5 mL) and the solution 
was cooled on ice. Methoxyacetyl chloride (0.14 g, 1.31 mmol) was then added dropwise. 
After stirring for 2 h at room temperature, H2O (10 mL) was added and the layers were 
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separated. The aqueous phase was extracted with DCM (2 x 10 mL). The combined organic 
phases were dried (MgSO4) and the solvent removed under vacuum to give a colourless oil. 
The crude product was purified by flash column chromatography (100% EtOAc) to give 2-
methoxy-N-(1-methyl-3-phenylpropyl)-acetamide as a colourless oil (0.043 g, 0.19 mmol, 
28%). 
1
H NMR (500 MHz, CDCl3): δ 1.20 (d, J = 6.7 Hz, 3H, CHCH3), 1.77 – 1.82 (m, 2H, 
CH2CH), 2.63 – 2.67 (m, 2H, Ar-CH2), 3.40 (s, 3H, OCH3), 3.87 (s, 2H, COCH2), 4.07 – 4.13 
(m, 1H, CHCH3), 6.36 (br s, 1H, NH), 7.16 – 7.19 (m, 3H, Ar-H), 7.26 – 7.29 (m , 2H, Ar-H); 
13
C NMR (126 MHz, CDCl3): δ 21.0 (CH3), 32.5 (CH2), 38.6 (CH2), 44.6 (CH), 59.1 (OCH3), 





222.4; Rf = 0.68 (100% EtOAc); Chiral GC oven method: 130 °C (hold for 30 
min): tR2R-methoxy-N-(1-methyl-3-phenylpropyl)-acetamide = 24.5 min, tR2S-methoxy-N-(1-
methyl-3-phenylpropyl)-acetamide = 25.2 min. Two drops of propyl chloroformate were 
added to samples to obtain ee for 2-amino-4-phenylbutane: tR2R-amino-4-phenylbutane = 







1-Phenylethanol (0.11 g, 0.93 mmol) was dissolved in DCM (5 mL). Triethylamine (0.17 g, 
1.65 mmol) was added and the mixture cooled on ice. Methoxyacetyl chloride (0.18 g, 1.64 
mmol) was then added dropwise and the mixture was stirred on ice for 1 h. After stirring for a 
further 22 h at room temperature, H2O (5 mL) was added and the layers were separated. The 
aqueous phase was extracted with DCM (3 x 10 mL). The combined organic phases were 
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dried (MgSO4) and the solvent removed under vacuum to give a yellow oil. The crude 
mixture was purified by column chromatography using the Biotage Isolera system (70:30 
PE/EtOAc) to give 1-phenylethyl-2-methoxyacetate as a colourless oil (0.052 g, 0.27 mmol, 
29%). 
1
H NMR (500 MHz, CDCl3): δ 1.50 (d, J = 6.6 Hz, 3H, CHCH3), 3.37 (s, 3H, OCH3), 
3.94 (d, J = 15 Hz, 1H, CHH), 3.99 (d, J = 15 Hz, 1H, CHH), 5.93 (quart, J = 6.6 Hz, 1H, 
CHCH3), 7.19 – 7.29 (m, 5H, Ar-H); 
13
C NMR (126 MHz, CDCl3): δ 22.1 (CH3), 59.4 (CH), 
70.0 (OCH3), 72.9 (OCH2), 126.2 (ArC-H), 128.1 (ArC-H), 128.6 (ArC-H), 141.1 (Ar-C), 
169.6 (CO); HRMS (ESI
+




 217.0841, found 
217.0840; Rf = 0.39 (70:30 PE/EtOAc); IR (liquid film): ν 2984, 2934, 2828, 1751 cm
-1
; 
Chiral GC analysis using standard method described in Section 7.2.1: tR((1R)-phenylethyl-2-
methoxyacetate) = 19.8 min, tR((1S)-phenylethyl-2-methoxyacetate) = 20.5 min, tR((1R)-
phenylethanol) = 6.4 min, tR((1S)-phenylethanol) = 6.9 min.  
 
7.2.2.6 2-(Methoxy)-1-(4-fluorophenyl)ethyl ester 
 
1-(4-Fluorophenyl)ethanol (1.00 g, 7.15 mmol) was dissolved in DCM (50 mL). 
Triethylamine (1.44 g, 14.2 mmol) was added and the mixture cooled on ice. Methoxyacetyl 
chloride (1.54 g, 14.2 mmol) was then added dropwise and the mixture was stirred on ice for 
1 h. After stirring for a further 1 h at room temperature, H2O (70 mL) was added and the 
layers were separated. The aqueous phase was extracted with DCM (30 mL). The combined 
organic phases were dried (MgSO4) and the solvent removed under vacuum to give a yellow 
oil. The crude mixture was purified by column chromatography using the Biotage Isolera 
system (90:10 PE/EtOAc) to give 2-(methoxy)-1-(4-fluorophenyl)ethyl ester as a colourless 
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oil (0.16 g, 0.77 mmol, 11%). 
1
H NMR (500 MHz, CDCl3): δ 1.56 (d, J = 6.6 Hz, 3H, 
CHCH3), 3.43 (s, 3H, OCH3), 4.00 (d, J = 15 Hz, 1H, CHH), 4.05 (d, J = 15 Hz, 1H CHH), 
5.98 (quart, J = 6.6 Hz, 1H, CHCH3), 7.02 – 7.05 (m, 2H, Ar-H), 7.33 – 7.35 (m, 2H, Ar-H); 
13
C NMR (126 MHz, CDCl3): δ 22.1 (CH3), 59.4 (CH), 70.0 (OCH3), 72.2 (OCH2), 115.3, 
115.5 (d, ArC-H), 128.0, 128.1 (d, ArC-H), 136.9, 136.9 (d, ArC) 161.5, 163.4 (d, CF), 169.5 
(CO); HRMS (ESI
+




 235.0746, found 
235.0745; Rf = 0.1 (90:10 PE/EtOAc); IR (liquid film): ν 2984, 2934, 2828, 1750, 1605 cm
-1
; 
Chiral GC oven method: 90 °C (hold for 30 min): tR(2-(Methoxy)-1R-(4-fluorophenyl)ethyl 
ester) = 21.5 min, tR(2-(Methoxy)-1S-(4-fluorophenyl)ethyl ester) = 22.8 min, tR(1R-(4-




4-Phenyl-2-butanol (0.11 g, 0.71 mmol) was dissolved in DCM (5 mL). Triethylamine (0.15 
g, 1.43 mmol) was added and the mixture cooled on ice. Methoxyacetyl chloride (0.14 g, 1.31 
mmol) was then added dropwise and the mixture was stirred on ice for 1 h. After stirring for a 
further 23 h at room temperature, H2O (10 mL) was added and the layers were separated. The 
aqueous phase was extracted with DCM (3 x 10 mL). The combined organic phases were 
dried (MgSO4) and the solvent removed under vacuum to give a yellow oil. The crude 
mixture was purified by column chromatography using the Biotage Isolera system (65:35 
PE/EtOAc) to give 4-phenylbutan-2-yl-2-methoxyacetate as a colourless oil (0.058 g, 0.26 
mmol, 37%).
1
H NMR (500 MHz, CDCl3): δ 1.21 (d, J = 6.3 Hz, 3H, CHCH3), 1.73 – 1.80 (m, 
1H, CHH), 1.87 – 1.94 (m, 1H, CHH), 2.52 – 2.64 (m, 2H, CH2), 3.38 (s, 3H OCH3), 3.89 (d, 
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J = 17.5 Hz, 1H, CHH), 3.93 (d, J = 17.5 Hz, 1H, CHH), 4.96 – 5.02 (m, 1H, CHCH3), 7.09 – 
7.13 (m, 3H, Ar-H), 7.19 – 7.22 (m, 2H, Ar-H); 
13
C NMR (126 MHz, CDCl3): δ 20.1 (CH3), 
31.8 (CH2), 37.5 (CH2), 59.3 (CH), 70.0 (OCH3), 71.4 (OCH2), 126.0 (ArC-H), 128.3 ArC-




245.4; Rf = 0.48 (65:35 
PE/EtOAc); IR (liquid film): ν 2984, 2934, 2828, 1751 cm
-1
; Chiral GC analysis using 
standard method described in Section 7.2.1: tR(R-4-phenylbutan-2-yl-2-methoxyacetate) = 
32.4 min, tR(S-4-phenylbutan-2-yl-2-methoxyacetate) = 32.5 min, tR(R-4-phenyl-2-butanol) = 





7.2.3 Novozyme 435 catalysed kinetic resolution 
7.2.3.1 General procedure for Novozyme 435 catalysed kinetic resolution of rac-1-
phenyethylamine in batch 
rac-1-Phenylethylamine (0.07 M) and acyl donor (1 Eq) were added to Novozyme 435 (10 
mg) in toluene (10 mL) at 60 °C. Samples were taken from the reaction every hour for chiral 
GC analysis. 100 µL samples were diluted to 1 mL with DCM for amide ee. 100 µL samples 
were diluted to 1 mL with DCM and 2 drops of trifluoroacetic anhydride was added for amine 
ee. 
 
7.2.3.2 Novozyme 435 catalysed kinetic resolution of rac-1-phenyethylamine in 
continuous flow 
Reactor set-up: Novozyme 435 was manually packed into a 316 stainless steel tubular reactor 
(1/4” OD, 1/8” ID, 3.0 mL), fitted with Supelco stainless steel frits (1/4” diameter). The 
packed reactor was housed within an aluminium heating block, under Eurotherm temperature 
control that was monitored by green K-type thermocouples inserted into the aluminium block. 
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The reaction solution was introduced into the reactor system using a PU-2085 dual piston 
pump, set to the desired flow rate. The pump was connected to the packed reactor using PTFE 
tubing (1/16” OD, 1/32” ID). All tee-pieces and unions used were Swagelock 316 stainless 
steel. Reaction samples were collected at the reactor outlet for each reactor volume, and then 
analysed by GC for ee.  
The reactor volume (RV) was determined by pumping a slug of food dye in an aqueous 
stream through the reactor at a specified flow rate. The time between the slug entering and 
leaving the packed bed was then used to determine the RV according to: 











Table 17. Residence time screen.
a
 
Entry Flow rate / 
mL min
-1 
tRes / min Amide ee / % Amine ee / % Conversion / 
% 
1 0.1 30 99 99 50 
2 0.5 6 99 96 49 
3 1 3 99 71 42 
4 2 1.5 99 47 32 
a
Reaction conditions: 0.07 M rac-1-phenylethylamine, 1 eq methylmethoxy acetate, 60 °C, 3 mL reactor 
volume; 
b
Determined by chiral GC analysis; 
c
Determined by chiral GC analysis after derivatisation with 
trifluoroacetic anhydride; 
d
Determined using Conversion = [eeamine / (eeamine + eeamide)]*100; 
Table 18. Temperature screen.
a 
Entry Temperature / °C Amide ee
e
 / % Amine ee
f
 / % Conversion
g
 / % 





100 98 49 
3
c 
30 100 75 43 
4
d 
30 100 81 45 
5 40 100 74 43 
6 50 100 91 48 
7 60 100 96 49 
8 70 100 98 50 
9 80 100 100 50 
10 90 100 100 50 
11 100 100 100 50 
a
Reaction conditions: 0.07 m rac-1-phenylethylamine, 1 eq methylmethoxy acetate, 3 mL reactor volume, 0.5 
mL min
-1
, tRes = 6 min; 
b
tRes = 30 min; 
c
Methylmethoxy acetate only pumped for 4 RV prior to reaction; 
d
Solvent pumped at 60 °C for 10 RV prior to reaction;
 e
Determined by chiral GC analysis; 
f
Determined by chiral 
GC analysis after derivatisation with trifluoroacetic anhydride; 
g
Determined using Conversion = [eeamine / (eeamine 
+ eeamide)]*100; 
Table 19. Concentration screen.
a
 
Entry Concentration / M Amide ee
b
 / % Amine ee
c
 / % Conversion
d
 / % 
1 0.07 99 96 49 
2 0.14 99 93 48 
3 0.28 99 86 46 
4 0.42 99 71 41 
5 0.56 99 70 41 
6 0.70 99 73 42 
a
Reaction conditions: 1 eq methylmethoxy acetate, 60 °C, 3 mL reactor volume, 0.5 mL min-1, tRes = 6 min; 
b
Determined by chiral GC analysis; 
c
Determined by chiral GC analysis after derivatisation with trifluoroacetic 
anhydride; 
d





Table 20. Catalyst recyclability testing.
a 
Time / h Amide ee
b
 / % Amine ee
c
 / % Conversion
d
 / % 
1 99 91 48 
2 99 98 49 
3 99 98 49 
4 99 96 48 
6 99 97 49 
7 99 97 49 
23 99 95 49 
24 99 95 49 
25 99 95 49 
27 99 97 49 
28 99 97 49 
29 99 96 49 
30 99 94 49 
a
Reaction conditions: 0.07 m rac-1-phenylethylamine, 1 eq methylmethoxy acetate, 60 °C, 3 mL reactor 
volume, 0.5 mL min
-1
, tRes = 6 min; 
b
Determined by chiral GC analysis; 
c
Determined by chiral GC analysis after 
derivatisation with trifluoroacetic anhydride; 
d
Determined using Conversion = [eeamine / (eeamine + eeamide)]*100; 
 
7.2.3.3 Expanded substrate scope for Novozyme 435 catalysed kinetic resolution in 
continuous flow 
General method: Substrate (0.14 mmol) was dissolved in toluene in 100 mL graduated flask. 
Methylmethoxy acetate (0.14 mmol) was dissolved in toluene in 100 mL graduated flask. The 
individual stock solutions were then combined in a 50:50 ratio for the reaction mixture. 
Novozyme 435 was packed into the stainless steel tubular reactor, which was heated to 60 °C 
whilst pumping toluene at 1 mL min
-1
. Once the reactor had reached temperature and air had 
been purged from the system, the reaction mixture was pumped into the reactor system at 0.5 
mL min
-1
 (tRes = 6 min). Product mixture was collected at the outlet of the reactor as separate 






7.3 Experimental Details Relating to Chapter 3 
7.3.1 GC Analysis of Components and Calibrations 
Samples were analysed by GCMS according to the following GC oven method: 70 °C (hold 
for 1 min); 5°/min to 100 °C; 20°/min to 300 °C (hold for 1 min); Inj = 250 °C; He carrier 
gas; 4.76 psi; tR(1-phenylethylamine) = 1.9 min, tR(N,N-di(1-phenylethyl)amine = 12.0 and 
12.2 min, tR(N-(α-methyl)benzylidene-1-phenylethanamine = 12.9 min. 
 
7.3.2 Preparation of analytical standards 
7.3.2.1 N-(α-methyl)benzylidene-1-phenylethanamine 
 
Acetophenone (0.90 g, 7.46 mmol) was added to rac-1-phenylethylamine (1.00 g, 8.28 mmol) 
in toluene (10 mL) and the mixture was heated to reflux. Concentrated H2SO4 (0.098 g, 0.99 
mmol) was then added. After 49 h, the reaction mixture was allowed to cool to room 
temperature and saturated NaHCO3(aq) (20 mL) was added. The layers were separated and the 
organic phase was washed with brine (20 mL). The organic layer was dried (MgSO4) and the 
solvent removed under vacuum to give the crude mixture as a yellow oil (0.96 g). The imine 
dimer was not isolated from the crude mixture, as purification by flash column 
chromatography returned only starting material, and was used for the synthesis of N,N-di(1-
phenylethyl)amine without any further purification. Analysis of imine dimer in crude mixture 
(64% imine dimer): 
1
H NMR (500 MHz, CDCl3): δ 1.47 (d, J = 6.6 Hz, 3H, CHCH3), 2.20 (s, 











NaBH4 (0.21 g, 5.45 mmol) was added to the imine crude mixture (0.50 g, 1.44 mmol imine) 
in MeOH (20 mL). The mixture was stirred at room temperature for 3 h. HCl (2 M) was then 
added to acidify and the solvent removed under reduced pressure to give an off-white solid. 
DCM (20 mL) and H2O (20 mL) were then added and the solution basified with NaOH (1 M). 
The layers were separated and the aqueous phase was extracted with DCM (2 x 20 mL). The 
combined organics were dried (MgSO4) and the solvent removed under vacuum to give a 
yellow oil. The crude was purified by flash column chromatography (80:20 PE/EtOAc) to 
give N,N-di(1-phenylethyl)amine as a pale yellow oil (0.23 g, 1.03 mmol, 72%). 
1
H NMR 
(500 MHz, CDCl3): δ 1.19 (d, J = 6.7 Hz, 3H, CHCH3), 1.27 (d, J = 6.6 Hz, 3H, CHCH3), 
3.42 (quart, J = 6.7 Hz, 1H CHCH3), 3.69 (quart, J = 6.6 Hz, 1H, CHCH3), 7.13 – 7.27 (m, 
10H, Ar-H);
 13
C NMR (126 MHz, CDCl3): δ 25.0 (CH3), 55.1 (CH), 126.7 (ArC-H), 126.8 




226.4; Rf = 0.21 (80:20 
PE/EtOAc); IR (liquid film): ν 3082, 3061, 3025, 2960, 2924, 2863, 1602, 1491, 1450 cm
-1
. 




7.3.3 Iridium catalysed racemisation reactions 
7.3.3.1 Racemisation of (S)-1-phenylethylamine using immobilised Ir-catalyst in flow 
1
st
 reactor type: (S)-1-Phenylethylamine in toluene was pumped, using a Harvard 11 syringe 
pump, through a stainless steel tubular reactor (4.0 mm ID, 25 cm, 3.1 mL) packed with 
immobilised Cp*Ir catalyst at the desired flow rate. The packed reactor was housed within a 
stainless steel heating jacket, which was placed on top of a hot-plate and heated to the desired 
temperature. The pump was connected to the packed reactor using PTFE tubing (1/16” OD, 
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1/32” ID). The product mixture was collected at the outlet of the reactor and analysed by GC 
to determine conversion and ee. The reaction mixture was transferred back into the syringes 
to be fed back into the reactor for re-circulation. 
2
nd
 reactor type: (S)-1-Phenylethylamine in toluene was pumped, using a Harvard PHD 2000 
infusion syringe pump, through a stainless steel tubular reactor (1/4” OD, 1/8” ID, 3.0 mL) 
packed with immobilised Cp*Ir catalyst at the desired flow rate. The packed reactor was 
housed within an aluminium heating block, under Eurotherm temperature control that was 
monitored by green K-type thermocouples inserted into the aluminium block. The pump was 
connected to the packed reactor using PTFE tubing (1/16” OD, 1/32” ID). The product 
mixture was collected at the outlet of the reactor and analysed by GC to determine conversion 
and ee. The reaction mixture was transferred back into the syringes to be fed back into the 
reactor for re-circulation. 
 


















 / % 
1 2.5 80 6 0 > 99 
2 2.5 100 6 6 > 99 
3 5 100 6 12 > 99 
4
b
 2.5 110 6 1 > 99 
5
b
 2.5 110 12 1 > 99 
6
b
 2.5 110 30 3 > 99 
a
Reaction conditions: heterogeneous Ir catalyst, 0.07 M (S)-1-phenylethylamine, toluene, reactor volume = 3.1 
mL; 
b
Second reactor type, reactor volume = 3.0 mL; 
c
Calculated relative to the entire solution flowed through 
the reactor over multiple cycles; 
d
Determined by achiral GC analysis; 
e
Determined by chiral GC analysis after 




7.3.3.2 Racemisation of (S)-1-phenylethylamine using [Cp*IrI2]2 in batch 
(S)-1-Phenylethylamine (76 mg, 0.63 mmol) was added to [Cp*IrI2]2 (15 mg, 0.01 mmol) in 
toluene (10 mL). Decane (14 mg, 0.10 mmol) was added and the reaction mixture was heated 
to 100 °C. 100 µL samples were taken and diluted with 900 µL DCM for GCMS analysis. 
Two drops of trifluouracetic anhydride were added to the samples for chiral GC analysis, to 
determine ee. 
 










 / % 
0 100 0 99 
0.5 90.5 9.5 99 
1 67.5 32.5 99 
1.5 58.8 41.2 99 
2.5 29.6 70.4 99 
3 24.3 75.7 99 
4 13.3 86.7 99 
5 5.6 94.4 99 
6 0.4 99.6 99 
7 0 100 X 
a
Reaction conditions: 0.23 M (S)-1-phenylethylamine, 2 mol% [Cp*IrI2]2 catalyst, toluene, 100 °C;  
b
Determined as Amine % = (Amine area / Total area)*100; 
c
Determined as Dimer % = (Dimer area / Total 
area)*100; 
d
Determined by chiral GC analysis, after derivatisation with trifluoroacetic anhydride; 
 
7.3.3.3 Racemisation of (S)-1-phenylethylamine using [Cp*IrI2]2 under microwave 
heating 
General procedure: Anisole was added to [Cp*IrI2]2 (0.5 mol%) and biphenyl in a microwave 
vial and the solution stirred to dissolve the biphenyl. (S)-1-Phenylethylamine (1 M) was then 
added and the mixture heated to the desired temperature under microwave conditions for 30 
min. 100 µL samples were taken before and after heating and diluted with 900 µL anisole for 
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achiral GC analysis, to determine conversion. Two drops of trifluoroacetic anhydride were 
added to the samples for chiral GC analysis, to determine ee. 
 
Table 23. Racemisation microwave reactions.
a
 
Entry Temperature / °C Amine conversion
b
 / % Amine ee
c
 / % 
1 150 34 94 
2 175 74 45 
3 200 85 5 
a
Reaction conditions: 1 M (S)-1-phenylethylamine, 0.5 mol% [Cp*IrI2]2, anisole, 2.5 mL total reaction 
volume, microwave heating, 30 min, biphenyl added as internal standard; 
b
Determined by achiral GC analysis, 
after calibration against internal standard; 
c
Determined by chiral GC analysis, after derivatisation with 
trifluoroacetic anhydride; 
 
7.3.4 Ruthenium catalysed racemisation reactions 
7.3.4.1 Racemisation of (S)-1-phenylethylamine using ruthenium Shvö catalyst in batch 
 (S)-1-Phenylethylamine (76 mg, 0.63 mmol) was added to Shvö catalyst (28 mg, 0.03 mmol) 
in toluene (2.5 mL). Decane (14 mg, 0.10 mmol) was added and the reaction mixture was 
heated to 100 °C. 100 µL samples were taken and diluted with 900 µL DCM for GCMS 
analysis. Two drops of trifluoroacetic anhydride were added to the samples for chiral GC 





















 / % 
0 100 0 100 
0.5 100 0 100 
1 100 0 89.6 
1.5 100 0 89.6 
2 100 0 94.2 
3 98.4 1.6 82.5 
4 97.5 2.5 82.2 
5 97.1 2.9 82.2 
6 94.9 5.1 80.1 
23 47.7 52.3 54.3 
25 42.9 57.1 - 
26 41.9 58.1 47.3 
27 37.1 62.9 46.9 
29 34.3 65.7 43.3 
46 11.3 88.7 - 
47 11.4 88.6 12.0 
49 10.4 89.6 6.9 
51 8.0 92.0 7.4 
53 5.6 94.4 2.0 
72 0 100 X 
a
Reaction conditions: 0.23 M (S)-1-phenylethylamine, 2 mol% Shvö catalyst, toluene, 100 °C; 
b
Determined as 
Amine % = (Amine area / Total area)*100; 
c
Determined as Dimer % = (Dimer area / Total area)*100; 
d
Determined by chiral GC analysis, after derivatisation with trifluoroacetic anhydride; 
 
7.3.5 Palladium catalysed racemisation reactions 
Reactions were monitored by achiral GC to determine conversion and chiral GC to determine 
ee, after derivatisation with trifluoroacetic anhydride. 
 
7.3.5.1 Racemisation of (S)-1-phenylethylamine using Pd/C and Pd/BaSO4 in batch 
General procedure: Toluene (4 mL) was added to Pd/C and the mixture heated to the desired 
temperature. (S)-1-Phenylethylamine (40 mg, 0.33 mmol) and decane (146 mg, 1.0 mmol) 
were then added. The reaction was monitored by GC: a 300 µL sample was taken and passed 
through a syringe filter to remove the catalyst. 100 µL of the filtrate was taken and diluted 
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with 900 µL MeCN for achiral GC analysis. Two drops of trifluoroacetic anhydride were 
added to the samples for chiral GC analysis, to determine ee. 
 



















 / % 
1 5% Pd/C 5.7 70 24 99 16 
2 5% Pd/C 6.4 100 23 99 50 
3 10% Pd/C 8.5 70 23 99 10 
4
b 




Reaction conditions: 0.33 mmol (S)-1-phenylethylamine, 4.0 mL toluene, decane added as internal standard; 
b
Reaction conditions: 0.35 mmol (S)-1-phenylethylamine, 5.0 mL toluene, 5% Pd/ BaSO4 catalyst, 70 °C; 
c
Determined by chiral GC after derivatisation with trifluoroacetic anhydride; 
d
Determined by chiral HPLC after 
derivatisation with acetic anhydride; 
e
Determined by achiral GC. 
 
Entry 4: Toluene (5 mL) was added to Pd/BaSO4 (10%, 3 mol%) and the mixture heated to 70 
°C. (S)-1-Phenylethylamine (42 mg, 0.35 mmol) was then added. The reaction was monitored 
by chiral HPLC according to the following method: Chiralpak AD column (0.46 cm x 25 cm, 
10 µm particle size), isohexane/EtOH/HNEt2 900:100:1, 1.0 mL min
-1
, 258 nm, 20 °C, 10 µL 
injection volume; tR(R-1-phenylethylamine) = 5.17 min, tR(S-1-phenylethylamine) = 6.39 
min; sample preparation: 100 µL sample was diluted with 900 µL isohexane/EtOH/HNEt2 
(900:100:1), and then two drops of acetic anhydride and two drops of triethylamine were 
added.  
 
7.3.5.2 Racemisation of (S)-1-phenylethylamine using Pd/C in continuous flow 
(S)-1-Phenylethylamine (203 mg, 1.67 mmol) and decane (73 mg, 0.51 mmol) in toluene (24 
mL) was pumped, using a Jasco PU-2085 dual piston pump, through a 316 stainless steel 
tubular reactor (1/4” OD, 1/8” ID, 3.0 mL) manually packed with Pd/C (5%, 857 mg, 0.40 
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mmol Pd) at a flow rate of 0.1 mL min
-1
 (tRes = 30 min). The packed column was installed 
within an aluminium heating block under Eurotherm temperature control, set to 70 °C. The 
product mixture was collected at the exit of the column. 100 µL samples were taken and 
diluted with 900 µL MeCN for achiral GC analysis. Two drops of trifluoroacetic anhydride 
were added to the samples for chiral GC analysis, to determine ee. No racemisation was 
observed. 
 
7.4 Experimental Details Relating to Chapter 4 
7.4.1 Nicotinamide Studies 
7.4.1.1 HPLC Analysis and calibrations 
All reactions towards nicotinamide were analysed by achiral HPLC using the following 
method: H2O (0.1% TFA)/MeCN (0.1% TFA) 95:5 to 5:95 over 7 min; then to 95:5 and hold 
for 2 min; 1.2 mL min
-1
; tR(nicotinamide) = 0.50 min, tR(nicotinic acid) = 0.53 min, tR(methyl 
nicotinate) = 1.2 min, tR(biphenyl) = 5.9 min. 
The HPLC was calibrated for the starting material and the desired product using biphenyl as 
internal standard to determine response factors for each component. Calibration stock 
solutions were made up according to:  
Stock 1: 1 mmol methyl nicotinate and 0.3 mmol internal standard were dissolved in MeCN 
to give a 10 mL solution (0.1 M). 







Table 26. Combination of methyl nicotinate calibration stock solutions for calibration 
samples. 
Sample Stock 1 volume 
/ µL 









1 1000 0 0.1 0.03 
2 900 100 0.09 0.03 
3 800 200 0.08 0.03 
4 700 300 0.07 0.03 
5 600 400 0.06 0.03 
6 500 500 0.05 0.03 
7 400 600 0.04 0.03 
8 300 700 0.03 0.03 
9 200 800 0.02 0.03 
10 100 900 0.01 0.03 
 
Stock 1: 1 mmol nicotinamide and 0.1 mmol internal standard were dissolved in MeCN to 
give a 10 mL solution (0.1 M). 
Stock 2: 0.1 mmol internal standard was dissolved in MeCN to give a 10 mL solution (0.01 
M). 
Table 27. Combination of nicotinamide calibration stock solutions for calibration samples. 
Sample Stock 1 volume 
/ µL 









1 1000 0 0.1 0.01 
2 900 100 0.09 0.01 
3 800 200 0.08 0.01 
4 700 300 0.07 0.01 
5 600 400 0.06 0.01 
6 500 500 0.05 0.01 
7 400 600 0.04 0.01 
8 300 700 0.03 0.01 
9 200 800 0.02 0.01 





Figure 48. HPLC calibration of methyl nicotinate with biphenyl as internal standard. 
 
 




Response factors for each of the analytes were derived from the gradient of the slope on the 







where y is the area ratio, x is the concentration ratio and the gradient of the slope is the 
response factor (Rf). The response factors for methyl nicotinate and nicotinamide were 
determined as 0.2907 and 0.2912, respectively. The response factors were used to determine 




when all other values are known. The conversion was then determined from the analyte 





7.4.1.2 Lipase catalysed nicotinamide formation from nicotinic acid batch procedure 
 
NH3 solution (20 mL, 0.5 M in 1,4-dioxane) was added to Novozyme 435 (20 mg) and the 
mixture heated to 60 °C. Nicotinic acid (172 mg, 1.40 mmol) was then added. Reaction 
monitoring by TLC (100% EtOAc) and LCMS analysis showed no product formation. After 
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24 h, the reaction mixture was allowed to cool to room temperature, filtered to remove the 
catalyst and the solvent removed under vacuum to recover the nicotinic acid starting material. 
 
7.4.1.3 Lipase catalysed nicotinamide formation from methyl nicotinate batch procedure 
 
NH3 solution (20 mL, 0.5 M in 1,4-dioxane) was added to Novozyme 435 (20 mg) and the 
mixture heated to 60 °C. Methyl nicotinate (192 mg, 1.40 mmol) was then added. After 27 h, 
the reaction mixture was allowed to cool to room temperature, the catalyst filtered off and the 
solvent removed under vacuum. The crude was purified by column chromatography using the 
Biotage Isolera system (Petroleum ether/EtOAc: 50% to 100% EtOAc, then EtOAc/MeOH: 
20% MeOH) to give nicotinamide as a white solid (25 mg, 0.20 mmol, 14%). 
1
H NMR (500 
MHz, DMSO-d
6
): δ 7.51 (dd, J = 8.0, 5.0 Hz, 1H, Ar-Hb), 7.60 (br s, 1H, NHH), 8.16 (br s, 
1H, NHH), 8.22 (dt, J = 8.0, 2.0 Hz, 1H, Ar-Hc), 8.71 (dd, J = 5.0, 2.0 Hz, 1H, Ar-Ha), 9.04 
(d, J = 2.0 Hz, 1H, Ar-Hd); 
13
C NMR (126 MHz, DMSO-d
6
): δ 123.4 (ArC-H), 129.6 (ArC-





Confirmed by comparison to analytical standard. 
 
7.4.1.4 General procedure for the continuous formation of nicotinamide 
Reaction solution: 1.75 mmol methyl nicotinate and 0.1 mmol biphenyl were dissolved in 
NH3 solution (0.5 M in 1,4-dioxane) to make a 25 mL stock solution. 
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Reactor set-up: Novozyme 435 was manually packed into a 316 stainless steel tubular reactor 
(1/4” OD, 1/8” ID, 2.8 mL), fitted with Supelco stainless steel frits (1/4” diameter). When the 
catalyst loading was varied, the reactor was packed with a mixture of Novozyme 435 and 
glass beads to fill the reactor tube and maintain the total reactor volume. The packed reactor 
was housed within an aluminium heating block, under Eurotherm temperature control that 
was monitored by green K-type thermocouples inserted into the aluminium block. The 
reaction solution was introduced into the reactor system using a PU-2085 dual piston pump, 
set to the desired flow rate. The pump was connected to the packed reactor using PTFE tubing 
(1/16” OD, 1/32” ID). All tee-pieces and unions used were Swagelock 316 stainless steel. The 
outlet of the reactor was connected to a back-pressure regulator (75 psi) and then fed into a 
collection vessel. Reaction samples were collected at the reactor outlet for each reactor 
volume, up to 5 RV, and then analysed by HPLC.  
 
7.4.1.5 Scoping reactions for continuous nicotinamide formation 
All scoping experiments were carried out according to the general procedure for the 
continuous nicotinamide formation. 








Conversion of methyl 
nicotinate
c
 / % 
Low 20 40 0.5
b 
29 
Mid 40 60 0.75
b 
78 
Mid 40 60 0.75
b 
76 
High 60 80 1.0 89 
a
Reaction solution =  1.75 mmol methyl nicotinate in 25 mL NH3 solution (0.5 M in 1,4-dioxane), biphenyl 
added as internal standard. Reactor volume = 2.8 mL; 
b
Glass beads added to fill the reactor; 
c
Determined by 




7.4.1.6 Optimisation reactions for continuous nicotinamide formation 
All optimisation experiments were carried out according to the general procedure for the 
continuous nicotinamide formation. Experimental data for the central composite face-centred 
(CCF) design are given in Appendix A. Optimum conditions were determined as 60 min tRes, 
67 °C and 1.0 g catalyst loading. 
 
7.4.1.7 Reactions for testing of optimum conditions 
The reaction was carried out according to the general procedure for the continuous formation 
of nicotinamide. The reactor was packed with Novozyme 435 (1.00 g) and heated to 67 °C. 
The reaction stock solution was pumped through the reactor at a flow rate of 0.047 mL min
-1
 
(tRes = 60 min). Reaction samples were collected at the reactor outlet for each reactor 
volume, up to 5 RV, and then analysed by HPLC. 94% conversion of methyl nicotinate was 
observed. 
 
7.4.1.8 Titration of NH3 solutions in MeOH against standardised HCl solutions 
Solution 1: 1.97 g of NaOH was dissolved in H2O to give a 100 mL stock solution (0.49 M). 
Solution 2: 4.2 mL of concentrated HCl was diluted with H2O to give a 100 mL stock 
solution. 
Titration of Solution 2 with Solution 1: A few drops of methyl orange indicator were added to 
a 10.0 mL aliquot of Solution 2. This was then titrated against standard Solution 1. The 





Table 29. Titration of HCl Solution 2 against standard NaOH Solution 1. 
















 titres were combined to give an average value for the 
concentration of Solution 2 of 0.52 M. 
 
Solution 3: 18 mL of 7 N NH3 in MeOH solution was diluted with MeOH to give a 250 mL 
stock solution. 
Titration of Solution 3 with standardised Solution 2: A few drops of bromothymol blue 
indicator was added to a 10.0 mL aliquot of Solution 3. This was then titrated against 
standardised Solution 2. The process was repeated 3 times. 
 
Table 30. Titration of NH3 Solution 3 against standardised HCl Solution 2. 


















 titres were combined to give an average value for the 
concentration of Solution 2 of 0.46 M. 
 
Solution 4: 7.96 g of NaOH was dissolved in H2O to give a 100 mL stock solution (0.49 M). 
Solution 5: 16.7 mL of concentrated HCl was diluted with H2O to give a 100 mL stock 
solution. 
Titration of Solution 5 with Solution 4: A few drops of methyl orange indicator was added to 
a 10.0 mL aliquot of Solution 5. This was then titrated against standard Solution 4. The 
process was repeated 3 times. 
 
Table 31. Titration of HCl Solution 5 against standard NaOH Solution 4. 





The concentration of Solution 5 was calculated according to equations described above and 




 titres were combined to give an average value for the 




Solution 6: 72 mL of 7 N NH3 in MeOH solution was diluted with MeOH to give a 250 mL 
stock solution. 
Titration of Solution 6 with standardised Solution 5: A few drops of bromothymol blue 
indicator was added to a 10.0 mL aliquot of Solution 6. This was then titrated against 
standardised Solution 5. The process was repeated 3 times. 
 
Table 32. Titration of NH3 Solution 6 against standardised HCl Solution 5. 





The concentration of Solution 6 was calculated according to equations described above and 




 titres were combined to give an average value for the 
concentration of Solution 6 of 1.79 M. 
 
7.4.1.9 Continuous formation of nicotinamide using NH3 solutions in methanol 
All reactions were carried out according to the general procedure for the continuous formation 
of nicotinamide. 
Reaction using 0.46 M NH3 solution: The reaction stock solution was made-up of 1.75 mmol 
methyl nicotinate and 0.2 mmol biphenyl dissolved in NH3 solution (0.46 M in MeOH) to 
make a 25 mL stock solution. The reactor was packed with Novozyme 435 (871 mg), fitted 
with a 100 psi back-pressure regulator and heated to 80 °C. The reaction stock solution was 
pumped through the reactor at a flow rate of 0.05 mL min
-1
 (tRes = 60 min). Reaction samples 
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were collected at the reactor outlet for each reactor volume, up to 5 RV, and then analysed by 
HPLC. No conversion was observed. 
Reaction using 1.79 M NH3 solution: The reaction stock solution was made-up of 1.75 mmol 
methyl nicotinate and 0.2 mmol biphenyl dissolved in NH3 solution (1.79 M in MeOH) to 
make a 25 mL stock solution. The reactor was packed with Novozyme 435 (873 mg), fitted 
with a 100 psi back-pressure regulator and heated to 80 °C. The reaction stock solution was 
pumped through the reactor at a flow rate of 0.05 mL min
-1
 (tRes = 60 min). Reaction samples 
were collected at the reactor outlet for each reactor volume, up to 5 RV, and then analysed by 
HPLC. No conversion was observed. 
 
7.4.2 Pyrazinamide Studies 
7.4.2.1 HPLC Analysis and calibrations 
All reactions towards pyrazinamide were analysed by achiral HPLC using the following 
method: H2O (0.1% TFA)/MeCN (0.1% TFA) 99:1 hold for 2.1 min; up to 5:95 over 3.9 min, 
hold for 0.5 min; to 99:1 over 0.1 min and then hold for 2 min; 1.2 mL min
-1
; 
tR(pyrazinamide) = 1.6 min, tR(pyrazine carboxylic acid) = 1.9 min, tR(methyl pyrazine-2-
carboxylate) = 3.5 min, tR(biphenyl) = 6.2 min. 
The HPLC was calibrated for methyl pyrazine-2-carboxylate and pyrazinamide using 
biphenyl as internal standard to determine response factors for each component. Calibration 
stock solutions were made up according to:  
Stock 1: 1 mmol analyte was dissolved in DMSO to give a 10 mL solution (0.1 M). 
(Pyrazinamide was dissolved in a mixture of MeOH and DMSO). 




Table 33. Combination of calibration stock solutions for calibration samples. 
Sample Stock 1 
volume / µL 
Stock 2 
volume / µL 
Solvent 





Concentration / M 
1 1000 100 0 0.091 0.0009 
2 900 100 0 0.09 0.0009 
3 800 100 100 0.08 0.001 
4 700 100 200 0.07 0.001 
5 600 100 300 0.06 0.001 
6 500 100 400 0.05 0.001 
7 400 100 500 0.04 0.001 
8 300 100 600 0.03 0.001 
9 200 100 700 0.02 0.001 
10 100 100 800 0.01 0.001 
 
 






Figure 51. HPLC calibration for pyrazinamide with biphenyl as internal standard. 
 
Response factors for each of the analytes were derived according to the method described 
above. The response factors for methyl pyrazine-2-carboxylate and pyrazinamide were 
determined as 0.2287 and 0.2344, respectively.  
 
7.4.2.2 Methyl pyrazine-2-carboxylate synthesis  
 
MeOH (8 mL) was added to pyrazine carboxylic acid (1.01 g, 8.13 mmol) and the mixture 
stirred. Concentrated H2SO4 (50 µL, 0.93 mmol) was then added and the reaction mixture 
heated to 85 °C. After 25 h, the mixture was then cooled to room temperature and the solvent 
removed under reduced pressure. The solid was dissolved in H2O (10 mL) and NaHCO3(aq) 
was added to pH 8. DCM (20 mL) was added and the layers separated. The aqueous layer was 
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extracted with DCM (3 x 10 mL). The combined organic extracts were dried (MgSO4) and the 
solvent removed under vacuum to give a white solid. The crude was purified using flash 
column chromatography (100% EtOAc) to give methyl pyrazine-2-carboxylate as a white 
solid (0.94 g, 6.84 mmol, 84.1%). 
1
H NMR (500 MHz, CDCl3): δ 4.06 (s, 3H, OCH3), 8.73 
(dd, J = 2.5, 1.5 Hz, 1H, Ar-Hb), 8.78 (d, J = 2.5 Hz, 1H, Ar-Ha), 9.33 (d, J = 1.5 Hz, 1H, Ar-
Hc); 
13
C NMR (126 MHz, CDCl3): δ 53.2 (CH3), 143.3 (ArC-H), 144.4 (ArC-H), 146.3 (ArC-




139.4; IR (solid): ν 3089, 3063, 3017, 2959, 
2920, 2853, 1718, 1581, 1525, 1441 cm
-1





7.4.2.3 Lipase catalysed pyrazinamide formation batch procedure 
 
Methyl pyrazine-2-carboxylate (0.19 g, 1.34 mmol) was dissolved in NH3 solution (0.5 M in 
1,4-dioxane, 20 mL). The mixture was heated to 60 °C and Novozyme 435 (0.02 g) was 
added. After 24 h, the reaction mixture was allowed to cool to room temperature, filtered to 
remove the catalyst and the solvent removed under vacuum to give a white solid (0.19 g). The 
crude product was purified by flash column chromatography (100% EtOAc) to give 
pyrazinamide as a white solid (0.15 g, 1.18 mmol, 88%). 
1
H NMR (500 MHz, DMSO-d
6
): δ 
7.87 (br s, 1H, NH), 8.26 (br s, 1H, NH), 8.73 (dd, J = 2.5, 1.5 Hz, 1H, Ar-Hb), 8.87 (d, J = 
2.5 Hz, 1H, Ar-Ha), 9.20 (d, J = 1.5 Hz, 1H, Ar-Hc);
 13
C NMR (126 MHz, DMSO-d
6
): δ 143.4 









7.4.2.4 General procedure for the continuous formation of pyrazinamide 
Reaction solution: 1.75 mmol methyl pyrazine-2-carboxylate and 0.1 mmol biphenyl were 
dissolved in NH3 solution (0.5 M in 1,4-dioxane) to make a 25 mL stock solution. 
Reactor set-up: Novozyme 435 was manually packed into a 316 stainless steel tubular reactor 
(1/4” OD, 1/8” ID, 2.8 mL), fitted with Supelco stainless steel frits (1/4” diameter). When the 
catalyst loading was varied, the reactor was packed with a mixture of Novozyme 435 and 
glass beads to fill the reactor tube and maintain the total reactor volume. The packed reactor 
was housed within an aluminium heating block, under Eurotherm temperature control that 
was monitored by green K-type thermocouples inserted into the aluminium block. The 
reaction solution was introduced into the reactor system using a PU-2085 dual piston pump, 
set to the desired flow rate. The pump was connected to the packed reactor using PTFE tubing 
(1/16” OD, 1/32” ID). All tee-pieces and unions used were Swagelock 316 stainless steel. The 
outlet of the reactor was connected to a back-pressure regulator (75 psi) and then fed into a 
collection vessel. Reaction samples were collected at the reactor outlet for each reactor 
volume, up to 5 RV, and then analysed by HPLC.  
 
Table 34. Results for the continuous formation of pyrazinamide.
a
 




1 60 67 1.0 100 
2 40 60 0.75
b 
100 
3 20 40 0.50
b 
100 
4 20 40 0.25
 b
 98 
5 20 40 0 1.5 
6 60 80 0 10 
a
Reaction solution =  1.75 mmol methyl pyrazine-2-carboxylate in 25 mL NH3 solution (0.5 M in 1,4-
dioxane), biphenyl added as internal standard. Reactor volume = 2.8 mL; 
b
Glass beads added to fill the reactor; 
c




7.4.2.5 Continuous formation of pyrazinamide using NH3 solutions in methanol 
The NH3 in MeOH solutions (0.46 M and 1.79 M) from the nicotinamide study were used for 
the following reactions and all reactions were carried out according to the general according 
to the general procedure for the continuous formation of pyrazinamide. 
Reaction using 0.46 M NH3 solution: The reaction stock solution was made-up of 1.76 mmol 
methyl pyrazine-2-carboxylate and 0.13 mmol biphenyl dissolved in NH3 solution (0.46 M in 
MeOH) to make a 25 mL stock solution. The reactor was packed with Novozyme 435 (500 
mg) and glass beads, fitted with a 100 psi back-pressure regulator and heated to 40 °C. Methyl 
pyrazine-2-carboxylate was not completely soluble in the reaction stock solution and so an in-
line filter was added before the pump. The reaction stock solution was pumped through the 
reactor at a flow rate of 0.15 mL min
-1
 (tRes = 20 min). Reaction samples were collected at 
the reactor outlet for each reactor volume, up to 5 RV, and then analysed by HPLC. 
Reaction using 1.79 M NH3 solution: The reaction stock solution was made-up of 1.80 mmol 
methyl pyrazine-2-carboxylate and 0.13 mmol biphenyl dissolved in NH3 solution (1.79 M in 
MeOH) to make a 25 mL stock solution. The reactor was packed with Novozyme 435 (505 
mg) and glass beads, fitted with a 100 psi back-pressure regulator and heated to 40 °C. Methyl 
pyrazine-2-carboxylate was not completely soluble in the reaction stock solution and so an in-
line filter was added before the pump. The reaction stock solution was pumped through the 
reactor at a flow rate of 0.15 mL min
-1
 (tRes = 20 min). Reaction samples were collected at 
the reactor outlet for each reactor volume, up to 5 RV, and then analysed by HPLC. 
 
7.4.3 N-Acetyl-(D/L)-phenylalanine studies 
7.4.3.1 Analytical Methods 
Samples were analysed by GCMS to monitor for product formation according to the 
following GC oven method: 70 °C (hold for 1 min); 5°/min to 100 °C; 20°/min to 300 °C 
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(hold for 1 min); Inj = 250 °C; He carrier gas; 4.76 psi; tR(N-acetylphenylalanine methyl 
ester) = 12.3 min; 
Samples were analysed by chiral GC to determine ee according to the following GC oven 
method: 140 °C (hold for 30 min); Inj = 300 °C; Det = 300 °C; H2 carrier gas; 15 psi; tR(R-N-
acetyl-phenylalanine) = 17.0 min, tR(S-N-acetyl-phenylalanine) = 17.5 min. 
 
7.4.3.2 N-Acetyl-phenylalanine methyl ester synthesis 
 
N-Acetylphenylalanine (4.97 g, 24.0 mmol) was dissolved in MeOH (125 mL). The mixture 
heated to reflux and then concentrated H2SO4 (0.15 mL, 2.87 mmol) was added. After 5 h, the 
mixture was allowed to cool to room temperature. NaHCO3(aq) (50 mL) and DCM (50 mL) 
were added and the layers separated. The aqueous phase was extracted with DCM (3 x 50 
mL). The combined organics were dried (MgSO4) and the solvent removed under vacuum to 
give N-acetylphenylalanine methyl ester as a cream coloured solid (4.04 g, 18.3 mmol, 76%). 
1
H NMR (500 MHz, CDCl3): δ 1.92 (s, 3H, OCH3), 3.03 (dd, J = 6.0, 14.0 Hz, 1H, CH2CH), 
3.08 (dd, J = 6.0, 14.0 Hz, 1H, CH2CH),3.66 (s, 3H, C(O)CH3), 4.82 (dt, J = 60., 8.0 Hz, 1H, 
CH2CH), 5.80 (br s, 1H, NH), 7.01 – 7.03 (m, 2H, Ar-H), 7.16 – 7.24 (m, 3H, Ar-H); 
13
C 
NMR (126 MHz, CDCl3): δ 22.2 (CH2), 36.7 (CH), 51.8 (COCH3), 53.6 (OCH3), 126.5 (ArC-





222.3; IR (solid): ν 3333, 3029, 3008, 2963, 2935, 1745, 1648, 1532, 1437 cm
-1
; Data 






7.4.3.3 Novozyme 435 catalysed ammoniolysis of N-acetylphenylalanine methyl ester 
batch procedure 
NH3 solution (10 mL, 0.5 M in 1,4-dioxane) was added to Novozyme 435 (730 mg) and the 
mixture heated to 67 °C. N-Acetylphenylalanine methyl ester (155 mg, 0.70 mmol) and 
biphenyl (49 mg, 0.32 mmol) were then added. After 24 h, the mixture was allowed to cool to 
room temperature, filtered to remove the immobilised lipase and the solvent removed under 
vacuum. No reaction was observed. 
 
7.4.3.4 General procedure for batch screening of lipases for the ammoniolysis of N-
acetylphenylalanine methyl ester 
N-Acetylphenylalanine methyl ester (110 mg, 0.50 mmol) was dissolved in NH3 solution (10 
mL, 0.5 M in 1,4-dioxane). The mixture heated to 40 °C and immobilised lipase (500 mg) was 
added. After 24 h, the mixture was allowed to cool to room temperature, filtered to remove 
the immobilised lipase and the solvent removed under vacuum. 
1
H NMR analysis was carried 
out to determine the presence of product. 
Immobilised lipase enzymes used in batch screen: 
Lipase B from Candida Antarctica immobilized on polyacrylic resin (Novozyme 435). 
Lipase A from Candida Antarctica (CalA) immobilised on Immobead 150, recombinant from 
Aspergillus oryzae, 3781 U/g. 
Lipase from Candida Rugosa immobilised on Immobead 150, 464 U/g. 









Entry Enzyme Conversion 
1 N435 0 
2 CalA (1892 U) 0 
3 C. Rugosa (232 U) 0 
4 C. Rugosa
b
 (1624 U) 0 
5 TLL (1502 U) 0 
a
Reaction conditions: 0.5 mmol substrate, 10 mL NH3 solution (0.5 M in 1,4-dioxane), 500 mg catalyst, 40 °C, 
24 h; 
b
3.5 g catalyst used; 
 
7.5 Experimental Details Relating to Chapter 5 
7.5.1 GC Analysis of Components and Calibrations 
Samples were analysed by GCMS according to the following GC oven method: 70 °C (hold 
for 1 min); 5°/min to 100 °C; 20°/min to 300 °C (hold for 1 min); Inj = 250 °C; He carrier 
gas; 4.76 psi; tR(1-phenylethylamine) = 1.9 min, tR(N-isopropyl-1-phenylethylamine) = 2.8 
min, tR(Biphenyl) = 5.5 min, tR(2-methoxy-N-(1-phenylethyl)acetamide) = 8.9 min; 
Samples were analysed by achiral GC according to the following GC oven method: 70 °C 
(hold for 1 min); 5°/min to 100 °C; 20°/min to 300 °C (hold for 1 min); Inj = 250 °C; Det = 
250 °C; H2 carrier gas; 10.8 psi; tR(1-phenylethylamine) = 1.9 min, tR(N-isopropyl-1-
phenylethylamine) = 2.8 min, tR(Biphenyl) = 5.5 min, tR(2-methoxy-N-(1-
phenylethyl)acetamide) = 8.9 min; 
The achiral GC was calibrated for the 1-phenylethylamine, N-isopropyl-1-phenylethylamine 
and 2-methoxy-N-(1-phenylethyl)acetamide using biphenyl as internal standard to determine 
response factors for each component. Calibration stock solutions were made up according to:  
Stock 1: 1 mmol analyte and 1 mmol internal standard were dissolved in toluene to give a 10 
mL solution (0.1 M). 
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Stock 2: 1 mmol internal standard was dissolved in toluene to give a 10 mL solution (0.1 M). 
Table 36. Combination of calibration stock solutions for calibration samples. 
Sample Stock 1 volume 
/ µL 









1 900 100 0.09 0.1 
2 800 200 0.08 0.1 
3 700 300 0.07 0.1 
4 600 400 0.06 0.1 
5 500 500 0.05 0.1 
6 400 600 0.04 0.1 
7 300 700 0.03 0.1 
8 200 800 0.02 0.1 
9 100 900 0.01 0.1 
 
 














Response factors for each of the analytes were derived according to the method described 
above. The response factors for 1-phenylethylamine, N-isopropyl-1-phenylethylamine and 2-
methoxy-N-(1-phenylethyl)acetamide were determined as 0.6314, 0.8955 and 0.7369, 
respectively.  
Samples were analysed by chiral GC to determine enantiomeric excess (ee) according to the 
following GC oven method: 80 °C (hold for 60 min); 40°/min to 180 °C (hold for 10 min); Inj 
= 300 °C; Det = 300 °C; H2 carrier gas; 15 psi; tR(2-Methoxy-N-[(1R)-1-
phenylethyl]acetamide) = 62.9 min, tR(2-Methoxy-N-[(1S)-1-phenylethyl]acetamide) = 63.0 
min. Two drops of trifluoroacetic anhydride were added to samples to obtain ee for 1-
penylethylamine and N-isopropyl-1-phenylethylamine: tR((R)-1-phenylethylamine) = 18.3 
min, tR((S)-1-phenylethylamine) = 18.7 min, tR((R)-N-isopropyl-1-phenylethylamine) = 30.5 
min, tR((S)-N-isopropyl-1-phenylethylamine) = 31.6 min. 
 
7.5.2 Diiodo(pentamethylcyclopentadienyl)iridium(III)dimer catalyst synthesis 
Acetone (45 mL) was added to [Cp*IrCl2]2 (1.00 g, 1.25 mmol) in a 3-necked flask fitted with 
thermometer and air condenser. NaI (1.90 g, 12.7 mmol) was added and the solution degassed 
with N2 for 15 min. The mixture was then heated to reflux (55 – 60 ºC) under N2. After 26 h, 
the mixture was allowed to cool to room temperature and DCM (50 mL) was added. The 
organic was washed with H2O (3 x 50 mL) and brine (1 x 50 mL). The organic was dried 
(MgSO4) and the solvent removed under vacuum to give a brown solid. The crude was 
recrystallised from DCM/PE to give a red/brown solid (1.02 g, 0.89 mmol, 71.2%). 
1
H NMR 
(500 MHz, CDCl3): δ 1.76 (s, 30H, Cp-CH3); 
13
C NMR (126 MHz, CDCl3): δ 10.7 (Cp-CH3), 






7.5.3 Preparation of analytical standards 
7.5.3.1 N-Isopropyl-1-phenylethylamine 
 
Acetone (250 mL) was added to rac-1-phenylethylamine (10.0 g, 82.5 mmol) and the solution 
heated to reflux. After 22.5 h, the reaction was allowed to cool to room temperature and the 
solvent removed to give a colourless oil. MeOH (220 mL) was added and the solution cooled 
on ice. NaBH4 (6.27 g, 166 mmol) was added and the mixture stirred on ice for 1 h and for a 
further 2 h at room temperature. HCl (2 M) was added to acidify and the solvent removed 
under vacuum to give a white slurry. H2O and DCM were added, the solution basified with 
NaOH (1 M) and extracted with DCM (3 x 50 mL). The combined organics were washed with 
H2O (1 x 50 mL), dried (MgSO4) and the solvent removed under vacuum to give the crude 
product as a colourless oil. The crude was purified by column chromatography using the 
Biotage Isolera system (EtOAc:EtOAc/Et3N(5%), 80:20 to 0:100) to give N-isopropyl-1-
phenylethylamine as a colourless liquid (3.49 g, 21.0 mmol, 25%). 
1
H NMR (500 MHz, 
CDCl3): δ 0.99 (d, J = 6.0 Hz, 3H, isopropyl-CH3), 1.02 (d, J = 6.0 Hz, 3H, isopropyl-CH3), 
1.33 (d, J = 6.5 Hz, 3H, CHCH3), 2.62 (sept, J = 6.0 Hz, 1H, isopropyl-CH), 3.88 (quart, J = 
6.5 Hz, 1H, CHCH3), 7.21 – 7.24 (m, 1H, Ar-H), 7.27 – 7.34 (m, 4H, Ar-H); 
13
C NMR (126 
MHz, CDCl3): δ 22.2 (CH3), 24.1 (CH3), 24.9 (CH3), 45.5 (CH), 55.1 (CH), 126.4 (ArC-H), 




164.5; Rf = 0.50 (100% 
EtOAc); IR (liquid film): ν 3062, 3025, 2960, 2926, 2865, 1602, 1492, 1465, 1451 cm
-1
; Data 






7.5.4 Heterogeneous catalyst testing 
7.5.4.1 Batch Reaction  
Xylene (5 mL) was added to immobilised catalyst (38 mg, 0.5 mol%, 6.28% Ir by ICP) and 
the mixture heated to 130 ºC. rac-1-Phenylethylamine (282 mg, 2.33 mmol) and di-
isopropylamine (722 mg, 7.14 mmol) were then added. The reaction was monitored by 
GCMS, using the standard method, by sampling 100 µL of the reaction mixture and diluting 
with 900 µL MeCN. After 20 h, the reaction mixture was allowed to cool to room temperature 
and then filtered to remove the catalyst. H2O (10 mL) was added and acidified with HCl (1 
M). The layers were separated, the aqueous phase was basified with NaOH (1 M) and then 
extracted with DCM (3 x 20 mL). The combined organics were dried (MgSO4) and the 
solvent removed under vacuum to give a yellow oil (0.24 g). 
1
H NMR analysis of the crude 
mixture showed only a mixture of desired product and dimers. 
 
Table 37. GCMS analysis of the N-alkylation of rac-1-phenylethylamine using immobilised 
Ir catalyst in batch. 
Time / h SM Area% Desired product Area% Dimers Area% 
0 100 0 0 
1 87 11 1.8 
2 71 25 4.2 
3 61 33 6.4 
5 36 52 13 
20 0 64 36 
 
7.5.4.2 Continuous reaction 
Reaction solution: rac-1-phenylethylamine (1.03 g, 8.53 mmol) and di-isopropylamine (2.53 
g, 25.0 mmol) were dissolved in toluene (12 mL) as a single stock solution. 
Reactor set-up: Heterogeneous Ir catalyst (ICP > 0.3 mmol/g) was manually packed into a 
316 stainless steel tubular reactor (1/4” OD, 1/8” ID, 2.8 mL) fitted with Supelco stainless 
steel frits (1/4” diameter), to a loading of 4.7 mol% calculated relative to one reactor volume 
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(RV). The packed reactor was housed within an aluminium heating block, under Eurotherm 
temperature control, set to 100 °C. The stock solution was fed into the reactor using a Jasco 
PU-2085 dual piston pump, with a 60 min tRes, under 40 psi back pressure. The pump was 
connected to the packed reactor using PTFE tubing (1/16” OD, 1/32” ID). All tee-pieces and 
unions used were Swagelock 316 stainless steel. Reaction samples were collected at the 
reactor outlet for each reactor volume, and then analysed by GCMS.  
 
Table 38. GCMS analysis of the N-alkylation of rac-1-phenylethylamine using immobilised 
Ir catalyst in continuous reactor. 









7.5.5 Homogeneous catalyst testing 
7.5.5.1 General procedure for rac-1-phenylethylamine N-alkylation microwave reactions 
Anisole was added to [Cp*IrI2]2 and biphenyl in a microwave vial and the solution stirred to 
dissolve the biphenyl. rac-1-Phenylethylamine and di-isopropylamine were then added and 
the mixture heated to the desired temperature under microwave conditions. 100 µL samples 
were taken before and after heating and diluted with 900 µL anisole for achiral GC analysis 































1 100 10 0.1 0.1 1 100 0 0 
2 100 30 0.2 1 3 100 0 0 
3 150 10 1.0 0.5 3 28 69 3 
4 200 10 1.0 0.5 3 5 84 11 
5 200 30 0.5 1 3 0 89 11 
6
b
 220 10 0.2 1 1 0 64 36 
7
b
 220 10 0.1 1 3 0 93 7 
a
Reaction conditions: rac-1-phenylethylamine, di-isopropylamine 5, [Cp*IrI2]2, toluene, biphenyl added as 
internal standard, total reaction volume = 2 mL; 
b
Solvent = anisole; 
c
Percentage composition determined by 
GCMS analysis; Eq = equivalents of di-isopropylamine. 
 
7.5.5.2 Scoping reactions for N-alkylation under microwave heating 



























Lower 10 180 0.3 0.5 2 79 50 29 63 
Mid 20 190 0.4 0.75 3.5 93 95 -2 102 
Upper 30 200 0.5 1.0 5 96 87 9 91 
a
Reaction conditions according to general procedure, total reaction volume = 5.0 mL; 
b
Determined by achiral 
GC analysis, after calibration against internal standard; 
c
Determined from: Dimers = (SM Conversion – Desired 
Product yield); 
d
Determined from: Selectivity = (Desired Product yield/(Desired Product yield + Dimer 
yield))*100; Eq = equivalents of di-isopropylamine; 
 
7.5.5.3 Screening reactions for N-alkylation under microwave heating 





 fractional factorial Resolution V screening designs are given in Appendix B. 
Optimum conditions were determined as 180 °C, 10 min, 0.5 mol% catalyst loading, 1 M rac-





7.5.5.4 Continuous N-alkylation Procedure 
Reaction solution, one pump: rac-1-Phenylethylamine (1 M or 0.5 M) and di-isopropylamine 
(5 Eq), [Cp*IrI2]2 (0.5 mol%), biphenyl (4.0 mmol) and anisole were combined in a stirred 
vessel that was heated to 40 °C in a sand bath. 
Reactor set-up, one pump: The reaction solution was fed into the stainless steel tubular 
reactor (1/4” OD, 1/8” ID, 2.8 mL) reactor using a Jasco PU-2085 dual piston pump, with a 
10 min tRes, under 100 psi back pressure. The packed reactor was housed within an 
aluminium heating block, under Eurotherm temperature control, set to 180 °C. The pump was 
connected to the packed reactor using PTFE tubing (1/16” OD, 1/32” ID), with an in-line 
filter fitted to the end of the tubing. All tee-pieces and unions used were Swagelock 316 
stainless steel. Reaction samples were collected at the reactor outlet for each reactor volume, 
and then analysed by achiral GC.  
Reaction solutions, two pumps: Pump A = di-isopropylamine (12.64 g, 125 mmol), biphenyl 
(299 mg, 1.94 mmol) and anisole (2.5 mL). Pump B = rac-1-phenylethylamine (12.13 g, 100 
mmol), [Cp*IrI2]2 (286 mg, 0.5 mol%), biphenyl (300 mg, 1.95 mmol) and anisole (7.1 mL) 
combined in a stirred vessel that was heated to 40 °C in a sand bath. 
Reactor set-up, two pumps: The reaction solutions were fed into the stainless steel tubular 
reactor (1/4” OD, 1/8” ID, 2.8 mL) reactor using Jasco PU-2085 and Jasco PU-1585 dual 
piston pumps, with a 10 min tRes, under 100 psi back pressure. The two feeds were combined 
in a tee-piece prior to entering the reactor. The packed reactor was housed within an 
aluminium heating block, under Eurotherm temperature control, set to 180 °C. The pump was 
connected to the packed reactor using PTFE tubing (1/16” OD, 1/32” ID), with an in-line 
filter fitted to the end of the tubing. All tee-pieces and unions used were Swagelock 316 
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stainless steel. Reaction samples were collected at the reactor outlet for each reactor volume, 
and then analysed by achiral GC. 
 
7.5.6 Single enantiomer N-alkylation reactions 
7.5.6.1 General procedure for (S)-1-phenylethylamine N-alkylation microwave reactions 
Anisole was added to [Cp*IrI2]2 and biphenyl in a microwave vial and the solution stirred to 
dissolve the biphenyl. (S)-1-Phenylethylamine and di-isopropylamine were then added and 
the mixture heated to the desired temperature under microwave conditions. 100 µL samples 
were taken before and after heating and diluted with 900 µL toluene for GC analysis 
according to the general methods to determine conversion and ee (Section 7.5.1).  
 






















 / % 
1 200 30 3 94 78 83 14 
2 175 30 3 93 85 91 77 
3 150 30 3 60 49 82 96 
4 150 30 5 58 53 91 99 
5 150 60 5 97 92 95 95 
a
Reaction conditions: 1 M (S)-1-phenylethylamine, 0.5 mol % [Cp*IrI2]2, anisole, biphenyl added as internal 
standard, 150 °C; 
b
Determined by achiral GC analysis after calibration against internal standard; 
c
Determined as 
(Desired product yield / Conversion of amine)*100; 
d
Determined by chiral GC as [(Area1 – Area2)/(Area1 + 
Area2)]*100; Eq = equivalents of di-isopropylamine. 
 
7.5.6.2 Inhibition microwave reactions 
For the following reactions a catalyst stock solution was prepared from [Cp*IrI2]2 (21 mg, 
0.019 mmol) in toluene (5 mL). 
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Microwave resolution inhibition test: Toluene (1.8 mL) was added to Novozyme 435 (145 
mg) and biphenyl (78 mg, 0.51 mmol) in a microwave vial and the solution stirred to dissolve 
the biphenyl. rac-1-Phenylethylamine (18 µL, 17 mg, 0.14 mmol), methylmethoxy acetate (14 
µL, 15 mg, 0.14 mmol), catalyst stock solution (100 µL) and di-isopropylamine (98 µL, 71 
mg, 0.70 mmol) were then added and the mixture heated to 60 °C for 6 min under microwave 
conditions. 100 µL samples were taken before and after heating and diluted with 900 µL 
toluene for GC analysis according to the general method to determine conversion (Section 
7.5.1). (14% amide yield). 
Control reaction: Toluene (2 mL) was added to Novozyme 435 (143 mg) and biphenyl (78 
mg, 0.51 mmol) in a microwave vial and the solution stirred to dissolve the biphenyl. rac-1-
Phenylethylamine (18 µL, 17 mg, 0.14 mmol) and methylmethoxy acetate (14 µL, 15 mg, 
0.14 mmol) were then added and the mixture heated to 60 °C for 6 min under microwave 
conditions. 100 µL samples were taken before and after heating and diluted with 900 µL 
toluene for GC analysis according to the general method to determine conversion (Section 
7.5.1). (14% amide yield). 
 
Microwave N-alkylation ester inhibition test: Toluene (1.8 mL) was added to catalyst stock 
solution (100 µL) and biphenyl (74 mg, 0.48 mmol) in a microwave vial and the solution 
stirred to dissolve the biphenyl. rac-1-Phenylethylamine (18 µL, 17 mg, 0.14 mmol), 
methylmethoxy acetate (14 µL, 15 mg, 0.14 mmol), and di-isopropylamine (98 µL, 71 mg, 
0.70 mmol) were then added and the mixture heated to 150 °C for 60 min under microwave 
conditions. 100 µL samples were taken before and after heating and diluted with 900 µL 
toluene for GC analysis according to the general method to determine conversion (Section 
7.5.1). (81% conversion, 76% N-alkylated yield). 
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Microwave N-alkylation amide inhibition test: Toluene (1.8 mL) was added to 2-methoxy-N-
(1-phenylethyl)acetamide (27 mg, 0.14 mmol) and biphenyl (73 mg, 0.47 mmol) in a 
microwave vial and the solution stirred to dissolve the solids. rac-1-Phenylethylamine (18 µL, 
17 mg, 0.14 mmol), catalyst stock solution (100 µL) and di-isopropylamine (98 µL, 71 mg, 
0.70 mmol) were then added and the mixture heated to 150 °C for 60 min under microwave 
conditions. 100 µL samples were taken before and after heating and diluted with 900 µL 
toluene for GC analysis according to the general method to determine conversion (Section 
7.5.1). (84% conversion, 70% N-alkylated yield). 
Control reaction: Toluene (1.9 mL) was added to catalyst stock solution (100 µL) and 
biphenyl (90 mg, 0.58 mmol) in a microwave vial and the solution stirred to dissolve the 
biphenyl. rac-1-Phenylethylamine (18 µL, 17 mg, 0.14 mmol) and di-isopropylamine (98 µL, 
71 mg, 0.70 mmol) were then added and the mixture heated to 150 °C for 60 min under 
microwave conditions. 100 µL samples were taken before and after heating and diluted with 
900 µL toluene for GC analysis according to the general method to determine conversion 
(Section 7.5.1). (60% conversion, 44% N-alkylated yield). 
 
7.5.6.3 Stepwise coupled procedure: microwave batch resolution with microwave batch 
N-alkylation 
Step 1, Resolution: Toluene (2 mL) was added to Novozyme 435 (144 mg) and biphenyl (73 
mg, 0.48 mmol) in a microwave vial and the solution stirred to dissolve the biphenyl. rac-1-
Phenylethylamine (18 µL, 17 mg, 0.14 mmol) and methylmethoxy acetate (14 µL, 15 mg, 
0.14 mmol) were then added and the mixture heated to 60 °C for 30 min under microwave 
conditions. 100 µL samples were taken before and after heating and diluted with 900 µL 
toluene for GC analysis according to the general methods to determine conversion and ee 
(Section 7.5.1). (42% conversion, 59% amine ee). 
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Step 2, N-alkylation: The product solution from Step 1 was filtered through cotton wool into a 
clean microwave vial. Catalyst stock solution (100 µL) and di-isopropylamine (98 µL, 71 mg, 
0.70 mmol) were then added and the mixture heated to 150 °C for 60 min under microwave 
conditions. 100 µL samples were taken before and after heating and diluted with 900 µL 
toluene for GC analysis according to the general methods to determine conversion and ee 
(Section 7.5.1). (12% conversion, 4% N-alkylated yield, amine ee 62%). 
 
7.5.6.4 Testing effect of Novozyme 435 on N-alkylation microwave reactions 
Novozyme 435 filtrate added to N-alkylation, Step 1: Toluene (2 mL) was added to 
Novozyme 435 (144 mg) in a microwave vial and the mixture heated to 60 °C for 30 min 
under microwave conditions. 
Step 2: The solution from Step 1 (1.5 mL) was filtered through cotton wool into a clean 
microwave vial and fresh toluene (0.4 mL) was added to make the total reaction volume up to 
2.0 mL. Catalyst stock solution (100 µL), biphenyl (80 mg, 0.52 mmol), rac-1-
phenylethylamine (18 µL, 17 mg, 0.14 mmol) and di-isopropylamine (98 µL, 71 mg, 0.70 
mmol) were then added and the mixture heated to 150 °C for 60 min under microwave 
conditions. 100 µL samples were taken before and after heating and diluted with 900 µL 
toluene for GC analysis according to the general method to determine conversion (Section 
7.5.1). (15% conversion, 6% N-alkylated yield). 
 
Novozyme 435 added to N-alkylation: Toluene (1.9 mL) was added to catalyst stock solution 
(100 µL), Novozyme 435 (145 mg) and biphenyl (72 mg, 0.46 mmol) in a microwave vial. 
rac-1-Phenylethylamine (18 µL, 17 mg, 0.14 mmol) and di-isopropylamine (98 µL, 71 mg, 
0.70 mmol) were then added and the mixture heated to 150 °C for 60 min under microwave 
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conditions. 100 µL samples were taken before and after heating and diluted with 900 µL 
toluene for GC analysis according to the general methods to determine conversion and ee 
(Section 7.5.1). (11% conversion, 1% N-alkylated yield). 
 
7.5.6.5 Stepwise coupled procedure: continuous resolution with microwave batch N-
alkylation 
Step 1, Resolution: Reaction stock solution was prepared from rac-1-phenylethylamine (3.03 
g, 25.0 mmol), methyl methoxyacetate (2.60 g, 25.0 mmol) and biphenyl (0.77 g, 5.0 mmol) 
dissolved in toluene, up to 25 mL. The stainless steel tubular reactor (1/4” OD, 1/8” ID, 2.8 
mL) was packed with Novozyme 435 (977 mg). The reactor was primed with toluene (1 mL 
min
-1
) and heated to 60 °C. Reaction stock solution was then pumped through the reactor at 
0.47 mL min
-1
 (tRes = 6 min) and samples were collected for each reactor volume, up to 5 
reactor volumes. 100 µL samples were taken before and after heating and diluted with 900 µL 
toluene for GC analysis according to the general methods to determine conversion and ee 
(Section 7.5.1). 
Step 2, N-alkylation: The 5
th
 reactor volume sample from Step 1 (2.0 mL) was added to 
[Cp*IrI2]2 (2.9 mg, 0.0026 mmol) and di-isopropylamine (700 µL, 505 mg, 5.0 mmol) and the 
mixture heated to 150 °C for 60 min under microwave conditions. 100 µL samples were taken 
before and after heating and diluted with 900 µL toluene for GC analysis according to the 
general methods to determine conversion and ee (Section 7.5.1).  
 
7.5.6.6 Coupled procedure: microwave batch heating 
Toluene (9.4 mL) was added to [Cp*IrI2]2 (1.9 mg, 0.0017 mmol) and biphenyl (387 mg, 2.51 
mmol) in a microwave vial. Novozyme 435 (718 mg), rac-1-phenylethylamine (90 µL, 85 
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mg, 0.70 mmol), methyl methoxyacetate (69 µL, 73 mg, 0.70 mmol) and di-isopropylamine 
(491 µL, 355 mg, 3.50 mmol) were then added and the mixture heated to 150 °C for 60 min 
under microwave conditions. 100 µL samples were taken before and after heating and diluted 
with 900 µL toluene for GC analysis according to the general methods to determine 
conversion and ee (Section 7.5.1). (22% conversion, 1% N-alkylated, 18% amine ee, 66% 
amide ee). 
 
7.5.6.7 Testing of filtrate for resolution activity 
Step 1: Toluene (2.5 mL) was added to Novozyme 435 (144 mg) in a microwave vial and the 
mixture heated to 60 °C for 30 min under microwave conditions. 
Step 2: The solution from Step 1 (1.8 mL) was filtered through cotton wool into a clean 
microwave vial and fresh toluene (0.16 mL) was added to make the total reaction volume up 
to 2.0 mL. rac-1-Phenylethylamine (18 µL, 17 mg, 0.14 mmol), methylmethoxy acetate (14 
µL, 15 mg, 0.14 mmol) and biphenyl (76 mg, 0.49 mmol) were then added and the mixture 
heated to 60 °C for 30 min under microwave conditions. 100 µL samples were taken before 
and after heating and diluted with 900 µL toluene for GC analysis according to the general 




8 Appendix A 
Table 42. Results from nicotinamide three-level, three variable CCF design.
a
 
Experiment Run order tRes / min Temperature / °C Catalyst loading / g Methyl nicotinate 
conversion
b




 / % 
1 9 20 40 0.5 32 34 
2 1 60 40 0.5 67 60 
3 3 20 80 0.5 44 41 
4 15 60 80 0.5 81 84 
5 14 20 40 1 51 49 
6 4 60 40 1 86 79 
7 11 20 80 1 75 72 
8 7 60 80 1 95 96 
9 5 20 60 0.75 63 57 
10 17 60 60 0.75 90 90 
11 6 40 40 0.75 64 60 
12 13 40 80 0.75 80 80 
13 8 40 60 0.5 71 68 
14 16 40 60 1 83 84 
15 12 40 60 0.75 80 80 
16 10 40 60 0.75 85 78 
17 2 40 60 0.75 78 74 
a
Reaction conditions: 1.75 mmol methyl nicotinate, 25 mL NH3 solution (0.5 M in 1,4-dioxane), biphenyl added as internal standard, catalyst = N435, reactor volume = 2.8 
mL; 
b










9 Appendix B 































1 11 150 10 0.1 0.1 3 0 0 0 0 
2 13 150 30 0.1 0.1 1 8 3 5 38 
3 6 200 10 0.1 0.1 1 34 7 27 21 
4 17 200 30 0.1 0.1 3 29 10 19 34 
5 15 150 10 0.5 0.1 1 0 0 0 0 
6 19 150 30 0.5 0.1 3 6 0.2 5.8 3 
7 8 200 10 0.5 0.1 3 77 34 43 44 
8 7 200 30 0.5 0.1 1 82 58 24 71 
9 4 150 10 0.1 1 1 3 0.7 2.3 23 
10 1 150 30 0.1 1 3 3 1 2 33 
11 2 200 10 0.1 1 3 47 38 9 81 
12 18 200 30 0.1 1 1 59 46 13 78 
13 9 150 10 0.5 1 3 19 11 8 58 
14 10 150 30 0.5 1 1 39 30 9 77 
15 5 200 10 0.5 1 1 82 63 19 77 
16 14 200 30 0.5 1 3 93 87 6 94 
17 12 175 20 0.3 0.55 2 62 53 9 85 
18 3 175 20 0.3 0.55 2 73 62 11 85 
19 16 175 20 0.3 0.55 2 80 66 14 83 
a
Reaction conditions: rac-1-phenylethylamine, di-isopropylamine, [Cp*IrI2]2, anisole, biphenyl added as internal standard, total reaction volume = 5.0 mL, microwave 
heating; 
b
Determined by achiral GC analysis, after calibration against internal standard; 
c
Determined as (Amine conversion – Desired product); 
d
Determined as (Desired 









































1 15 180 10 0.3 0.5 5 73.5 67.2 6.3 91 
2 11 200 10 0.3 0.5 2 90.0 86.0 4.0 96 
3 4 180 30 0.3 0.5 2 91.0 79.9 11.1 88 
4 8 200 30 0.3 0.5 5 96.9 90.2 6.7 93 
5 14 180 10 0.5 0.5 2 87.1 79.2 7.9 91 
6 9 200 10 0.5 0.5 5 92.8 82.3 10.5 89 
7 5 180 30 0.5 0.5 5 96.8 90.6 6.2 94 
8 13 200 30 0.5 0.5 2 92.8 78.6 14.2 85 
9 16 180 10 0.3 1 2 73.8 65.5 8.3 89 
10 18 200 10 0.3 1 5 96.5 90.6 6.0 94 
11 7 180 30 0.3 1 5 96.9 91.4 5.4 94 
12 6 200 30 0.3 1 2 92.4 78.2 14.3 85 
13 19 180 10 0.5 1 5 96.2 90.6 5.6 94 
14 1 200 10 0.5 1 2 91.9 79.1 12.8 86 
15 2 180 30 0.5 1 2 90.5 84.9 5.6 94 
16 17 200 30 0.5 1 5 97.4 90.6 6.8 93 
17 10 190 20 0.4 0.75 3.5 94.8 87.4 7.4 92 
18 12 190 20 0.4 0.75 3.5 95.4 88.6 6.9 93 
19 3 190 20 0.4 0.75 3.5 95.1 87.8 7.3 92 
a
Reaction conditions: rac-1-phenylethylamine, di-isopropylamine, [Cp*IrI2]2, anisole, biphenyl added as internal standard, total reaction volume = 2.5 mL, microwave 
heating; 
b
Determined by achiral GC analysis, after calibration against internal standard; 
c
Determined as (Amine conversion – Desired product); 
d
Determined as (Desired 










1. D. Ghislieri and N. J. Turner, Top. Catal., 2014, 57, 284-300. 
2. M. Breuer, K. Ditrich, T. Habicher, B. Hauer, M. Keßeler, R. Stürmer and T. 
Zelinski, Angew. Chem. Int. Ed., 2004, 43, 788-824. 
3. P. T. Anastas and J. C. Warner, Green Chemistry: Theory and Practice, 1st edn., 
Oxford University Press, 1998. 
4. P. T. Anastas and M. M. Kirchhoff, Acc. Chem. Res., 2002, 35, 686-694. 
5. Comprehensive asymmetric catalysis, eds. E. N. Jacobsen, A. Pfaltz and H. 
Yamamoto, Springer-Verlag Berlin Heidelberg, 1999. 
6. R. Noyori, Chem. Soc. Rev., 1989, 18, 187-208. 
7. M. Kitamura, T. Ohkuma, S. Inoue, N. Sayo, H. Kumobayashi, S. Akutagawa, T. 
Ohta, H. Takaya and R. Noyori, J. Am. Chem. Soc., 1988, 110, 629-631. 
8. T. Ohkuma, H. Ooka, S. Hashiguchi, T. Ikariya and R. Noyori, J. Am. Chem. Soc., 
1995, 117, 2675-2676. 
9. W. S. Knowles, Acc. Chem. Res., 1983, 16, 106-112. 
10. W. S. Knowles, J. Chem. Educ., 1986, 63, 222. 
11. R. Noyori, Angew. Chem. Int. Ed., 2002, 41, 2008-2022. 
12. W. S. Knowles, Angew. Chem. Int. Ed., 2002, 41, 1998-2007. 
13. J.-H. Xie, S.-F. Zhu and Q.-L. Zhou, Chem. Rev., 2011, 111, 1713-1760. 
14. K. Huang, S. Li, M. Chang and X. Zhang, Org. Lett., 2013, 15, 484-487. 
15. S. Gladiali and E. Alberico, Chem. Soc. Rev., 2006, 35, 226-236. 
16. S. Hashiguchi, A. Fujii, J. Takehara, T. Ikariya and R. Noyori, J. Am. Chem. Soc., 
1995, 117, 7562-7563. 
17. R. Noyori and S. Hashiguchi, Acc. Chem. Res., 1997, 30, 97-102. 
18. T. Ikariya and A. J. Blacker, Acc. Chem. Res., 2007, 40, 1300-1308. 
19. X. Wu, X. Li, A. Zanotti-Gerosa, A. Pettman, J. Liu, A. J. Mills and J. Xiao, Chem. 
Eur. J., 2008, 14, 2209-2222. 
20. A. J. Blacker and P. Thompson, in Asymmetric Catalysis on Industrial Scale: 
Challenges, Approaches and Solutions, eds. H.-U. Blaser and H.-J. Federsel, 
Wiley-VCH, 2nd edn., 2010, pp. 265-290. 
21. X. Sun and A. Gavriilidis, Org. Process. Res. Dev., 2008, 12, 1218-1222. 
22. M. Zanfir, X. Sun and A. Gavriilidis, Chem. Eng. Sci., 2007, 62, 741-755. 
23. A. Fujii, S. Hashiguchi, N. Uematsu, T. Ikariya and R. Noyori, J. Am. Chem. Soc., 
1996, 118, 2521-2522. 
24. N. Uematsu, A. Fujii, S. Hashiguchi, T. Ikariya and R. Noyori, J. Am. Chem. Soc., 
1996, 118, 4916-4917. 
25. G. K. M. Verzijl, A. H. M. de Vries, J. G. de Vries, P. Kapitan, T. Dax, M. Helms, 
Z. Nazir, W. Skranc, C. Imboden, J. Stichler, R. A. Ward, S. Abele and L. Lefort, 
Org. Process. Res. Dev., 2013, 17, 1531-1539. 
26. X. Wu, C. Wang and J. Xiao, Platinum Metals Rev., 2010, 54, 3-19. 
27. X. Li, J. Blacker, I. Houson, X. Wu and J. Xiao, Synlett, 2006, 2006, 1155-1160. 
28. O. Saidi, A. J. Blacker, M. M. Farah, S. P. Marsden and J. M. J. Williams, Chem. 
Commun., 2010, 46, 1541-1543. 
29. O. Saidi, A. J. Blacker, M. M. Farah, S. P. Marsden and J. M. J. Williams, Angew. 
Chem. Int. Ed., 2009, 48, 7375-7378. 
30. K.-i. Fujita, Z. Li, N. Ozeki and R. Yamaguchi, Tet. Lett., 2003, 44, 2687-2690. 
31. S. Bähn, D. Hollmann, A. Tillack and M. Beller, Adv. Synth. Catal., 2008, 350, 
2099-2103. 
32. Y. Zhang, C.-S. Lim, D. S. B. Sim, H.-J. Pan and Y. Zhao, Angew. Chem. Int. Ed., 




33. F. Leipold, S. Hussain, D. Ghislieri and N. J. Turner, ChemCatChem, 2013, 5, 
3505-3508. 
34. D. Ghislieri, A. P. Green, M. Pontini, S. C. Willies, I. Rowles, A. Frank, G. Grogan 
and N. J. Turner, J. Am. Chem. Soc., 2013, 135, 10863-10869. 
35. N. J. Turner, Nat. Chem. Biol., 2009, 5, 567-573. 
36. V. Köhler, K. R. Bailey, A. Znabet, J. Raftery, M. Helliwell and N. J. Turner, 
Angew. Chem. Int. Ed., 2010, 49, 2182-2184. 
37. T. Li, J. Liang, A. Ambrogelly, T. Brennan, G. Gloor, G. Huisman, J. Lalonde, A. 
Lekhal, B. Mijts, S. Muley, L. Newman, M. Tobin, G. Wong, A. Zaks and X. 
Zhang, J. Am. Chem. Soc., 2012, 134, 6467-6472. 
38. D. Ghislieri, D. Houghton, A. P. Green, S. C. Willies and N. J. Turner, ACS Catal., 
2013, 3, 2869-2872. 
39. M. J. Abrahamson, E. Vázquez-Figueroa, N. B. Woodall, J. C. Moore and A. S. 
Bommarius, Angew. Chem. Int. Ed., 2012, 51, 3969-3972. 
40. C. K. Savile, J. M. Janey, E. C. Mundorff, J. C. Moore, S. Tam, W. R. Jarvis, J. C. 
Colbeck, A. Krebber, F. J. Fleitz, J. Brands, P. N. Devine, G. W. Huisman and G. J. 
Hughes, Science, 2010, 329, 305-309. 
41. M. D. Truppo, N. J. Turner and J. D. Rozzell, Chem. Commun., 2009, 2127-2129. 
42. L. Pasteur, Comptes Rendus Hebdomadaires des Seances de l’Academie des 
Sciences, 1853, 37. 
43. A. J. Blacker, S. Brown, B. Clique, B. Gourlay, C. E. Headley, S. Ingham, D. 
Ritson, T. Screen, M. J. Stirling, D. Taylor and G. Thompson, Org. Process. Res. 
Dev., 2009, 13, 1370-1378. 
44. F. W. Reimherr, W. F. Byerley, M. F. Ward, B. J. Lebegue and P. H. Wender, 
Psychopharmacology Bulletin, 1988, 24, 200-205. 
45. A. Ghanem and H. Y. Aboul-Enein, Chirality, 2005, 17, 1-15. 
46. A. S. de Miranda, L. S. M. Miranda and R. O. M. A. de Souza, Biotechnol. Adv., 
2015, 33, 372-393. 
47. H. Kitaguchi, P. A. Fitzpatrick, J. E. Huber and A. M. Klibanov, J. Am. Chem. Soc., 
1989, 111, 3094-3095. 
48. E. Juaristi, J. Escalante, J. L. León-Romo and A. Reyes, Tetrahedron: Asymm., 
1998, 9, 715-740. 
49. E. Juaristi, J. L. León-Romo, A. Reyes and J. Escalante, Tetrahedron: Asymm., 
1999, 10, 2441-2495. 
50. Novozymes, Immobilised lipase enzymes, 
http://www.novozymes.com/en/solutions/pharmaceuticals/biocatalysis/immobilized
-lipase-enzymes, Accessed 14th February 2017. 
51. M. T. Reetz and C. Dreisbach, CHIMIA International Journal for Chemistry, 1994, 
48, 570-570. 
52. V. Gotor-Fernández, R. Brieva and V. Gotor, J. Mol. Catal. B, 2006, 40, 111-120. 
53. O. Verho and J.-E. Bäckvall, J. Am. Chem. Soc., 2015, 137, 3996-4009. 
54. C. E. Hoben, L. Kanupp and J.-E. Bäckvall, Tet. Lett., 2008, 49, 977-979. 
55. G. F. Breen, Tetrahedron: Asymm., 2004, 15, 1427-1430. 
56. O. Pàmies and J.-E. Bäckvall, Trends Biotechnol., 2004, 22, 130-135. 
57. A. J. Blacker, M. J. Stirling and M. I. Page, Org. Process. Res. Dev., 2007, 11, 642-
648. 
58. S. Murahashi, N. Yoshimura, T. Tsumiyama and T. Kojima, J. Am. Chem. Soc., 
1983, 105, 5002-5011. 
59. M. T. Reetz and K. Schimossek, CHIMIA 1996, 50, 668-669. 





61. A. N. Parvulescu, E. Van der Eycken, P. A. Jacobs and D. E. De Vos, J. Catal., 
2008, 255, 206-212. 
62. A. N. Parvulescu, P. A. Jacobs and D. E. De Vos, Adv. Synth. Catal., 2008, 350, 
113-121. 
63. A. L. E. Larsson, B. A. Persson and J.-E. Bäckvall, Angewandte Chemie 
International Edition in English, 1997, 36, 1211-1212. 
64. B. A. Persson, A. L. E. Larsson, M. Le Ray and J.-E. Bäckvall, J. Am. Chem. Soc., 
1999, 121, 1645-1650. 
65. O. Pàmies, A. H. Éll, J. S. M. Samec, N. Hermanns and J.-E. Bäckvall, Tet. Lett., 
2002, 43, 4699-4702. 
66. L. K. Thalén, D. Zhao, J.-B. Sortais, J. Paetzold, C. Hoben and J.-E. Bäckvall, 
Chem. Eur. J., 2009, 15, 3403-3410. 
67. O. Verho, E. V. Johnston, E. Karlsson and J.-E. Bäckvall, Chem. Eur. J., 2011, 17, 
11216-11222. 
68. C. A. Denard, J. F. Hartwig and H. Zhao, ACS Catal., 2013, 3, 2856-2864. 
69. K. Engström, E. V. Johnston, O. Verho, K. P. J. Gustafson, M. Shakeri, C.-W. Tai 
and J.-E. Bäckvall, Angewandte Chemie (International Ed. in English), 2013, 52, 
14006-14010. 
70. E. V. Johnston, O. Verho, M. D. Kärkäs, M. Shakeri, C.-W. Tai, P. Palmgren, K. 
Eriksson, S. Oscarsson and J.-E. Bäckvall, Chem. Eur. J., 2012, 18, 12202-12206. 
71. L. K. Thalén and J.-E. Bäckvall, Beilstein J. Org. chem., 2010, 6, 823-829. 
72. M. Stirling, J. Blacker and M. I. Page, Tet. Lett., 2007, 48, 1247-1250. 
73. F. Darvas and D. György, in Flow Chemistry, Volume 1: Fundamentals, eds. F. 
Darvas, G. Dorman and V. Hessel, De Gruyter, 2014, pp. 9-58. 
74. V. Hessel, D. Kralisch, N. Kockmann, T. Noël and Q. Wang, ChemSusChem, 2013, 
6, 746-789. 
75. D. Webb and T. F. Jamison, Chem. Sci., 2010, 1, 675-680. 
76. A. Adamo, P. L. Heider, N. Weeranoppanant and K. F. Jensen, Ind. Eng. Chem. 
Res., 2013, 52, 10802-10808. 
77. D. R. Snead and T. F. Jamison, Angew. Chem. Int. Ed., 2015, 54, 983-987. 
78. D. C. Fabry, E. Sugiono and M. Rueping, React. Chem. Eng., 2016, 1, 129-133. 
79. N. Holmes, G. R. Akien, R. J. D. Savage, C. Stanetty, I. R. Baxendale, A. J. 
Blacker, B. A. Taylor, R. L. Woodward, R. E. Meadows and R. A. Bourne, React. 
Chem. Eng., 2016, 1, 96-100. 
80. C. R. Matte, C. Bordinhão, J. K. Poppe, R. C. Rodrigues, P. F. Hertz and M. A. Z. 
Ayub, J. Mol. Catal. B, 2016, 127, 67-75. 
81. O. Levenspiel, Chemical Reaction Engineering, 3rd edn., John Wiley & Sons, 
1999. 
82. G. W. Lamb, F. A. Al Badran, J. M. J. Williams and S. T. Kolaczkowski, Chemical 
Engineering Research and Design, 2010, 88, 1533-1540. 
83. N. Zotova, F. J. Roberts, G. H. Kelsall, A. S. Jessiman, K. Hellgardt and K. K. Hii, 
Green Chem., 2012, 14, 226-232. 
84. L. H. Andrade, W. Kroutil and T. F. Jamison, Org. Lett., 2014, 16, 6092-6095. 
85. I. Itabaiana Jr, L. S. de Mariz e Miranda and R. O. M. A. de Souza, J. Mol. Catal. 
B, 2013, 85–86, 1-9. 
86. K. Frings, M. Koch and W. Hartmeier, Enzyme and Microbial Technology, 1999, 
25, 303-309. 
87. C. Csajági, G. Szatzker, E. Rita Tőke, L. Ürge, F. Darvas and L. Poppe, 
Tetrahedron: Asymm., 2008, 19, 237-246. 
88. C. Thomas Juliana, D. Burich Martha, T. Bandeira Pamela, R. Marques de Oliveira 




89. A. Sánchez, F. Valero, J. Lafuente and C. Solà, Enzyme and Microbial Technology, 
2000, 27, 157-166. 
90. J.-C. Chen and S.-W. Tsai, Biotechnology Progress, 2000, 16, 986-992. 
91. ThalesNano, ThalesNano Flow Chemistry Reactors, http://thalesnano.com/, 
Accessed 14th May 2017. 
92. A. S. de Miranda, L. S. M. Miranda and R. O. M. A. de Souza, Org. Biomol. 
Chem., 2013, 11, 3332-3336. 
93. C. Roengpithya, D. A. Patterson, A. G. Livingston, P. C. Taylor, J. L. Irwin and M. 
R. Parrett, Chem. Commun., 2007, 3462-3463. 
94. A. S. de Miranda, R. O. M. A. de Souza and L. S. M. Miranda, RSC Adv., 2014, 4, 
13620-13625. 
95. A. S. de Miranda, M. V. de M. Silva, F. C. Dias, S. P. de Souza, R. A. C. Leao and 
R. O. M. A. de Souza, React. Chem. Eng., 2017. 
96. S. Wuyts, J. Wahlen, P. A. Jacobs and D. E. De Vos, Green Chem., 2007, 9, 1104-
1108. 
97. WHO, WHO Model List of Essential Medicines, 
http://www.who.int/medicines/publications/essentialmedicines/en/, Accessed 23rd 
June 2016. 
98. D. Mandala, S. Chada and P. Watts, Org. Biomol. Chem., 2017, 15, 3444-3454. 
99. J. Verghese, C. Kong, D. Rivalti, E. Yu, R. Krack, J. Alcazar, J. B. Manley, D. T. 
McQuade, S. Ahmad, K. Belecki and F. Gupton, Green Chem., 2017. 
100. A. Adamo, R. L. Beingessner, M. Behnam, J. Chen, T. F. Jamison, K. F. Jensen, J.-
C. M. Monbaliu, A. S. Myerson, E. M. Revalor, D. R. Snead, T. Stelzer, N. 
Weeranoppanant, S. Y. Wong and P. Zhang, Science, 2016, 352, 61-67. 
101. R. Munirathinam, J. Huskens and W. Verboom, Adv. Synth. Catal., 2015, 357, 
1093-1123. 
102. S. J. Fletcher and C. M. Rayner, Tet. Lett., 1999, 40, 7139-7142. 
103. R. E. Gawley, J. Org. Chem., 2006, 71, 2411-2416. 
104. M. Cammenberg, K. Hult and S. Park, ChemBioChem, 2006, 7, 1745-1749. 
105. M. C. de Zoete, F. van Rantwijk and R. A. Sheldon, Catalysis Today, 1994, 22, 
563-590. 
106. L. Michaelis and M. L. Menten, Biochemische Zeitschrift, 1913, 49, 333-369. 
107. K. A. Johnson and R. S. Goody, Biochemistry, 2011, 50, 8264-8269. 
108. D. N. Jumbam, R. A. Skilton, A. J. Parrott, R. A. Bourne and M. Poliakoff, J. Flow 
Chem., 2012, 2, 24-27. 
109. R. A. Sheldon, Green Chem., 2007, 9, 1273-1283. 
110. M.-J. Kim, W.-H. Kim, K. Han, Y. K. Choi and J. Park, Org. Lett., 2007, 9, 1157-
1159. 
111. K. P. J. Gustafson, R. Lihammar, O. Verho, K. Engström and J.-E. Bäckvall, J. 
Org. Chem., 2014, 79, 3747-3751. 
112. J. Paetzold and J. E. Bäckvall, J. Am. Chem. Soc., 2005, 127, 17620-17621. 
113. A. C. Eliot and J. F. Kirsch, Annual Review of Biochemistry, 2004, 73, 383-415. 
114. S. J. Lucas, B. D. Crossley, A. J. Pettman, A. D. Vassileiou, T. E. O. Screen, A. J. 
Blacker and P. C. McGowan, Chem. Commun., 2013, 49, 5562-5564. 
115. M. J. Stirling, J. M. Mwansa, G. Sweeney, A. J. Blacker and M. I. Page, Org. 
Biomol. Chem., 2016, 14, 7092-7098. 
116. P. G. A. Winkworth and A. J. Blacker, Unpublished Results. 
117. J. R. Breen, M. T. H. Kwan and A. J. Blacker, Unpublished Results. 
118. J.-S. Im, S.-H. Ahn and Y.-H. Park, Chemical Engineering Journal, 2013, 234, 49-
56. 
119. ThalesNano, H-Cube Continuous-flow Hydrogenation Reactor, 




120. M. R. Chapman, M. H. T. Kwan, G. King, K. E. Jolley, M. Hussain, S. Hussain, I. 
E. Salama, C. González Niño, L. A. Thompson, M. E. Bayana, A. D. Clayton, B. N. 
Nguyen, N. J. Turner, N. Kapur and A. J. Blacker, Org. Process. Res. Dev., 2017. 
121. C. Astorga, F. Rebolledo and V. Gotor, Synthesis, 1993, 1993, 287-289. 
122. M. A. P. J. Hacking, F. van Rantwijk and R. A. Sheldon, J. Mol. Catal. B, 2001, 11, 
315-321. 
123. F. Björkling, H. Frykman, S. E. Godtfredsen and O. Kirk, Tetrahedron, 1992, 48, 
4587-4592. 
124. E. G. Ankudey, H. F. Olivo and T. L. Peeples, Green Chem., 2006, 8, 923-926. 
125. S. Ranganathan, T. Gärtner, L. O. Wiemann and V. Sieber, J. Mol. Catal. B, 2015, 
114, 72-76. 
126. M. C. de Zoete, A. C. K.-v. Dalen, F. van Rantwijk and R. A. Sheldon, J. Chem. 
Soc., Chem. Commun., 1993, 1831-1832. 
127. M. C. de Zoete, A. C. Kock-van Dalen, F. van Rantwijk and R. A. Sheldon, J. Mol. 
Catal. B, 1996, 2, 19-25. 
128. M. A. P. J. Hacking, M. A. Wegman, J. Rops, F. van Rantwijk and R. A. Sheldon, 
J. Mol. Catal. B, 1998, 5, 155-157. 
129. M. A. Wegman, M. A. P. J. Hacking, J. Rops, P. Pereira, F. van Rantwijk and R. A. 
Sheldon, Tetrahedron: Asymm., 1999, 10, 1739-1750. 
130. W. F. Slotema, G. Sandoval, D. Guieysse, A. J. J. Straathof and A. Marty, 
Biotechnol. Bioeng., 2003, 82, 664–669. 
131. S. Luque, J. R. Álvarez and F. P. Cuperus, J. Mol. Catal. B, 2014, 107, 73-78. 
132. R. Chuck, Applied Catalysis A: General, 2005, 280, 75-82. 
133. T. Nagasawa, C. D. Mathew, J. Mauger and H. Yamada, Applied and 
Environmental Microbiology, 1988, 54, 1766-1769. 
134. Eur. Pat., EP0307926 (A2), 1989. 
135. Eur. Pat., EP0770687 A3, 1998. 
136. N. M. Shaw, K. T. Robins and A. Kiener, Adv. Synth. Catal., 2003, 345, 425–435. 
137. R. K. Henderson, C. Jimenez-Gonzalez, D. J. C. Constable, S. R. Alston, G. G. A. 
Inglis, G. Fisher, J. Sherwood, S. P. Binks and A. D. Curzons, Green Chem., 2011, 
13, 854-862. 
138. M. R. Owen, C. Luscombe, Lai, S. Godbert, D. L. Crookes and D. Emiabata-Smith, 
Org. Process. Res. Dev., 2001, 5, 308-323. 
139. G. E. P. Box, W. G. Hunter and J. S. Hunter, in Statistics for Experimenters, Wiley, 
1st edn., 1978, pp. 510-539. 
140. Umetrics, User guide to MODDE, Version 10.1, 
http://mksdataanalytics.com/sites/default/files/downloads/1/user_guide_to_modde_
10.1.pdf, Accessed 2nd February 2017. 
141. A. M. Klibanov, Nature, 2001, 409, 241-246. 
142. P. J. Halling, Philosophical Transactions of the Royal Society of London. Series B: 
Biological Sciences, 2004, 359, 1287-1297. 
143. C. Jimenez-Gonzalez, C. S. Ponder, Q. B. Broxterman and J. B. Manley, Org. 
Process. Res. Dev., 2011, 15, 912-917. 
144. WHO, WHO Media Centre Fact Sheet - Tuberculosis, 
http://www.who.int/mediacentre/factsheets/fs104/en/, Accessed 17th February 
2017. 
145. S. A. Hall and P. E. Spoerri, J. Am. Chem. Soc., 1940, 62, 664-665. 
146. A. S. Suresh, P. Baburajan and M. Ahmed, Tet. Lett., 2015, 56, 4864-4867. 
147. U. S. D. o. H. a. H. S. F. a. D. Administration, 2015. 
148. R. J. Ingham, C. Battilocchio, J. M. Hawkins and S. V. Ley, Beilstein J. Org. 




149. P. López-Serrano, M. A. Wegman, F. van Rantwijk and R. A. Sheldon, 
Tetrahedron: Asymm., 2001, 12, 235-240. 
150. L. H. Andrade, B. A. Sousa and T. F. Jamison, J. Flow Chem., 2016, 6, 67-72. 
151. V. Hessel, S. Hardt and H. Löwe, in Chemical Micro Process Engineering: 
Fundamentals, Modelling and Reactions, Wiley-VCH, 10th edn., 2004. 
152. G. E. P. Box and J. S. Hunter, Technometrics, 2000, 42, 28-47. 
153. G. E. P. Box and J. S. Hunter, Technometrics 1961, 3, 449-458. 
154. G. E. P. Box and D. W. Behnken, Technometrics, 1960, 2, 455-475. 
155. T. N. Glasnov and C. O. Kappe, Chem. Eur. J., 2011, 17, 11956-11968. 
156. N. Kim, S.-B. Ko, M. S. Kwon, M.-J. Kim and J. Park, Org. Lett., 2005, 7, 4523-
4526. 
157. S. B. Ötvös, I. M. Mándity and F. Fülöp, J. Catal., 2012, 295, 179-185. 
158. M. J. Burk, Y. M. Wang and J. R. Lee, J. Am. Chem. Soc., 1996, 118, 5142-5143. 
159. L. K. Thalén, C. Roesch and J.-E. Bäckvall, Organic Syntheses, 2012, 89, 255-266. 
160. M. Päiviö, P. Perkiö and L. T. Kanerva, Tetrahedron: Asymm., 2012, 23, 230-236. 
161. A. Chighine, S. Crosignani, M.-C. Arnal, M. Bradley and B. Linclau, J. Org. 
Chem., 2009, 74, 4753-4762. 
162. N. Mistry and S. P. Fletcher, Adv. Synth. Catal., 2016, 358, 2489-2496. 
163. C. B. P. Ligiero, L. C. Visentin, R. Giacomini, C. A. L. Filgueiras and P. C. M. L. 
Miranda, Tet. Lett., 2009, 50, 4030-4032. 
164. J. E. Taylor, M. D. Jones, J. M. J. Williams and S. D. Bull, J. Org. Chem., 2012, 
77, 2808-2818. 
 
 
